Investigating the mechanisms of silver nanoparticle toxicity in Daphnia magna: a multi-omics approach by Gavin, Alex
  
i 
 
 
 
 
 
Investigating the Mechanisms of Silver Nanoparticle Toxicity in 
Daphnia magna: A Multi-Omics Approach 
 
By 
 
Alex Gavin 
 
 
A thesis submitted to 
The University of Birmingham 
 for the degree of  
DOCTOR OF PHILOSOPHY 
 
 
 
 
 
 
School of Biosciences 
College of Life and Environmental Sciences 
University of Birmingham 
September 2014 
  
 
 
 
 
 
 
 
 
 
University of Birmingham Research Archive 
 
e-theses repository 
 
 
This unpublished thesis/dissertation is copyright of the author and/or third 
parties. The intellectual property rights of the author or third parties in respect 
of this work are as defined by The Copyright Designs and Patents Act 1988 or 
as modified by any successor legislation.   
 
Any use made of information contained in this thesis/dissertation must be in 
accordance with that legislation and must be properly acknowledged.  Further 
distribution or reproduction in any format is prohibited without the permission 
of the copyright holder.  
 
 
 
  
ii 
 
Abstract 
Silver nanoparticles (AgNPs), one of the most common nanomaterials in use today, have 
been shown to enter the aquatic environment through use of commercially obtained 
products. Although toxicity to aquatic organisms has been demonstrated, there is still 
uncertainty surrounding the molecular mechanism of AgNP-induced toxicity. The work 
presented in this thesis investigates the hypothesis that AgNP toxicity is induced indirectly 
through the release of ionic silver (Ag+) upon dissolution.  The mechanism of AgNP 
toxicity would therefore be identical to that induced by dissolved silver. This hypothesis 
was tested through the comparison of the molecular-level changes in Daphnia magna, a 
global keystone species of freshwater ecosystems, induced by AgNP and AgNO3 exposure. 
Through use of Agilent microarray transcriptomics and direct-infusion mass spectrometry 
metabolomics, the same molecular profile changes were observed in D. magna exposed to 
AgNPs and to the dissolved Ag fraction alone. However, a greater magnitude of effect was 
observed in AgNP exposures. The measurement of the uptake and depuration of both 
forms of silver suggested the increased magnitude of molecular response to AgNP 
exposure fit a Trojan-horse type mechanism.  Therefore, AgNPs absorbed by D. magna, 
resulted in higher internal concentration of toxic Ag+. Further investigation into the 
mechanism of AgNP toxicity revealed significant changes to constituents of the purine 
metabolism pathway.  Additionally, measurement of the expression of glutathione-S-
transferase and heme-oxygenase 1 (traditional markers for oxidative stress) by quantitative 
RT-PCR showed no significant changes.  This suggested that if oxidative stress was a 
primary mechanism of AgNP toxicity in D. magna, the transcriptional response may not be 
through well-conserved anti-oxidant enzymes. Overall, this research advances the 
mechanistic understanding of AgNP toxicity to aquatic organisms, and highlights the 
ability of omics technologies to provide unique insights into mechanisms of toxicity.  
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Chapter 1: General Introduction 
1.1 Nanotechnologies and the emergence of Nanotoxicology 
Nanotechnology has become of huge interest, both industrially and politically, over the 
past decade and has amassed billions of dollars in investment (Wardak et al., 2007).  This 
has led to a wide range of available nanomaterials and an equally wide range of 
applications that make use of their unique size-related properties.  For example, the use of 
TiO2 nanoparticles as UV filters in sunscreens (Johnson et al., 2011) and as photocatalytic 
degrading agents in self-cleaning windows (Parkin and Palgrave, 2005), carbon nanotubes 
as high tensile strength fibres, cerium dioxide nanoparticles as a diesel fuel additive and 
constituent of catalytic converters (Bekyarova et al., 1998), and an increasing number of 
products which benefit from the antimicrobial properties of silver nanoparticles (AgNPs) 
(Chaloupka et al., 2010).  This is just a handful of examples of the products known to 
contain nanomaterials; 1827 products are currently listed on the nanotechnology consumer 
product inventory (http://www.nanotechproject.org/cpi/) (Vance et al., 2015) and that 
number is certain to rise.   
Despite an increasing body of literature in nanotechnology and nanotoxicology, there is 
still, as of yet, no single internationally agreed definition of a nanomaterial with individual 
organisations each providing their own interpretation of a definition.  These definitions 
have gradually expanded and developed over time.  Early definitions of nanomaterials 
were based principally on size parameters alone (Kreyling et al., 2010), for example, the 
British Standards Institution (BSI) (British Standards Institution, 2007) and the 
International Organisation for Standardisation (ISO) (ISO, 2010) define nanomaterials 
simply as materials with one or more external dimensions in the nanoscale (British 
Standards Institution, 2007).  The ISO also includes materials with internal structures or 
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surface structures within the nanoscale (ISO, 2010).  Both of these institutions define the 
nanoscale as a size range from approximately 1 nm to 100 nm (British Standards 
Institution 2007; ISO, 2010), a definition which was first held by the Scientific Committee 
on Emerging and Newly Identified Health Risks (SCENIHR).  To put things in 
perspective, the smallest particles in this scale would be of similar size to a molecule of 
glucose, whereas the largest molecules would be of similar size to coated vesicles and 
some virus molecules.  In practice however, this range is arbitrary and there is no scientific 
evidence to date that clearly defines a size cut-off where the characteristic effects of 
nanomaterials begin to appear (Bleeker et al., 2013; Horbach et al., 2014). 
These simplistic definitions of nanomaterials have since been deemed inadequate by some 
institutions.  Recent recommendations given by both SCENIHR (2010) and the EC (2011), 
include the number size distribution of the material as an additional tool to aid 
classification.  The number size distribution represents the number of particles within a 
given size range, and is used to account for the poly-disperse nature of nanomaterials. 
SCENIHR recommends that if greater than 0.15 % of a material contains dimensions 
within the nanoscale, then it may be classified as a nanomaterial (SCENIHR, 2010).  The 
EU definition published in 2011 (EU, 2011) recommends that this threshold be increased 
to 50 %.  Particle aggregates and agglomerates are often not considered as nanomaterials, 
however the EU recommended definition recognises that agglomerates and aggregates 
may exhibit the same properties as disperse particles and therefore includes them if 
constituent particles are in the nanoscale.   
The necessity for a definition arises from the growing recognition that some nanomaterials 
may be hazardous to human and environmental health (Bleeker et al., 2013). As such a 
definition will be necessary should legislation be required for their regulation.  It has been 
found that nanomaterials often display physical and chemical properties which can be 
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substantially different from those of their bulk counterparts.  These unique properties are 
thought to arise from the increased available surface area that a given mass of 
nanoparticles has when compared to the same mass of bulk-scale particles.  Currently, 
there is no specific legislation surrounding the regulation of nanomaterials.  The main 
concern regarding this lack of regulation is that as well as beneficial effects, the nanoscale 
could also bestow a “nanostructure-dependant biological activity” (Oberdörster et al., 
2005b), which could result in the amplification of any inherent toxic properties that are 
otherwise unseen in the substance at larger scales.  There is also concern surrounding the 
potential of particles at the lower end of the scale being able to cross biological membranes 
with relative ease.  This property has been shown in multiple particle types (Geiser et al., 
2005; Ryman-Rasmussen et al., 2009; Bhabra et al., 2009), and in some cases has been 
used to our benefit in the areas of nanomedicine and drug delivery (Roy and Vij, 2010; 
Couvreur, 2013). 
Although engineered nanomaterials are relatively new, the idea that a substance can 
become toxic simply by being at a reduced scale is not; particle toxicology is a well-
established discipline, and it is two paradigms of this science, quartz and asbestos, that 
formed the basis of research into nanomaterial toxicity (Seaton et al., 2010).  In their larger 
crystalline forms, these two substances are inert, however, if inhaled in powder form these 
two substances become toxic, with asbestos responsible for over 4,000 deaths in the UK in 
2011 alone (http://www.hse.gov.uk/statistics/causdis/asbestos.htm).  They also serve as a 
reminder that in the advancement of technology, thorough assessment of potential risks 
and hazards that any new technology may present should not be forfeit (Seaton et al., 
2010).  The discipline of nanotoxicology was therefore created to investigate the potential 
threats that widespread use of nanoparticles may present to humans and the wider 
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environment (Donaldson et al., 2004) with the aim of better risk assessment and regulation 
for nanomaterials. 
1.2 Silver nanoparticles: The most commercially prominent nanomaterial 
AgNPs have become one of the most commercially available varieties of nanomaterial due 
to their ease of manufacture and potent antimicrobial properties. They are found in a 
growing list of medical (Chen and Schluesener, 2008; Rai et al., 2009; Chaloupka et al., 
2010) and consumer-based (Chaudhry et al., 2008) products with 442 products currently 
listed as containing AgNPs on the nanotechnology consumer product inventory 
(http://www.nanotechproject.org/cpi/) (Vance et al., 2015). Products containing silver salts 
(such as silver nitrate)  have been recognised for their medicinal properties since ancient 
times and until the widespread use of antibiotics in the 1940s, were the antiseptic treatment 
of choice for burns and open wounds.  AgNPs are a much more recent addition though 
arguably have been used as antimicrobial agents in the form of colloidal silver for over 100 
years (Nowack et al., 2011).  In the past decade the use of AgNPs has increased 
dramatically, partially in response to increasing numbers of antibiotic-resistant strains of 
bacteria (Rai et al., 2012).  As well as being potent bactericides (reviewed in Rai et al., 
2012 and Mijnendonckx et al., 2013), they have shown anti-fungal (Chladek et al., 2011) 
as well as anti-viral properties (Rogers et al., 2008; De Gusseme et al., 2011).  As a direct 
consequence of their growing use there is an increased likelihood of AgNPs entering the 
aquatic environment.  Prior to the development and use of AgNPs, the primary source of 
Ag contamination was from the photographic industry, as well as from mining and 
leaching from natural sources (Purcell and Peters, 1998).  The environmental 
concentrations of Ag in natural waters have been measured in the ng/L range (Luoma, 
2008; Gottschalk et al., 2013).  The points of AgNP environmental contamination are most 
likely during synthesis, during the incorporation of AgNPs into products and through the 
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use and disposal of these products (Fabrega et al., 2011).  Experimental evidence has 
identified their release from the washing of commercially available sock fabrics into waste 
water (Benn and Westerhoff, 2008; Geranio et al., 2009), as well as from outdoor facades 
coated in nano-silver paints in rainwater runoff (Kaegi et al., 2010).  Despite evidence of 
their release, there is a lack of experimental data on the exact environmental 
concentrations due to a lack of analytical methods available for quantification of trace 
concentrations of nanoparticles (Mueller and Nowack, 2008).  This has subsequently led to 
a number of modelling studies in an attempt to predict environmental conditions from 
limited measurements or effluent data (reviewed in Gottshalk et al., 2013).  
These studies suggest that freshwater ecosystems are likely to act as terminal sinks for 
AgNP products, which raises concerns for the potential effects that these products may 
have on organisms within these ecosystems.  Although the toxicity of AgNPs to aquatic 
organisms is not fully understood, dissolved Ag is a well-known, highly potent aquatic 
toxicant.  If we use this prior knowledge as a baseline for our assessment of AgNPs, then 
obtaining a detailed understanding of the exact risks posed by AgNPs to the environment 
should become a priority.  
1.2.1 The toxicity of dissolved silver 
The toxicity of a substance is ultimately determined by the level of exposure an organism 
has to that particular toxicant and the amount that is available for internalisation over time.  
The availability of metals in the aqueous environment is primarily dependant on their 
speciation – the distribution of a metal between its ionic or ligand-bound forms (Luoma, 
2008).  As a rule of thumb, it is usually the free metal ion which is the most toxic form, 
with reductions in toxicity observed for ion-complexes with dissolved organic matter and 
inorganic cations.  For example, the free ion form of silver (Ag+) is easily adsorbed into an 
organism’s cells through ion transport proteins which normally transport the essential ions 
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sodium (Na+) and copper (transported as Cu1+) (Bury and Wood, 1999; Fabrega et al., 
2011).   
It is the relative ease with which Ag+ are internalised into the cells of organisms which 
results in their high toxicity.  If the uptake of these ions is prevented, then their 
bioavailability and hence their toxicity is reduced. The free Ag+ ion can form strong 
complexes with organic and inorganic ligands such as the chloride anion (Cl-) and 
sulfhydryl groups (-SH), which can either be free in solution or incorporated within 
dissolved organic materials (Adams and Kramer, 1998; Luoma, 2008).  In environments 
where these ligands are present in greater concentrations than Ag+, it is possible for all 
silver to complex with these materials and precipitate out of solution, rendering them non-
toxic and unavailable for uptake by organisms (Leblanc et al., 1984; Erikson et al., 1997; 
Bianchini and Wood, 2008).  In these instances silver cannot enter cells through ion-
transport proteins leaving them less available for adsorption than the free ionic form.  
However it is still possible for these forms of silver to enter an organism’s cells by 
alternative pathways such as endocytosis.  As a consequence of this decreased 
bioavailability, complexed silver ions are less toxic than their free counterparts (Bianchini 
and Wood, 2008).   
Following internalisation, Ag+ ions are free to induce toxicity through interaction with 
cellular components (Figure 1.1) such as -SH groups of cysteine residues (Liau et al., 
1997; Jung et al., 2008).  These residues are often important in maintaining conformation 
of cytosolic or membrane-associated proteins; interaction of silver with these groups leads 
to the production of strong S-Ag bonds which prevent disulphide bond formation.  This 
ultimately results in the disruption of protein structure and loss of function (Ratte, 1999; 
Luoma, 2008).  
  
7 
 
This protein-function disruption through interaction with sulfhydryl groups has long been 
associated with the primary antibacterial mechanism of Ag+ (Yudkin, 1937; Chambers et 
al., 1962; Russell and Hugo, 1994), namely the interruption of the bacterial respiratory 
chain by proton-pump inhibition which has been observed in Escherichia coli and 
Staphylococcus aureus (Bragg et al., 1974; Jung et al., 2008; Mijnendonckx et al., 2013).  
This impairment has been shown to induce the generation of the superoxide radical (O2
-) in 
both organisms (Park et al., 2009) leading to cell death.  A similar mechanism has been 
observed in rat liver mitochondria; Ag has been shown to induce the permeability of the 
inner mitochondrial membrane through disruption and opening of the permeability 
transition pore (Almofti et al., 2003).  This was shown to result in a loss of proton potential 
(the driving force of oxidative phosphorylation) and the release of cytochrome c; an 
apoptosis-inducing factor (Almofti et al., 2003).  The authors summarised that Ag induced 
the opening of this pore through interaction with sulfhydryl groups within its structure 
(Almofti et al., 2003).   
The primary mechanism of acute, aquatic Ag+ toxicity is well established in rainbow trout 
(Oncorhynchus mykiss) (for reviews see (Hogstrand and Wood, 1998; Wood, 1999); near-
total reduction of the active transport of Na+ and Cl- at the gill. This reduction was shown 
to occur primarily through the inhibition of Na+/K+-ATPase activity in the basolateral 
membrane of the gill epithelium following absorption into the cell (Morgan et al., 1997). 
This occurs through a direct interaction of Ag with cytoplasmic side of this enzyme, 
specifically a competitive inhibition of the Mg2+ binding site, preventing the binding and 
hydrolysis of ATP (Ferguson et al., 1996).  This inhibition reduces the transport capacity 
of this enzyme, leading to a net loss of Na+ and Cl- from blood plasma. This results in an 
osmotic imbalance between the plasma and surrounding tissues, causing a net shift of 
water from the blood to the intracellular compartment.  Death is finally thought to occur 
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from circulatory failure induced by low blood volume and high blood viscosity (Hogstrand 
and Wood, 1998; Wood, 1999; Bianchini and Wood, 2003).  This is also thought to be the 
primary mechanism of Ag toxicity in D. magna; exposure to Ag in the form of AgNO3 
induced a reduction of whole-body Na concentration as well as a rapid inhibition of 
Na+/K+-ATPase activity (Bianchini and Wood, 2003). 
Ag is also known to induce the formation of reactive oxygen species (ROS). This has been 
observed in E. coli, S. aureus (Park et al., 2009), and human skin fibroblasts (Cortese-
Krott et al., 2009) in response to AgNO3 exposure.  Ag is thought to induce ROS formation 
by two mechanisms; either through the disruption of the respiratory chain via interaction 
with thiol groups of mitochondrial proteins (Mijnendonckx et al., 2013), or through the 
catalysis of the production of superoxide radicals, hydroxyl radicals and hydrogen 
peroxide from O2. If the production of ROS becomes excessive, cellular anti-oxidant 
systems can become overwhelmed resulting in a state of oxidative stress (Finkel and 
Holbrook, 2000). Common consequences of oxidative stress include damage to DNA, the 
oxidation of polyunsaturated fatty acids in lipids (lipid peroxidation) and oxidation of 
amino acids in cellular proteins.  This can result in genotoxicity and mutations, as well as 
membrane and enzyme dysfunction potentially leading to cytotoxicity and cell death.  Ag+ 
has also been observed to complex directly with DNA and RNA molecules, specifically at 
the N7 site of the purine bases guanine and adenine (Arakawa et al., 2001) which has been 
shown to interrupt DNA replication leading to mutagenesis and genotoxicity.   
The reason that metallic silver is essentially non-toxic to humans and other mammalian 
species is removal of Ag occurs much more proficiently than in aquatic organisms 
(Fabrega et al., 2011).  Protection against, and sequestration of, Ag occurs either through 
precipitation with chloride, sulfide or phosphate ions within the cytoplasm, or through 
binding with antioxidants (such as cysteine and glutathione), or with sulfhydryl-rich metal-
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specific binding proteins like the metallothionein family of proteins (Ferguson et al., 
1996).  Precipitated forms of silver (chloride, sulfide and phosphate complexes) are 
deposited outside cells in connective tissue, whereas silver sequestered by antioxidants and 
proteins aggregate together and are encased by lysosomes.  These methods of Ag 
sequestration have been hinted to occur in aquatic organisms, but do not do so with the 
efficiency of some other organisms. A summary of the cellular mechanisms of toxicity of 
dissolved Ag and also AgNPs, is depicted in Figure 1.1. 
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Figure 1.1: Summary of some of the major molecular interactions of Ag+ and AgNPs 
reported in the literature.  AgNPs have been shown to enter eukaryotic cells via endocytosis 
whereas Ag+ enter through ion transport channels.  AgNPs are then thought to enact toxicity 
primarily through the release of Ag+ within the cell, but they have been shown to directly 
affect transcription through RNA polymerase inhibition. Once within the cell, silver ions 
interact with –SH groups on cellular proteins, such as ion-transport pumps, which can lead 
to disruption of conformation and loss of function.  Ag+ can induce DNA damage and ROS 
production through direct interaction with genomic DNA and mitochondria respectively.  
Unchecked production of ROS can lead to oxidative stress, resulting in DNA damage and the 
oxidation of cellular lipids and proteins. The presence of Ag and AgNP is primarily combated 
through the increased production of antioxidant enzymes and metallothionein. 
Metallothionein sequesters Ag+ and removes it from the cell.
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1.2.2 The molecular toxicity of silver nanoparticles 
The efficiency with which a metal can exert toxicity depends on its bioavailability; how 
readily it can be internalised within the cells of an organism.  Metal bioavailability is itself 
dependent upon speciation, with the free ion form of a metal typically being the most toxic 
due to their mimicry of major essential ions such as Na+ and subsequent uptake via ion-
transport pumps (Bury and Wood, 1999).  These methods of uptake are rapid, and are 
unavailable to the larger, nanoparticle forms of metals thus reducing the rate at which they 
are internalised by cells and organisms.  Metallic nanoparticles are therefore less 
bioavailable than their free ion counterparts, an observation which is reflected in the 
reported LC50 and EC50 data.  A recent review has compared terrestrial and aquatic 
ecotoxicity data for three metal and metal oxide nanoparticles; silver, zinc oxide and 
copper oxide (Notter et al., 2014).  Through calculation of a ratio comparing nanomaterial 
and metal LC50, LD50 and EC50 data, it was determined that in almost all cases the 
nanoparticle forms of these compounds were less toxic than their ionic counterparts 
(Notter et al., 2014).  Although the authors themselves did not provide an explanation for 
this observation, it is possible that this is the result of reduced availability for the 
nanoparticle form of the metal in question. 
It is unlikely that metallic nanoparticles cross cellular membranes via the same mechanism 
as metal ions, however a large variety of nanomaterials have been shown to be taken into 
cells by endocytosis (Zhao et al., 2011).  Using selective inhibitors of the different 
endocytotic pathways, it was determined that AgNPs are adsorbed primarily by both 
clathrin-mediated endocytosis and macropinocytosis in human lung fibroblasts and 
glioblastoma cells (Asharani et al., 2009), as well as in human mesenchymal stem cells 
(Greulich et al., 2011).  Endocytosis was also confirmed as the primary mechanism of 
AgNP transport in the ragworm, Nereis diversicolor, using Transmission Electron 
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Microscopy (TEM) and Energy Dispersive X-ray analysis, but the exact form of 
endocytosis was not detailed in this study (García-Alonso et al., 2011).  AgNPs have been 
identified as being localised to the lysosomes of mouse macrophage cells using confocal 
laser microscopy following a 24 h exposure to 10 µg/ml of AgNPs with a 20 nm core 
diameter (Arai et al., 2015).  This observation has also been made using fluorescence 
microscopy in human mesenchymal stem cells; AgNPs were found to co-localise to endo-
lysosomes after a 24 h exposure to AgNPs (Greulich et al., 2011).  Lysosomes are an 
endpoint of endocytosis; they are specifically designed for the degradation of foreign 
material.  The detection of AgNPs within these structures was considered by the authors of 
both papers to be evidence of uptake via endocytosis. Nanoparticles of other forms have 
been reported to escape these structures should the internal concentration of particles 
become high enough (Nam et al., 2009). A summary of the cellular interactions of AgNP 
is depicted in Figure 1.1. 
Investigations into the molecular mechanisms of AgNP toxicity are mostly inconclusive 
but one thing which is frequently investigated is the potential indirect induction of toxicity 
through the release of the free silver ion, Ag+.   
1.2.3 The potential role of dissolved Ag+ in AgNP toxicity 
Several studies have suggested that toxicity induced by AgNPs can be fully accounted for 
by the Ag+ fraction of AgNP dispersions (Kennedy et al., 2010; Zhao and Wang, 2011; 
Newton et al., 2013). Kennedy et al. (2010) assessed the acute toxicity of AgNPs to 
P. subcapitata D. magna, and P. promelas.  They discovered that when expressed in terms 
of “fractionated nanosilver” (their terminology for the free silver ion) and/or <4nm 
particles), the LC50 values of AgNPs were comparable to those of AgNO3 within 95% 
confidence intervals (Kennedy et al., 2010).  A separate study by Newton et al. in 2013 
characterised the dose-response relationship of AgNO3 and AgNPs with three different 
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capping agents to D. magna.  When the dissolved Ag content was measured at the 48 h 
LC50 values for each of these, they were found to be similar for all nanoparticles and 
AgNO3. This led the authors to conclude that toxicity of AgNPs was a function of 
dissolved silver released by AgNP dissolution.   
Chelating agents have been used frequently alongside AgNP exposures in order to 
sequester dissolved Ag ions and test their role in toxicity (Zhao and Wang, 2011; Kim et 
al., 2011; Zhao and Wang, 2013; Groh et al., 2014).  The toxicity of AgNO3 and 
carbonate-coated AgNPs to zebrafish embryos was shown to be prevented by the addition 
of cysteine (Groh et al., 2014).  Addition of cysteine was also seen to protect against PVP-
coated AgNP and AgNO3 toxicity to D. magna (Zhao and Wang, 2011) as well as the 
disruptive effects of both AgNO3 and AgNPs to Na and Ca regulation in D. magna (Zhao 
and Wang, 2013).  In each of these studies the authors surmised that the reduction or 
removal of toxicity was the direct result of the successful sequestration of dissolved Ag 
from all exposures.  They followed by concluding that all toxicity observed in these 
exposures could be fully accounted for by the dissolved Ag fraction, and that AgNP would 
have no independent toxicity.  
One shortfall of the work referenced above is that the comparison of the ultimate outcome 
of toxicant exposure, namely mortality, gives no information as to the underlying 
molecular perturbations which are induced following exposure to AgNPs and AgNO3.  
Comparison of these profiles will allow a more detailed assessment of which form is 
responsible for toxicity, or if unique mechanisms are induced by either species of Ag.  
There has been an increase in the number of robust investigations into the molecular 
mechanism of AgNP toxicity in recent years, utilising large combinations of traditional 
biochemical techniques (Yang et al., 2012; Stensberg et al., 2013; Wang et al., 2013; Ahn 
et al., 2014; De Matteis et al., 2015) or high-throughput omics technologies (Scown et al., 
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2010; Poynton et al., 2012; Aerle et al., 2013; Rainville et al., 2014; Li et al., 2015a, 
2015b) to address the role of Ag+ in AgNP toxicity.  A number of these studies have 
shown agreement between the molecular responses induced by nanoparticle and ionic Ag 
(Scown et al., 2010; Poynton et al., 2012; Aerle et al., 2013; Rainville et al., 2014; Li et al., 
2015a, 2015b).  A comparison of the transcriptional changes observed in zebrafish 
embryos (Danio rerio) following exposure to 5 µg/L of 10 nm commercial AgNPs, 5 µg/L 
of Bulk Ag (600 -1600 nm) and 0.25 µg/L of AgNO3 showed significant over-
representation of mitochondrial disruption pathways across all treatments (Aerle et al., 
2013). This was primarily caused by down-regulation of genes encoding complexes I, II, 
III and IV of the oxidative phosphorylation machinery (Aerle et al., 2013).  This study 
aligns with other work demonstrating the disruption of mitochondrial membrane potential 
by AgNPs (Stensberg et al., 2013) and also with a previous study demonstrating 
mitochondrial disruption by AgNO3 (Almofti et al., 2003).  A 
1H NMR-based 
metabolomics investigation in D. magna saw similar profiles induced in response to AgNP 
and AgNO3 (Li et al., 2015a).  This investigation also saw disturbances in energy 
metabolism and oxidative stress.  Western blot analysis and immunofluorescence showed a 
significant increase in expression of the metallothionein family of proteins in human lung 
carcinoma and human cervix carcinoma cells exposed to 20 nM AgNPs over 48 h (De 
Matteis et al., 2015).  The metallothionein family of proteins, as metal-specific, thiol-rich 
proteins appear to be a primary response to Ag exposure in many organisms (Ferguson et 
al., 1996; Chae et al., 2009; Meyer et al., 2010; García-Alonso et al., 2011; Johari et al., 
2015). This further supports the notion that both nanoparticle and dissolved forms of silver 
induce a similar response. 
Other studies have proposed that AgNPs may have a particle-specific mechanism, which 
may either be the sole cause of toxicity, or may act alongside effects initiated by Ag+ 
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release.  In 2013, Stensberg and colleagues measured the impact of AgNP and Ag+ 
exposure to D. magna on Na+ transport and mitochondrial activity – processes known to be 
affected by Ag+ (Stensberg et al., 2013).  They discovered that AgNPs were not as 
effective at disrupting Na+ transportation as their ionic counterparts, but induced greater 
H+ efflux from mitochondria.  This led the authors to conclude that AgNP and Ag+ have 
different mechanisms of toxicity, though they may act in a synergistic mechanism to 
produce a greater overall response (Stensberg et al., 2013).  The inhibition of RNA 
polymerase has been previously observed as an adverse effect induced specifically by the 
nanoparticle form of Ag (Wang et al., 2013).  Wang and colleagues demonstrated that 
exposure of erythroid progenitor cells to 8 µg/l AgNP resulted in >50 % inhibition of RNA 
synthesis (Wang et al., 2013).  The study also used a pull down assay to demonstrate the 
association of AgNPs with Sp6 RNA polymerase.  
A transcriptomics investigation by Poynton et al. showed the induction of different gene 
expression profiles by AgNP and Ag+ (Poynton et al., 2012).  They showed that Ag+ 
resulted in a down-regulation of developmental processes, whereas AgNPs increased 
expression of metallothionein and genes involved in the repair of DNA (Poynton et al., 
2012).  A proteomic study by Rainville et al. revealed that both forms of silver induced an 
increase of protein-thiol content, but only AgNPs caused an increase of protein carbonyls 
(Rainville et al., 2014).  The authors suggest that the increase in protein-thiol content is in 
response to the presence of Ag+ ions within the organisms; to directly chelate the ions and 
decrease their toxicity, or to reduce toxicity by ROS.  The increased carbonyl content 
induced by AgNPs is thought to be an indication of AgNP-induced oxidative stress.  The 
authors surmise that signs of different MoAs were discovered suggesting AgNP can induce 
toxicity independently of Ag+ (Rainville et al., 2014). 
  
16 
 
From the data discussed above, it seems highly likely that Ag+ play a role in AgNP 
toxicity, but there is great uncertainty on whether they are solely responsible.  Importantly, 
studies taking a mechanistic approach report discrepancies in the mechanisms induced by 
the two compounds, which may suggest independent but synergistic MoAs (Poynton et al., 
2012; Stensberg et al., 2013; Rainville et al., 2014).  One of the more popular hypotheses 
to arise in recent years is the ‘Trojan horse’ hypothesis.  It addresses the conflicting 
evidence, some of which is discussed above, stating that AgNPs act as a vehicle for Ag+ 
toxicity.  The hypothesis states that AgNPs are taken into an organism, tissue, or cell, 
resulting in a concentrated, internalised dissolution of AgNPs resulting in toxicity induced 
by the released free Ag+ ion (Moore, 2006; Luoma, 2008; Lubick, 2008).  This MoA has 
been suggested to occur in a mouse macrophage cell line (Park et al., 2010) and has also 
been implied within the digestive tract of D. magna  (Zhao and Wang, 2010).  The gradual 
dissolution of internalised AgNPs has been observed previously using a fluorescent 
chemosensor specific for the observation of Ag+ in living cells (RC-1) by confocal 
microscopy (De Matteis et al., 2015).  Following a 3 h exposure to 0.6 nM of 20 nm 
AgNPs, human lung carcinoma cells were observed for 96 h.  A significant increase in 
fluorescence was observed after 24 h and again 48 h and 96 h after the initial exposure 
distributed across the cytoplasm, organelles and nuclei.  The authors concluded that this 
internal release of Ag+ was a direct result of adsorption of AgNP by the endocytosis 
pathway leading to an accumulation of AgNP in the lysosomes.  The acidic environment of 
these structures was thought to then accelerate the dissolution of the particles, resulting in 
toxicity via Ag+ (De Matteis et al., 2015) which is consistent with the Trojan-horse 
hypothesis.  However it is not evident, from this study, which species of silver is 
responsible for toxicity following AgNP absorption, only that dissolution of can occur 
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following internalisation.  To better compare the exact role each form of silver plays in 
AgNP toxicity, a more detailed comparison of the global molecular response is required. 
1.3 Omics-technologies and their application to silver nanotoxicology 
The majority of investigations into the molecular mechanism of AgNP toxicity have 
primarily centred on the traditional biochemical targets of dissolved Ag toxicity (reviewed 
in section 1.2.3).  This has potentially led to a narrow perspective on the molecular 
perturbations induced by AgNPs, leaving potential novel changes undiscovered.  In order 
to give greater insight into the entire molecular mechanisms of toxicity an increasing 
number of studies, including those investigation AgNP toxicity, are utilising high-
throughput omics technologies. Omics technologies enable us to employ a non-targeted or 
hypothesis-forming approach as a platform from which to direct further investigations.  
The global molecular perturbations induced by toxicant-exposure can be assessed at the 
level of: gene expression (transcriptomics), protein synthesis and modification 
(proteomics), and the entire profile of small molecular metabolites (metabolomics) 
(Figure 1.2).  The use of transcriptomics techniques in tandem with metabolomics for 
example, will allow for the mapping of the initial transcriptional changes onto the 
phenotypic response of the organism. Through use of these techniques it is possible to 
observe the molecular responses that occur as a result of exposure to a particular toxicant, 
such as AgNPs (Figure 1.2), and from this one can infer the MoA (Fiehn, 2002; Taylor et 
al., 2010; Piña and Barata, 2011). 
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Figure 1.2: Representation of the different molecular processes measured by 'omics technologies and the potential interactions of Ag at each level.  
Shown are the connections between the chromosomal DNA sequences (genomics), followed by the entire profile of mRNA transcripts 
(transcriptomics), the proteins and modified proteins produced by those transcripts (proteomics), to the metabolites that those proteins act upon 
(metabolomics). 
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1.3.1 Analytical platforms for Transcriptomics  
Transcriptomics represents one of the most developed and utilised high-throughput ‘omics 
approaches, which aims to measure the entire gene transcription profile of an organism or 
tissue i.e. the entire complement of ribonucleic acid (RNA) molecules .  There are three 
major forms of RNA: ribosomal RNA (rRNA), which forms the bulk of the translational 
machinery; messenger RNA (mRNA) which is a transcription of the protein-coding 
regions of a particular gene, and transfer RNA (tRNA) which provides the physical link 
between mRNA and the encoded amino acid sequence during translation.  The aim of 
transcriptomics is to gain an insight into all genes being expressed at any given time, and it 
is the mRNA fraction which contains this information.  The expression of certain genes 
changes during toxicity, either as a direct or indirect result of exposure (Nuwaysir et al., 
1999).  By measuring these changes in comparison with untreated conditions we can begin 
to infer which molecular pathways or processes are involved in the toxicant response.   
The most commonly utilised transcriptomics technology when applied to toxicology is the 
gene expression microarray (Nuwaysir et al., 1999; Schirmer et al., 2010; Piña and Barata, 
2011) which allows for rapid analysis of genome-wide expression profiles.  Various 
microarray technologies have been developed but currently oligonucleotide microarrays 
are most commonly used. These microarrays consist of short single-stranded 60-mer DNA 
oligonucleotide probes, synthesised in situ on glass arrays, corresponding to transcribed 
regions and hence RNA transcripts, of known genes. The total RNA content of control and 
treated samples is extracted then simultaneously amplified and labelled with a fluorescent 
dye by reverse transcription (Piña and Barata, 2011).  Samples are then hybridised to 
individual arrays, and the fluorescence measured from each probe corresponds to relative 
concentration, and hence expression, of that particular mRNA molecule (Nguyen et al., 
2002).  The major disadvantage to DNA microarrays is that they require some prior 
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knowledge of the test organism’s genome or transcriptome, as this information is 
necessary to synthesise the DNA probes. 
1.3.2 Analytical platforms for metabolomics 
Metabolomics is the measurement of the entire profile of low molecular weight products 
within a cell-line, tissue or whole organism (Viant, 2008).  An organism’s metabolic 
profile is the direct result of gene expression and cellular metabolism (Figure 1.2) and as 
such can be considered the phenotype of alterations in gene-expression (Fiehn, 2002).  
Metabolomics has been readily applied to ecotoxicology studies through comparison of the 
metabolic profiles of treated and untreated samples.  To detect and identify as many 
components of an organism’s metabolome as possible, the discipline requires highly 
sensitive and highly selective analytical techniques (Lenz and Wilson, 2006).  Two 
technologies come close to meeting this paradigm; Nuclear Magnetic Resonance (NMR) 
and Mass Spectrometry (MS). 
NMR has been used in metabolomics-based toxicology and ecotoxicology studies for years 
and is still used extensively for this purpose.  NMR is rapid, highly-reproducible between 
procedures and laboratories (Viant et al., 2009), and does not alter the original sample i.e. 
it is non-destructive (Lenz and Wilson, 2007).  As a major limitation however, NMR is not 
as sensitive as MS and as such struggles to detect the naturally low-concentration 
metabolites that make up a majority of the metabolome.  For this reason NMR was not 
appropriate for this thesis.  
Unlike NMR, MS is a destructive technique that depends upon the ionisation of 
metabolites in order to separate and detect them based on their molecular mass/charge 
(m/z) ratios.  The end result of MS analysis is a spectrum of m/z values plotted against their 
respective relative intensities which correspond to metabolite abundance.  MS techniques 
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are often as rapid as NMR but have much greater sensitivity, enabling the detection of the 
large number of low-concentration metabolites that exist in biological mixtures (Lenz and 
Wilson, 2007).  This enhanced sensitivity has resulted in an increased use of MS 
techniques in environmental metabolomics due to a need for greater exploration of 
organism metabolomes (Viant and Sommer, 2012).   
MS analysis usually occurs either through an initial separation of metabolites by 
chromatography or electrophoresis techniques (hyphenated MS), or through the direct-
infusion of mixtures with the ionisation source (Direct Infusion MS (DIMS)) (Robertson et 
al., 2007).  Prior separation using Gas-Chromatography (GC-MS), Liquid-
Chromatography (LC-MS) or capillary electrophoresis is often employed to enable better 
separation of peaks thus enhancing identification and quantification of metabolites 
(Allwood and Goodacre, 2010).  However the price for this enhanced level of 
identification is longer preparation and analysis time which reduces the efficiency of this 
technique as a high-throughput technology. 
DIMS allows rapid sample throughput, with each analysis potentially acquired within 
minutes.  However, without the addition of one of the techniques above the separation of 
peaks is based on m/z values only.  To address this problem mass spectrometers with high 
mass resolution and high mass accuracy are required to accurately differentiate peaks with 
similar m/z values (Dettmer et al., 2007). Of the various forms of MS technique, Fourier 
Transform Ion Cyclotron Resonance (FT-ICR) and Orbitrap MS are the most favoured for 
DIMS (Junot et al., 2010).  In this thesis, data is acquired using a FT-ICR MS, hybridised 
with a Linear Trap Quadropole (LTQ) ion trap MS (LTQ-FT Ultra).  Metabolites within 
samples are first ionised using a nano-Electrospray Ionisation (nESI) source. This utilises 
electrical energy to ionise samples as either positively or negatively charged droplets 
which are transferred into the LTQ-MS (Bruins, 1998).  The LTQ is used as an ion-trap; 
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this allows collection of a specific number of ions of a particular m/z range prior to 
injection into the ICR cell.  Contrary to conventional mass spectrometers, the ICR is not 
dependent upon the collision of ions with a detector plate.  Instead, ions are trapped within 
a strong magnetic field and excited by electrodes to rotate at a frequency which is 
dependent upon their m/z.  This rotation of ions allows them to be detected as they pass the 
surrounding detector plates. 
1.3.3 Statistical analysis of ‘omics datasets 
Transcriptomics and metabolomics data are intrinsically multivariate and as such 
multivariate statistical methods are commonly used.  Principal Components Analysis 
(PCA) allows perception of inherent similarities between transcriptional or metabolic 
profiles of samples based upon the relative proportions of the constituent genes or 
metabolites. PCA does not use sample class information in the construction of models, but 
rather attempts to describe the dataset based on the overall variation in the data (Wise et 
al., 2006).  Patterns of variation are described as principal components (PCs).  Each 
subsequent PC in a PCA model describes a decreasing amount of variance within the data; 
that is PC1 accounts for the greatest patterns variance, followed by PC2 then PC3 and so 
on (Robertson, 2005).  Each sample is assigned a score value based upon how it reflects 
the variation described by a PC.  Score plots (typically PC1 against PC2) are used to 
visually determine if there are any natural similarities in the profiles of samples through 
clustering of scores values (Robertson et al., 2007). These clusters allow for rapid 
identification of similar and dissimilar samples, indicating a common effect or mechanism 
(Keun, 2006).  
1.3.4 Annotation of genes and metabolites and methods of pathway analysis 
Assigning functional or chemical identities to genes and compounds is referred to as 
annotation.  For transcriptomics data, online databases allow the comparison of transcript 
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sequences with those of other documented genes (Piña and Barata, 2011). Examples of 
such databases include the Gene Ontology consortium (http://geneontology.org/) and the 
National Centre for Biotechnology Information (http://blast.st-
va.ncbi.nlm.nih.gov/Blast.cgi).  This allows the user to identify genes with the greatest 
sequence homology/similarity to their target genes across multiple species in an effort to 
assign an appropriate annotation (such as gene- function).   
For metabolomics techniques, the process of metabolite identification is still a major 
limiting factor.  Metabolite identification is possible through tandem mass spectrometry 
(MS/MS) which fragments metabolites allowing the elucidation of structures.  However, 
this approach is time-consuming, and is unfeasible for the thousands of peaks that can be 
detected by FT-ICR MS.  Theoretically, through the accurate mass values obtained by the 
FT-ICR, putative identification of metabolites is possible following a database search for 
each peak in turn (Kind and Fiehn, 2006).  This process is known as a Single Peak Search 
(SPS).  The Metabolite Identification Package (MI-Pack) is a software package which 
enables the automated putative annotation of m/z peaks by SPS and by the Transformation 
Mapping (TM) algorithm.  TM utilises prior information of the metabolic interactions 
mapped in the Kyoto Encyclopaedia of Genes and Genomes (KEGG) to improve putative 
annotation of m/z peaks. The TM algorithm has been shown to reduce the false positive 
rate (FPR) of metabolite annotation from 68% (by SPS) to 15.9 % while maintaining a 
minimal false negative rate of 5.6% (Weber and Viant, 2010).  However the number of 
known metabolites is comparatively small to the numbers of peaks possible to detect in an 
FT-ICR spectrum.  Additionally, many metabolites are present at concentrations or for 
periods of time which make them very difficult to detect. 
Pathway analysis allows us to make sense of large lists of putative genes or metabolites by 
putting them into context of known molecular interactions.  As our understanding of 
  
24 
 
molecular pathways grow, the available methods for pathway analysis have also grown to 
incorporate more and more variables (Khatri et al., 2012).  There are three major 
categories of pathway analysis; Over-Representation Analysis (ORA), Function Class 
Scoring Analysis (FCSA) and Pathway Topology Analysis (PTA) (Khatri et al., 2012).  
The general principles surrounding each category are outlined below. 
ORA is a qualitative form of pathway analysis that determines the fraction of detected 
genes or metabolites within a pathway that change in expression or concentration (Khatri 
et al., 2012).  An input list is formed consisting of genes or metabolites deemed to be of 
interest, normally by statistical significance tests or through use of an arbitrary fold-change 
threshold.  The number of these compounds within each tested pathway-definition is then 
counted, and the same process is repeated for an appropriate background list.  Traditionally 
for microarray analyses this background consists of all detected genes on the microarray, 
regardless of expression or significance.  When applied to metabolomics, determining this 
background list has proven problematic due to the minute fraction of detected metabolites 
which are successfully identified (Bouhifd et al., 2013).  Statistical tests for ORA are based 
around the hypergeometric or binomial distributions such as the Fisher’s exact test.  The 
major disadvantage of ORA is that it purely accounts for the presence or absence of 
‘interesting’ pathway components and does not take into account associated intensity 
values (Khatri et al., 2012). 
FCSA is based on the notion that small, but co-ordinated pathway-wide increases or 
decreases in gene expression or metabolite production are equally as important as large 
changes in individual genes or metabolites.  As such FCSA takes into account the changes 
in expression or production of all pathway constituents and not just a selection (Khatri et 
al., 2012).  Most methods of FCSA follow the same three steps (Ackermann and Strimmer, 
2009).  Firstly differential expression of individual pathway components is calculated 
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through univariate statistics.  Secondly the component-level statistics are combined to 
create pathway-level statistics which are then ranked in order of importance.  Finally, the 
significance of the pathway-level statistic is assessed.   
Pathway topology analysis is the most recent development in pathway analysis techniques.  
This method follows the same three steps as FCSA but instead use information on pathway 
topology, interactions of constituent genes and metabolites, to compute component-level 
statistics (Khatri et al., 2012).  One major challenged faced by this method that the 
topology of many pathways is entirely dependent on the cells or organisms used and 
largely unavailable.  
In the field of transcriptomics, pathway analysis has proven invaluable for years and as a 
result large numbers of analysis tools are available (reviewed in Khatri et al., 2012). For 
the relatively new discipline of metabolomics, the connection of metabolomics results to 
the genome has long been predicted (Fiehn, 2002) and only recently enabled (Xia and 
Wishart, 2010; Xia et al., 2012).  Online tools have also become available for combined 
transcriptomics and metabolomics pathway analysis (Kamburov et al., 2011).  This enables 
an objective, statistical approach which avoids speculation as to how statistically 
significant genes and metabolites interact (Cavill et al., 2011). One massive disadvantage 
of all categories of pathway analysis is that they rely upon absolute confidence in the 
assigned, imputed identities.  For microarray transcriptomics, where the identity of each 
probe is known prior to analysis, this is less of a problem.  However for DIMS, where 
high-throughput identification of detected metabolites is limited, it presents an additional 
limitation. 
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1.3.5 The application of omics-technologies for the elution of the AgNP MoA   
As stated above, the non-targeted approach of mechanistic investigation that omics 
technologies provide us with, allows us to bypass the potential limitations of traditional 
hypothesis-driven research. Several omics-investigations into AgNP toxicity have 
highlighted mechanisms known also to be shared by dissolved silver, such as disruption of 
mitochondrial activity (Aerle et al., 2013), energy metabolism (Li et al., 2015a; 2015b) and 
the induction of oxidative stress following production of ROS (Poynton et al., 2012; 
Rainville et al., 2014).  However some studies have highlighted potential mechanisms of 
AgNP toxicity that have not been investigated as extensively. A summary of omics 
investigations into AgNP toxicity is given in Table 1.1. 
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Table 1.1 – Summary of the key findings of omics-investigations into AgNP toxicity to date. 
Technique Organism Summary of principal findings Reference 
Microarray transcriptomics Daphnia magna 
PVP-AgNPs induce a significant (p<0.05) increase in metallothionien and the 
DNA-damage repair gene REV1 (2-fold and 1.5-fold respectively) expression, 
and cause an increase in expression of genes involved in  protein degradation 
and signal transduction. AgNO3 induces a down-regulation of genes involved in 
developmental processes. 
Poynton et al 2012 
2DE proteomics Daphnia magna 
Both AgNP and AgNO3 exposure significantly (p<0.01 in both cases) increases 
protein-thiol content approximately 1.5 fold- a potential response to oxidative 
stress or metal toxicity.  AgNP alone induce a significant (p<0.001) 1.5-fold 
increase in protein carbonyl content, a potential sign of oxidative stress. 
Rainville et al 2014 
1H NMR metabolomics Daphnia magna 
AgNPs and Ag ions induce significant (p<0.05) separations along PC1 compared 
to control groups.  the same metabolic profiles.  Authors conclude that released 
Ag+ from AgNPs disrupt energy metabolism and induces oxidative stress. 
Li et al 2015  
SuperSAGE RNA sequencing Danio rerio 
AgNP toxicity is thought to be induced by bioavailable Ag ions.  Toxicity is 
induced through disruption of mitochondrial activity and oxidative 
phosphorylation. Disruption of genes within oxidative phosphorylation 
complexes I, II, III and IV with expression decreasing between 2 and 10 fold in 
response to both AgNO3 and AgNP exposure. 
Van Aerle et al 2013 
LC-MS/MS proteomics LoVo cells 
Treatment with 20nm and 100nm AgNPs lead to significant changes in 
regulation of 620 and 717 proteins respectively.  Of these, 252 and 458 proteins 
in the proteome of 20 nm and 100 nm AgNP exposed animals respectively, were 
determined to be induced by Ag+ through comparison to exposures with the 
AgNP supernatant (Ag+).  Potential impact of AgNP size observed. 100 nm AgNP 
exposure resulted in upregulation of proteins involved in apoptotic signalling 
cascades (PAK, MAPK, PP2A). Exposure to 20 nm AgNPs caused generation of 
ROS and carbonylation of proteins and an increase in protein SUMOlation  
Verano-Braga et al 
2014 
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HPLC-QTOF metabolomics Wistar rat 
Significantly elevated production of uric acid and allantoin (p<0.0001 for both 
metabolites) found in urine of rats exposed to 9 mg/kg body weight of AgNP.  
Suspected disruption of purine metabolism. 
Hadrup et al 2012 
1H NMR metabolomics Eisenia fetida 
Induction of oxidative stress following exposure to both AgNP and Ag ions. PCA 
loadings depict depletion of malate, glucose, ATP and inosine and increase in 
leucine and arginine in response to AgNP exposure.  Elevation of succinate and 
depletion of fumerate in response to dissolved Ag.  A significant (p<0.05) 1.4-
fold increase in SOD activity and 1.3-fold increase in catalase activity in worms 
exposed to AgNO3. No change in these enzymes observed following AgNP 
exposures.   
Li et al 2015 
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A quantitative proteomics investigation identified up-regulation of serine/threonine protein 
kinase (PAK), mitogen-activated protein kinase (MAPK) and protein phosphatase 2A 
(PP2A) subunits following exposure of human colon carcinoma cells to 100 nm citrate-
coated AgNPs (Verano-Braga et al., 2014). PAK and MAPK are both involved in 
signalling cascades that result in caspase-dependent and caspase-independent apoptosis 
respectively, and PP2A is involved in the regulation of the cell cycle.  This study also 
detected an increase in protein ubiquitination, as well as an upregulation of proteins 
involved in the ribosome and proteasome complexes. This implies an increase in 
degradation of proteins by the ubiquitin-proteasome system, possibly damage proteins, 
followed by the synthesis of replacement proteins (Verano-Braga et al., 2014).  In addition 
to concluding that both AgNPs and dissolved silver impact oxidative phosphorylation and 
mitochondrial activity, Van Aerle et al (2013) identified significant down-regulation (6.3 
fold over 24 h) in cryptochrome 1a transcription, a protein involved in the repressor of 
clock function.  Additional observations included down-regulation of proteasome subunit 
beta type-1 and up-regulation of ribosomal protein S6 modification-like protein B, the 
authors suggested that together these alterations imply an increased level of protein 
turnover due to oxidative damage (Aerle et al., 2013).  AgNP-exposed rats were identified 
as having an increase in the concentration of uric acid and allantoin excreted in their urine 
suggested a disruption of purine metabolism (Hadrup et al., 2012).  These pathways are 
unlikely to have been targeted through use of a traditional approach, as the background 
knowledge of AgNP toxicity is still relatively low.  AgNPs are therefore ideal candidates 
for a non-targeted omics approach to investigating their mechanism of toxicity in 
environmentally relevant test organisms. 
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1.4 Ecotoxicogenomics and the importance of relevant test organisms  
Ecotoxicology, the combination of ecology and toxicology, is the discipline of observing 
toxicant effects upon ecological systems.  Although heavily influenced by toxicology with 
regards to experimental methods, the influence of ecology is most notable in the selection 
of ecologically relevant test species and test conditions (Chapman, 2002).  Environmental 
risk assessment differs from standard toxicological risk assessment, in that it not only aims 
to look at the effects of toxicants on individual organisms, but also the consequences of 
these effects upon the wider ecosystem (Breitholtz et al., 2006).  In an ideal situation all 
species in a particular ecosystem would be tested to fully investigate the potential impact 
of a toxicant (Breitholtz et al., 2006).  However, as this is impossible, it is vital to select an 
organism that is representative of the ecosystem under investigation (Chapman, 2002; 
Breitholtz et al., 2006).  Examples of such organisms recommended by the OECD are 
summarised in Table 1.2 along with examples of recommended testing guidelines. 
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Table 1.2: The OECD recommended species for aquatic ecotoxicology tests alongside the biological endpoints for testing.  This list covers a broad 
range of species including algae, cyanobacteria, water fleas, non-biting midges and many species of fish. 
Test species Common name OECD Test No. Biological endpoints 
Anabaena flos-aquae Cyanobacteria 
201 Acute growth inhibition 
Desmodesmus subspicatus Pond algae 
Navicula pelliculosa Diatom algae 
Pseudokirchneriella subcapitata Micro-algae 
Synechococcus leopoliensis Cyanobacteria 
Lemna gibba Duckweed 
221 Acute growth inhibition 
Lemna minor Duckweed 
Daphnia magna Water flea 
202, 211 Neonate immobilisation, Reproductive output 
Daphnia pulex Water flea 
Cyprinodon variegatus Sheepshead minnow 210 Embryonic development abnormalities 
Xenopus laevis Clawed frog 231 Chronic metamorphosis  
Gasterostreus aculeatus Three-spined stickleback 234 Sexual development 
Chironomus dilutus Non-biting midge 
235 Acute larval immobilisation Chironomus riparius Non-biting midge 
Chironomus yoshimatsui Non-biting midge 
Lepomis macrochirus Bluegill 
203, 204 Acute adult mortality, Chronic adult mortality 
Poecilia reticulata Fathead minnow 
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Oncorhynchus mykiss Rainbow trout 
203, 204, 210, 212, 
215 
Acute adult mortality, Chronic adult mortality, Chronic 
embryonic development, Acute embryonic 
development, Juvenile growth 
Oryzias latipes Japanese medaka 
203, 204, 210, 212, 
215, 229, 230, 234 
Acute adult mortality, Chronic adult mortality, Chronic 
embryonic development, Acute embryonic 
development, Juvenile growth, Acute endochrine 
disruption, Chronic endochrine disruption, Sexual 
development 
Danio rerio Zebra fish 
203, 204, 210, 212, 
215, 229, 230, 234, 
236 
Acute adult mortality, Chronic adult mortality, Chronic 
embryonic development, Acute embryonic 
development, Juvenile growth, Acute endochrine 
disruption, Chronic endochrine disruption, Sexual 
development, Acute embryo mortality 
Pimephales promelas Fathead minnow 
203, 204, 210, 212, 
229, 230 
Acute adult mortality, Chronic adult mortality, Chronic 
embryonic development, Acute embryonic 
development, Acute endochrine disruption, Chronic 
endochrine disruption 
Cyprinus carpio Common carp 203, 204, 212 
Acute adult mortality, Chronic adult mortality, 
Embryonic development abnormalities 
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Daphnia magna (Figure 1.3), a species of small crustacean of the order Cladocera 
commonly known as water fleas, are found in freshwater ecosystems across the globe 
(Lampert, 2011).  They represent a keystone species in aquatic environments serving as an 
important link between primary producers (in this case phytoplankton) and many species 
of fish (Tatarazako and Oda, 2007).  They have been used extensively as a model organism 
for aquatic toxicology for many years (Martins et al., 2007; Altshuler et al., 2011) and they 
are being used increasingly in environmental nanotoxicology (Gaiser et al., 2011; 
Skjolding et al., 2014; Adam et al., 2014). 
All species of Daphnia share a cyclical parthenogenetic reproductive cycle (Figure 1.4). In 
the absence of environmental stressors such as shortened photoperiod, starvation, and 
overcrowding, adult female Daphnids reproduce asexually yielding genetically-identical 
daughters.  The life cycle of Daphnid species is short with individuals reaching asexual 
maturity within 6-9 days.  This rapid production of genetically identical keystone animals, 
coupled with low maintenance costs and a presence in freshwater ecosystems the world 
over make D. magna an ideal choice for aquatic ecotoxicology tests.   
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Figure 1.3: Image of a D. magna adult female with a brood chamber full of developing 
parthenogenetic eggs.   
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Figure 1.4: The Daphnia reproductive cycle.  Outlined in this image is the asexual, 
parthenogenetic cycle which is able to switch to the sexual cycle under unfavourable or 
stressful conditions (Ebert, 2005) 
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1.4.1 Ecotoxicogenomics and Daphnia magna 
In recent years, the number of studies which have applied omics technologies to D. magna 
toxicology studies has grown, with applications of transcriptomics (Garcia-Reyero et al., 
2009; David et al., 2011; Poynton et al., 2012; Campos et al., 2013; Rivetti et al., 2014), 
proteomics (Le et al., 2013; Otte et al., 2014; Rainville et al., 2014), and metabolomics 
(Taylor et al., 2009; Bunescu et al., 2010; Poynton et al., 2011b; Nagato et al., 2013) being 
reported.  With the publication of the Daphnia pulex genome in 2011 (Colbourne et al., 
2011), it was not long before gene-expression microarrays were constructed for the sister 
species D. magna from EST libraries (Watanabe et al., 2007; Heckmann et al., 2008; 
Garcia-Reyero et al., 2009).  The transcriptomics analysis in this thesis uses a custom 
D. magna microarray developed in 2009 (Garcia-Reyero et al., 2009) and used previously 
for nanoparticle toxicology (Poynton et al., 2011a, 2012; Scanlan et al., 2013).  Despite its 
value as a toxicity test species, only a few metabolomic toxicity studies using D. magna 
have been reported (Taylor et al., 2009, 2010; Bunescu et al., 2010; Poynton et al., 2011b; 
Nagato et al., 2013).  The first recorded metabolomics study using D. magna was in 2009, 
where Taylor et al. validated the use of FT-ICR MS in metabolomic studies of D. magna, 
using copper as a model toxicant.  This model has already been used previously with 
AgNPs for mechanistic investigations using transcriptomics (Poynton et al., 2012), 
proteomics (Rainville et al., 2014) and NMR-metabolomics (Li et al., 2015a). This 
organism therefore represents an ideal model for a dual-omic assessment of molecular 
mechanisms of toxicity of AgNPs.  Omics-technologies present a unique opportunity in 
the on-going debate over the role of Ag+ in AgNP toxicity through direct comparison of 
the pathways perturbed by both forms of silver.  These technologies can also be used to 
direct further research into the elution of the changes induced in D. magna by exposure to 
Ag.  
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1.5 Research hypothesis, aims and objectives 
The primary objective of this research was to investigate the molecular mechanisms of 
AgNP toxicity to the freshwater Cladocera, D. magna, using a combined analysis platform 
of microarray transcriptomics and FT-ICR MS metabolomics.  The work within this thesis 
tested the hypothesis that toxicity by AgNPs to D. magna is induced through the actions of 
dissolved Ag released upon nanoparticle dissolution. Specifically that, if the nanoparticle 
fraction plays no part in toxicity, AgNP toxicity is induced through mechanisms known to 
be induced by dissolved Ag; such as oxidative stress, disruption of mitochondrial function 
and inhibition of ion-transport proteins. 
The primary aims were: 
1. To compare the transcriptional and metabolic perturbations induced by AgNPs and 
dissolved Ag, to determine whether AgNP toxicity is induced solely by the 
dissolved Ag component.  
2. To use the non-targeted approach offered by omics technologies to identify the 
prominent molecular pathways impacted by AgNP exposure. This platform would 
then be used to develop and test hypotheses with the aim of elucidating the AgNP 
mechanism of toxicity. 
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Chapter 2: Materials and Methods  
2.1 Standard chemicals and reagents 
Unless otherwise stated, all standard chemicals and reagents were purchased from Sigma-
Aldrich. 
2.2 Acid-wash cleaning procedures 
All glassware and plastic-ware used for exposures, ultrafiltration, or in the preparation of 
samples for ICP-MS were rinsed and then soaked in a bath of 10 % nitric acid (analytical 
grade, Fisher Scientific) made with ultrapure water (18.2 MΩ, Purelab) for 24 h. 
Following this, items were rinsed thoroughly and left to soak in ultrapure water for a 
further 24 h. All equipment was then left to dry overnight and wrapped in cling-film prior 
to use. 
2.3 Nanoparticle synthesis and characterisation 
2.3.1 Silver nanoparticle synthesis – conducted by Dr. Isabella Römer and Dr. Mila 
Tejamaya (University of Birmingham) 
AgNPs stabilised with citrate (cit-AgNPs) were synthesised by Dr. Isabella Römer  
through the reduction of AgNO3 (100 ml, 0.25 mM) by sodium borohydride (NaBH4, 6 ml, 
10 mM) in the presence of sodium citrate (100 ml, 0.31 mM) using a method outlined 
previously (Römer et al. 2011).  AgNPs stabilised with polyvinyl pyrrolidone (PVP-
AgNPs) were synthesised by Dr. Mila Tejamaya using a similar method, again through the 
reduction of AgNO3 (60 ml, 1 mM) with NaBH4 (180 ml, 2 mM) however this time in the 
presence of PVP10 (Tejamaya et al. 2012).  Newly synthesised nanoparticles were 
‘cleaned’ to remove excess reagents using ultrafiltration (UF) through a 1 kDa regenerated 
cellulose membrane (Millipore, USA) in a stirred UF cell under N2. The volume was 
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maintained with capping agent solution (sodium citrate or PVP) using a diafiltration 
method to keep particles in solution. Particles underwent cleaning 3 times following 
preparation and a further 3 times prior to all exposure work, with the final clean always 
finishing less than 1 h before the initiation of particle exposures. All UF equipment was 
washed in 2% nitric acid and rinsed thoroughly in ultrapure water prior to use.  
2.3.2 Particle characterisation – conducted by Dr. Isabella Römer and Dr. Mila 
Tejamaya (University of Birmingham) 
The cit-AgNPs and PVP-AgNPs used in this research were characterised in ultrapure 
water, by Dr Isabella Romer and Dr Mila Tejamaya respectively, using flow field flow 
fractionation (Fl-FFF), dynamic light scattering (DLS), transmission electron microscopy 
(TEM) and in the case of cit-AgNPs only, atomic force microscopy (AFM) as outlined 
previously (Römer et al. 2011; Roche 2012; Tejamaya et al. 2012) and summarised in 
Table 2.1.  Briefly, both particles were dispersed in ultrapure water and deemed spherical 
in shape by TEM analysis.  The cit-AgNPs had mean diameters measured as 7.2 ± 0.2, 7.0 
± 2.0 and 6.0 ± 3.0 nm by Fl-FFF, TEM and AFM respectively and 16 ± 1.0 nm by DLS. 
The discrepancy in the measurement made by DLS when compared to the other techniques 
is indicative of the particles hydrated radius (Baalousha and Lead, 2012).  The PVP-
AgNPs had mean diameter measurements of 25.6, 10.8 ± 3.3 and 28.3 ± 0.8 nm by Fl-FFF, 
TEM and DLS.  The discrepancy between measurements of the PVP-AgNPs by TEM and 
Fl-FFF is due to the inability of TEM to visualise the increased diameter of the particles 
caused by the PVP polymer coating (Domingos et al., 2009). Observational techniques 
such as TEM and AFM therefore give an assessment of the particles’ core diameter 
whereas Fl-FFF also measures the PVP shell (Baalousha and Lead, 2012).  As it is the 
technique which directly measures the core of the nanoparticles, the measurements made 
by TEM will be used when referring to nanoparticle size in this thesis.  
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Table 2.1: Average hydrodynamic and core particle diameter ± standard deviation (nm) of 
citrate and PVP-coated AgNPs measured by DLS, Fl-FFF, TEM and AFM.  Measurements 
made by DLS and Fl-FFF represent the hydrodynamic diameter of the particles whereas 
measurements by TEM and AFM give the core particle diameter. 
Measurement Technique Average diameter (nm) ± SD 
  Citrate-AgNPs PVP-AgNPs 
Hydrodynamic 
diameter 
DLS 16 ± 1.0 28.3 ± 0.8 
Fl-FFF 7.2 ± 0.2 25.6 ± 0.3 
Core diameter 
TEM 7.0 ± 2.0 10.8 ± 3.3 
AFM 6 .0 ± 3.0 N/A 
 
2.3.3 Measurement of total Ag concentration of stock solutions by Inductively 
Coupled Plasma Mass Spectrometry (ICP-MS) 
Concentrations of AgNP and AgNO3 stocks prepared in ultrapure water for use throughout 
this thesis were measured by Inductively Coupled Plamsa Mass Spectrometry (ICP-MS). 
Prior to measurement of particle concentration, AgNP solutions were acidified to 20 % 
HNO3 for 24 h to promote digestion and dissolution of the particles.  All acidified samples 
were diluted 10-fold to a final HNO3 concentration of approximately 2% and were 
subsequently analysed for total silver concentration by ICP-MS.  The analysis was 
conducted using an Agilent 7500c with an Octopole Reaction System calibrated for use 
between 0.1 and 200 µg/l.  Silver standards were prepared from a 1000 mg/l stock solution 
(VWR) in 2% nitric acid.  A calibration graph of counts (ppb) against concentration (µg/l) 
gave an R2 correlation coefficient of 1.000.  An average was taken from 4 technical 
replicate measurements (in ppb) for each sample of dosed media; these readings were then 
converted into a concentration (in µg/l) from the calibration graph.  The recovery of 
known concentrations of Ag via this method was tested and confirmed in section 6.2.3. 
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2.4 Daphnia magna culturing 
2.4.1 Preparation and composition of media 
Three different preparations of ISO test water (1) (Annex 3, OECD 202, 2004) with 
additional sodium selenite (Keating and Dagbusan, 1984; Taylor et al., 2009) were used 
throughout this thesis (Table 2.2).  These consisted of the standard strength media 
(media1) as well as a 2-fold (media2) and 10-fold (media10) dilution as reported 
previously (Römer et al., 2011; Tejamaya et al., 2012; Römer et al., 2013).  Media were 
prepared through the addition of concentrated stocks of the composite salts to deionised 
water (15 MΩ).  The composition of media1, media2 and media10 is outlined below 
(Table 2.2).  Following preparation, media was aerated for a minimum of 24 h after which 
the pH and dissolved oxygen concentration were measured before use.  Media was used 
only with a pH between 6.0 and 9.0 and a dissolved oxygen concentration above 60 % 
relative saturation as outlined in the OECD guidelines (OECD 202, 2004).   
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Table 2.2: Chemical composition of modified OECD ISO media used within this thesis for 
D. magna culturing and chemical exposures.  All solutions were made using deionised water 
(15 MΩ), concentrations given are nominal values. 
  Final concentration (mM) 
Compound name Empirical Formula Media 1 Media2 Media10 
Calcium chloride CaCl2.2H2O 2.00 1.00 0.20 
Magnesium sulfate MgSO4.7H20 0.50 0.25 0.05 
Sodium bicarbonate NaHCO3 0.77 0.39 0.08 
Potassium chloride KCl 0.77 0.39 0.08 
Sodium selenite Na2SeO3 116 nM 58 nM 12 nM 
 
2.4.2 Chlorella vulgaris maintenance and preparation of feeding solution 
Chlorella vulgaris was cultured in semi-static conditions for use as feed for D. magna 
cultures.  Algal cells were suspended in Bold’s basal medium (BBM, pH 6.7 ± 0.3), 
constantly aerated and kept under constant light at room temperature.  The composition of 
BBM is outlined below in Table 2.3. 
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Table 2.3: Chemical composition of Bold’s basal medium (BBM) used in the culture of 
C. vulgaris algal feed.  All solutions were made using deionised water (15 MΩ), 
concentrations given are nominal values. 
Stock 
No. 
Compound 
Empirical 
formula 
Final conc (mM) 
1 di-Potassium hydrogen orthophosphate K2HPO4 0.43 
2 Potassium di-hydrogen orthophosphate KH2PO4 1.29 
3 Magnesium sulfate MgSO4.7H2O 0.33 
4 Sodium nitrate NaNO3 3.62 
5 Calcium chloride CaCl2.2H2O 0.17 
6 Sodium chloride NaCl 0.43 
7 
EDTA tetrasodium salt & EDTA-Na4 0.13 
Potassium hydroxide KOH 0.55 
8 Iron(II) sulfate in Sulfuric acid (0.1 %) FeSO4.7H2O 0.02 
9 Boric acid H3BO3 0.18 
Stock 
No. 
Compound 
Empirical 
formula 
Final conc (µM) 
10 Zinc sulfate ZnSO4.7H2O 4.91 
11 Manganese chloride MnCl2.4H2O 1.17 
12 Cupric sulfate CuSO4.5H2O 1.01 
13 Cobaltous nitrate Co(NO3)2.6H2O 0.27 
14 Sodium molybdate Na2MoO4.2H2O 0.79 
 
For feeding, an aliquot of algae was removed from the main culture and the optical density 
of a 1 in 10 dilution was assessed at 440 nm by spectophotometry.  The sample was then 
centrifuged at 3000 rpm for 30 minutes (Falcon 6/300 centrifuge, 4x750 ml Windshield 
rotor, MSE, UK), the supernatant was discarded and the pellet re-suspended in de-ionised 
water so that a 1 in 10 dilution would have an optical density of 0.8 at 440 nm.  The re-
suspension volume was calculated using Equation 2.1.  This food stock was then used in 
D. magna culture. 
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Equation 2.1: Calculation of the re-suspension volume (V2) is required to produce algal feed 
with an optical density of 0.8 at 440 nm.  The original volume and optical density of collected 
algae are represented by V1 and A440 respectively.  
𝑉2 =
𝑉1 × 𝐴440
0.8
 
2.4.3 Preparation of dietary supplements for D. magna culture 
Saccharomyces cerevisiae (Baker’s yeast, Sigma-Aldrich) and Ascophyllum nodosum 
(Marinure, Wilfrid-Smith Ltd, UK)  were used as dietary supplements for the feeding of 
D. magna cultures.  Dried Baker’s yeast was suspended at a concentration of 
10 mg/ 100 ml of deionised water and stirred magnetically until fully suspended, and 
added to D. magna cultures as described in Section 2.4.5.  A fresh batch of this solution 
was made every 14 days.  A working stock of A. nodosum (Marinure, Wilfrid-Smith Ltd, 
UK) is obtained through the dilution of a concentrated aliquot with deionised water to 
yield an optical density of 0.8 ± 5 % at a wavelength of 400 nm.  Volumes of this working 
stock were added to culture beakers as described in Section 2.4.5. 
2.4.4 Daphnia magna strain origin 
The D. magna strain used in this study originated from the National Institute for Applied 
Chemical Research, France, and was obtained from the University of Reading in 2007.  
These animals have been cultured continuously since this date according to OECD 
guidelines. 
2.4.5 Daphnia magna culture maintenance  
D. magna cultures were maintained as described previously in media1 (Taylor et al., 
2009), and media10 (Römer et al., 2011).  D. magna were cultured at a density of 20 
animals per 1200 ml of media, with a 16:8 h light:dark cycle and an ambient temperature 
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of 19 °C.  D. magna were fed daily with 0.5 ml baker’s yeast solution (Section 2.4.3), and 
a set volume of the C. vulgaris food stock depending on the age of the organisms within 
the culture.  Animals aged between 0-2 d were fed 1 ml, 3-7 d daphnids were fed 1.5 ml, 
and daphnids aged 8 d and older were fed 2 ml.  Marinure (Section 2.4.3) was added upon 
culture initiation and bi-weekly media change; 3 ml was added aged 1-7 d, and 4 ml for 
daphnids aged 8 d and over.  Cultures were maintained for 14 days allowing the 
production of at least three broods of neonates before exposures were set up or colonies 
restarted with < 24 h old neonates.   
2.5 Daphnia magna toxicity exposure conditions 
Before their neonates could be collected for use, animals were cultured for at least one full 
generation (ca. 14 days) in the appropriate medium as outlined in section 2.4.5.  D. magna 
neonates (< 24 h) from at least the third reproductive brood of a culture were used in all 
toxicity exposures described in this thesis.  The concentration of all AgNP and AgNO3 
exposure stocks was measured by ICP-MS prior to use in toxicity exposures.  A spike-in 
method was used for exposure; groups of D. magna neonates (<24 h) were added to 
vessels (250 ml glass beaker, Fisher Scientific) containing between approximately 50% 
and 80% of the total desired exposure volume.  A pre-calculated volume of AgNP or 
AgNO3 exposure stock was then used to spike the study medium followed immediately by 
the remaining volume of exposure medium to mix.  The exact volumes of medium and 
exposure stock concentrations used in each exposure, as well as exposure durations, are 
reported in greater detail in the respective chapters of this thesis.  Once prepared, exposure 
vessels were kept at 19 ± 1 °C and on a 16h:8h light:dark cycle with no additional 
administration of food or supplements. Tests were only considered valid if no more than 
10% of control animals were immobilised during the exposure.   
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Chapter 3: Optimisation of aqueous nanoparticle toxicity exposure 
conditions and characterisation of AgNPs* 
3.1 Introduction 
One of the major setbacks of many published nanoparticle toxicology studies is improper 
characterisation of the particles or experimental conditions that are used.  As stated earlier, 
the unique effects of the nano-scale are directly related to the area of the particles’ surface 
available for interaction (Section 1.1).  The composition of the medium in which 
nanoparticles are dispersed can impact their stability; either allowing for an even dispersal 
or the formation of particle aggregates (Badawy et al., 2010; Römer et al., 2011; Tejamaya 
et al., 2012).  According to Derjaguin, Landau, Verwey, and Overbeek (DLVO) theory, the 
colloidal stability of nanoparticles in solution is dictated by the balance between attractive 
forces such as van der Waal’s (VDW), which promote aggregation, and electrostatic 
repulsion forces which oppose aggregation (Badawy et al., 2010).  In high purity water and 
at neutral pH two particles of the same type in suspension will have the same surface 
charge and will therefore repel one another.  This electrostatic repulsion will prevent the 
two particles from getting close enough for VDW forces to promote aggregation.  The 
dispersion of particles within an aqueous medium can be impacted by the ionic strength 
and the pH of the medium (Stebounova et al., 2011).  Free-ions present in the aqueous 
medium such as Ca2+, Cl-, H+ and OH-, will be attracted to disperse particles if they are of 
the opposing charge to the particle’s surface.  Interactions between these ions within the 
medium and dispersed particles may result in a shielding of the particle’s surface charge.  
This reduces the level of electrostatic repulsion between colloidal particles allowing for 
                                                 
* Contents of this chapter, including the figures, have been published in Toxicology Letters:   
Römer, I., Gavin, A. J., White, T. A., Merrifield, R. C., Chipman, J. K., Viant, M. R., & Lead, J. R. (2013). 
The critical importance of defined media conditions in Daphnia magna nanotoxicity studies. Toxicology 
letters, 223(1), 103-108. 
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VDW forces to induce formation of particle aggregates.  To reduce the likelihood of 
aggregation, particles are often coated in substances which either increase the electrostatic 
repulsion between particles, such as citrate or that prevent VDW interactions through steric 
hindrance of particle interactions such as polyvinylpyrrolidone (PVP) (Christian et al., 
2008). 
When particles are aggregated, the quantity of surface area available for interaction is 
reduced, potentially suppressing toxicity (Jiang et al., 2008).  The bioavailaility of 
aggregates is also seen to be less than dispersed particles, as large aggregates are more 
likely to be deposited in sediments removing them from the water column (Bradford et al., 
2009). If we are to account for any potential impact that aggregation may have on AgNP 
toxicity, particle stability must be fully characterised in the appropriate exposure 
conditions.  It has been shown previously that AgNPs stabilised with various capping 
agents (citrate, PVP and PEG) form aggregates in standard OECD ISO test media 
(media1) for D. magna acute toxicity tests (Römer et al., 2011; Tejamaya et al., 2012).  By 
diluting the standard media 10-fold, aggregation is reduced substantially without inducing 
immobilisation or a significant reduction in daphnid reproductive output (Römer et al., 
2011). What has not yet been observed is whether the aggregation induced by media 
composition has a significant impact upon the results of a D. magna acute immobilisation 
test.   
The primary aim of this chapter is to assess the impact that dilution of standard exposure 
media, and hence particle stability, has on acute nanoparticle toxicity. To that end, the 
dose-response relationships of cit-AgNPs and a non-nanoparticle control (AgNO3) were 
characterised in standard strength OECD ISO test water (media1) and a 10-fold dilution of 
this medium (media10).  To investigate the potential role of particle stability in any 
observed effect, stability assessed in media1, and a two-fold (media2) and ten-fold 
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(media10) dilution of media1 using AFM and TEM.  The results of this and previous 
studies determined the optimum combination of exposure medium and AgNPs that yield 
dispersed particles. 
To study the molecular level changes that occur in response to AgNP exposure, the use of 
exposure concentrations which do not induce organism death are required.  The large 
number of transcriptional and metabolic changes associated with death may mask the more 
subtle changes associated purely with adaptive responses to toxicant exposure.  To 
accurately select an appropriate concentration for omics exposures, the full dose-response 
relationship of both toxicants must be characterised.  As stated above (Section 1.2.3), the 
mechanism of AgNP toxicity is widely thought to be mediated by Ag+ ions which are 
released from the particles’ surface.  It is therefore imperative to control for the dissolved 
Ag+ component of nanoparticle exposures if we are to attempt to elucidate its role in AgNP 
toxicity (Allen et al., 2010; Kennedy et al., 2010; Zhao and Wang, 2012a).  Therefore the 
secondary aim of this chapter was to characterise the full dose-response relationship of 
both the AgNPs and Ag+ ions in the optimum test media, and to assess the amount of Ag+ 
released from AgNPs over the standard exposure period.  This enables the calculation of 
EC50 values for each toxicant and an accurate selection of sub-lethal exposure 
concentrations.  Through use of ultracentrifugation (UC) and ultrafiltration (UF) followed 
by inductively coupled plasma mass spectrometry (ICP-MS), the release of Ag+ from 
AgNPs in the selected exposure conditions can be assessed.   
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3.2 Materials and Methods 
3.2.1 Nanoparticle synthesis and characterisation - conducted by Dr. Isabella Römer 
& Dr. Mila Tejamaya (University of Birmingham) 
AgNPs stabilised with citrate and PVP were synthesised and characterised according to the 
methods outlined in Section 2.3. 
3.2.2 Determining the impact of media composition on cit-AgNP toxicity 
The impact of media composition on AgNP toxicity to D. magna was investigated through 
the exposure of D. magna neonates to increasing concentrations of 0.1, 0.5, 1.0, 2.5, 5.0, 
7.5, 10, 11.25 and 20 µg/l cit-AgNPs in media1 and media10 (compositions outlined in 
section 2.4.1).  To control for any potential change in toxicity due to sequestration of 
dissolved Ag by Cl- ions, D. magna neonates were also exposed to increasing 
concentrations of 0.1, 0.25, 0.5, 0.75, 1.00, 5.00 and 10.00 µg/l AgNO3 in media1 and 
media10 (equating to total silver concentrations of 0.06, 0.13, 0.31, 0.47, 0.63, 3.15 and 
6.30 µg/l).  Additional concentrations of 1.78, 2.37, 3.16 and 4.22 µg/l AgNO3 (equating 
to total silver concentrations of 1.12, 1.49, 1.99 and 2.66 µg/l respectively) were required 
to induce partial death in media1 to better characterise the dose-response curve.  The 
concentration ranges used for each form of silver were based upon the results of range-
finding exposures (unreported) that identified the EC50 for each AgNPs and AgNO3 as 
being between 1 - 10 µg/l and between 0.1 - 1 µg/l respectively.  Capping agent and 
untreated (water, 18.5 MΩ) controls were used to assess the potential adverse effects of the 
capping agent and background mortality. 
To initiate exposures, groups of 10 D. magna neonates (<24 h old) were added to exposure 
vessels (250 ml glass beaker, Fisher Scientific) containing either 200 ml of media1 or 
200 ml of media10 (adjusted to pH 7.5 as in section 2.4.1).  Volumes of a 12 mg/l stock of 
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cit-AgNP (prepared and concentration measured as in Sections 2.3 and 2.3.3 respectively) 
were added, in groups of 3 replicates per media composition, to prepare each of the nine 
nominal cit-AgNP exposure concentrations.  An analogous protocol was used with a 
1.79 mg/l stock of AgNO3 to prepare each of the 7 and 11 intended exposure 
concentrations in media 10 and media1 respectively. Once spiked, an additional 50 ml of 
appropriate media was added to each vessel to mix.  The exact volumes used in the 
production of these control groups and nominal exposure concentrations are outlined in 
Table 3.1.  Exposure conditions were otherwise as outlined in section 2.5.  
Animals were exposed for 24 h after which the total number of dead or immobilised 
neonates was counted.  Immobilisation is defined by the OECD, as “those animals not able 
to swim within 15 seconds after gentle agitation of the test container” (OECD, 2004). 
EC50s were calculated using the logistic analysis algorithms in Prism6 statistical analysis 
software (version 6.03, GraphPad Software Inc., California).  Briefly, the mean % 
immobilisation (± SEM) values were calculated from the raw data and plotted against their 
respective log10-transformed nominal concentration values using a sigmoidal (four-
parametric logistic) curve with lower and upper constraints of 0 and 100 % respectively.  
Where possible the resulting EC50 values were compared between exposures in media1 
and media10 for each toxicant by a sum-of-squares F-test in Prism6.   
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Table 3.1: Spiking volumes of a 1.79 mg/l AgNO3 stock needed to make the desired exposure 
concentrations upon addition to a total volume of 250 ml media1 or media10 
Desired Exposure 
conc. (µg/l) 
Spike volume 
(µl) 
0.10 14 
0.25 35 
0.50 70 
0.75 105 
1.00 140 
1.78 249 
2.37 331 
3.16 441 
4.22 589 
5.00 698 
10.00 1397 
 
Table 3.2: Spiking volumes of a 12.0 mg/l AgNP stock needed to make the desired exposure 
concentrations upon addition to a total volume of 250 ml media1 or media10 
Desired Exposure 
conc. (µg/l) 
Spike volume 
(µl) 
0.10 2 
0.50 10 
1.00 21 
2.50 52 
5.00 104 
7.50 156 
10.00 208 
11.25 234 
20.00 417 
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3.2.3 Determining the impact of media composition on cit-AgNP stability 
In parallel to the toxicity assessment of cit-AgNPs described above (section 3.2.2) the 
impact of media composition (outlined for all media types in Table 2.1) on particle 
stability was assessed through TEM and AFM measurement of particle size distributions 
and TEM measurement of particle circularity.  To assess stability, 46 ml aliquots (n=3 per 
media type) of a 12 mg/l stock solution of cit-AgNPs were added to 250 ml of media1, as 
well as media2 and media10, to a final concentration of 2.2 mg/l.  The final pH of 
solutions was adjusted to 7.5 through addition of 1 M HNO3 or NaOH to lower or raise the 
pH respectively. Suspensions were maintained at room temperature for 24 h to match the 
duration of an acute toxicity exposure before imaging with TEM and AFM.   
These suspensions of AgNPs were then prepared for TEM analysis by using the “drop 
method” as outlined previously (Domingos et al., 2009; Römer et al., 2013).  Briefly, a 
single droplet of AgNP suspension was partially dried at room temperature on a carbon-
coated copper mesh (Agar Scientific).  Once dry, samples were washed with ultrapure 
water (18.2 MΩ) and images were obtained with a transmission electron microscope 
(Tecnai F20, Phillips, Netherlands), and recorded and analysed using digital micrograph 
software (Gatan, Abingdon, UK) to measure size distribution and Image J to measure 
particle circularity.  Circularity is defined as the ratio of a particle’s area to its perimeter 
(Stevenson et al., 2012), and ranges from 0 (elongated or irregular shape) to 1 (circular 
shape). Where possible, mean circularity values as well as mean particle size distributions 
were compared between particle suspensions in each media composition by a 1-way 
ANOVA followed by a Tukey post-hoc test for multiple comparisons. 
Samples for AFM measurements were prepared by ultracentrifugation.  Briefly, 10 ml 
aliquots of AgNP suspensions were transferred into ultracentrifuge tubes containing a 
cleaved mica sheet on a flat polytetrafluoroethylene support.  Samples were then ultra-
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centrifuged (Beckman L7-65 Ultracentrifuge with SW40 swinging bucket rotor) at 10,000 
rpm, for 60 minutes at 15°C.  After centrifugation, the tubes were emptied, the PTFE 
supports removed and the mica sheets washed in high purity water (18.2 MΩ) and dried at 
ambient conditions prior to AFM analysis. Images were obtained with an AFM (XE 100, 
Park Systems) in non-contact mode, as described previously (Römer et al., 2013). Non-
contact mode silicon AFM Cantilevers PPP-NCHR were used (spring constant 42 N m−1), 
X–Y scan sizes were 5 µm × 5 µm with resolution of 250 pixels per line. Scanning rates 
were optimised to acquire a stable and clear image without damaging the tip or detaching 
particles during scanning, usually 0.3–1 Hz.  Images were recorded using XEP data 
acquisition software and analysed with XEI data analysis software (Park systems). Where 
possible, mean particle size distributions were compared between particle suspensions in 
each media composition by a 1-way ANOVA followed by a Tukey post-hoc test for 
multiple comparisons.  Both TEM and AFM analysis were done in equal collaboration 
with Dr Isabella Romer (University of Birmingham). 
3.2.4 Full characterisation of dose-response curves of PVP-AgNPs and dissolved Ag 
(from AgNO3) to D. magna neonates in media10 
Initial range-finding exposures (not reported) in media10 identified the EC50 for each form 
of Ag as being between 1 and 10 µg/l for AgNPs and between 0.1 and 1 µg/l of total Ag 
for AgNO3.  Following these range-finding exposures, nominal exposure concentrations of 
3.08, 3.54, 4.07, 4.70, 6.29, 8.38, 9.69, and 11.17 μg/l of PVP-AgNPs and 0.10, 0.18, 0.32, 
0.56, 0.75, 1.00 and 1.78 µg/l of AgNO3 (equating to 0.07, 0.12, 0.20, 0.37, 0.41, 0.62 and 
1.07 μg/l theoretical total Ag) were assembled to map the dose-response relationship for 
each form of Ag.  Capping agent (0.03 % v/v. PVP) and no-added silver controls were 
used to account for any potential impact of the nanoparticle capping agent and background 
mortality respectively.  
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PVP-coated AgNPs were prepared as outlined in section 2.3 and the final concentration 
was measured as 14.70 mg/l by ICP-MS using methods outlined in section 2.3.3.  This 
AgNP Master-Stock was then used directly to prepare Spiking-Stocks for each of the 8 
desired nominal AgNP exposure concentrations mentioned above using volumes outlined 
in Table 3.3.  A Master Stock of AgNO3 was prepared through the addition of 100.0 mg of 
AgNO3 (Sigma Aldrich) to 100 ml MilliQ water giving a nominal concentration of 1000 
mg/l.  A 1 in 100 dilution of this master stock, followed by a further 1 in 10 dilution was 
made to yield a Working Stock with a nominal concentration of 1 mg/l AgNO3. This 
AgNO3 Working-Stock was then used directly to prepare Spiking-Stocks for each of the 7 
desired nominal AgNO3 exposure concentrations using volumes outlined in Table 3.4.
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Table 3.3: Preparation of the AgNP spiking stocks from the 14.7 mg/l master stock.  The 
table gives the volumes of the 14.7 mg/l AgNP master stock used to prepare each of the 
spiking stocks.  Each spiking stock was designed to be 250 times more concentrated than the 
desired exposure concentration. 
Nominal conc. of AgNP (µg/l)   
Desired 
exposure conc. 
Spiking stock 
conc.  
Volume of 14.7 mg/l 
Master stock (µl) 
3.08 769 52 
3.54 884 60 
4.07 1016 69 
4.70 1176 80 
6.29 1573 107 
8.38 2095 143 
9.69 2422 165 
11.17 2793 190 
 
Table 3.4: Preparation of the AgNO3 spiking stocks from the 1 mg/l working stock.  The table 
gives the volumes of working stock used to prepare each spiking stock in a total volume of 10 
ml.  Each spiking stock was designed to be 250 times more concentrated than the desired 
exposure concentration. 
Nominal conc. of AgNO3 (µg/l)   
Desired 
exposure conc. 
Spiking stock 
conc.  
Volume of 1.0 mg/l 
Working stock (ml) 
0.10 25 0.25 
0.18 45 0.45 
0.32 80 0.80 
0.56 140 1.40 
0.75 188 1.88 
1.00 250 2.50 
1.78 445 4.45 
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To initiate toxicant exposures, groups of 10 neonates (<24 h old) were added using a 
plastic Pasteur pipette to 200 ml of media10 in 72 x 250 ml glass beakers.  In groups of 
four, these vessels were spiked with 1 ml of a Spiking-Stock immediately followed by a 
further 49 ml of media10 to mix. This produced the 8 desired AgNP concentrations along 
with the 7 desired AgNO3 concentrations complete with one PVP control and two no-
added silver control groups. Exposure conditions were otherwise as outlined in section 2.5.  
Animals were exposed for 48 h in total, with the number of dead or immobilised neonates 
counted after 24 h and 48 h.  Immobilisation is defined by the OECD, as “those animals 
not able to swim within 15 seconds after gentle agitation of the test container” (OECD, 
2004). EC50s were calculated using the logistic analysis algorithms in Prism6 statistical 
analysis software (version 6.03, GraphPad Software Inc., California).  Briefly, the mean % 
immobilisation (± SEM) values were calculated from the raw data for each group and 
plotted against their respective log10-transformed nominal total Ag concentrations using a 
sigmoidal (four-parametric logistic) curve using lower and upper constraints of 0 and 
100 % respectively. The resulting EC50 values of PVP-AgNPs and AgNO3 were compared 
at each time point by a sum of squares F-test in Prism6. 
3.2.5 Measurement of PVP-AgNP dissolution in media10  
Three individual suspensions of PVP-AgNPs were made through the addition of 140 µl 
from a 8.839 mg/l stock solution (approximately 8 mg/l) in triplicate to 200 ml of 
media10.  The final volume was made up to 250 ml to mix yielding a final nominal AgNP 
concentration of approximately 5 µg/l.  No daphnids were present during the 48 h period.  
Kept alongside the three nanoparticle suspensions were three control beakers consisting of 
250 ml of media10 and no additional nanoparticles. The separation of the nanoparticle and 
ionic fractions of PVP-AgNP suspensions was attempted using ultacentrifugation (UC) 
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and ultrafiltration (UF) prior to measurement of their respective concentrations by ICP-MS 
(section 3.2.8). 
3.2.6 Assessment of particle dissolution by ultracentrifugation 
Aliquots (5 ml) of the PVP-AgNP suspensions and control samples were removed at 0, 24 
and 48 h after particle dispersal into UC tubes (14 ml, Ultra-Clear, Beckman Coulter, 
USA). These aliquots were then made up to a total volume of 10 ml with ultrapure water 
(18.2 MΩ, Purelab), and vortex mixed before centrifugation at 30000 rpm for 1 h at 10 °C 
in a (L7-65 ultracentrifuge using a SW 40 swinging-bucket rotor, Beckman Coulter, USA).  
In theory, ultracentrifugation of AgNP suspensions should result in the concentration of 
AgNPs at the bottom of the test tube, while any dissolved Ag should remain in solution 
dispersed evenly throughout the solution.  Following UC separation, 4.9 ml of solution 
was removed from the top of each sample.  This 4.9 ml top aliquot, along with the 
remaining 5.1 ml bottom aliquot for each sample, was subsequently acidified by the 
addition of 2.0 ml and 1.8 ml concentrated (69 % v/v) nitric acid (HNO3, trace metal 
grade, Fisher Scientific) respectively.  The acidification of samples to 20 % HNO3 
followed by vortex mixing until colourless ensured the total Ag content of each sample 
was fully dissolved ready for analysis.   
3.2.7 Assessment of particle dissolution by ultrafiltration 
Triplicate aliquots (10 ml) of the 5 μg/l PVP-AgNP dilutions were taken at 0, 24 and 48 h 
after particle dispersal and transferred directly into separate UF cells (10 ml, Millipore 
UK). Each cell was fitted with a 1 kDa NMWL filter with a 2nm pore (25 mm, Ultracel 
regenerated cellulose) and a magnetic stir-bar.  Cells were pressurised with nitrogen gas 
(N2, 1 bar) for approximately 1 h, with constant stirring, until the volume of solution had 
reduced by half.  The 2 nm pore filter used in this study should trap AgNPs (which are 
10.8 ± 3.3 nm in diameter) inside the ultrafiltration cell allowing only water and dissolved 
  
58 
 
substances through the pores.  Any form of Ag that passes through the 2nm pore should, in 
theory, be dissolved silver.  However in actuality this will include the free silver ion, Ag 
salt complexes and any Ag compounds < 2 nm.  All nanoparticles used in this study have 
been filtered and washed by ultrafiltration previously so only particles which are 10.8 ± 
3.3 nm in diameter remain within the sample.  Stirring was stopped and pressure relieved 
before 4 ml aliquots of both the filtrate and filtrand were transferred to acid-washed 
scintillation vials. Nanoparticle aliquots were acidified to 20 % HNO3 by the addition of 
1.9 ml of concentrated HNO3 (trace metal grade, Fisher Scientific) and vortex-mixed to 
ensure complete dissolution of total silver prior to measurement by ICP-MS.  Aliquots 
expected to contain dissolved silver (the top fraction of UC samples and the filtrand of UF 
samples) were acidified to 10 % HNO3 by the addition of 0.95 ml of concentrated HNO3 
(trace metal grade, Fisher Scientific) and vortex-mixed to ensure complete dissolution of 
total silver.  The dissolved Ag fractions were expected to contain concentrations of silver 
close to the detection limit of the ICP-MS instrumentation so the lower concentration of 
HNO3 used was to minimise dilution of samples. 
3.2.8 Measurement of silver dissolution samples by ICP-MS 
All acidified samples from sections 3.2.6 and 3.2.7 were diluted 10-fold to a final HNO3 
concentration of approximately 2% and were subsequently analysed for total silver 
concentration by ICP-MS as outlined in Section 2.3.3.  The analyses were conducted using 
an Agilent 7500c with an Octopole Reaction System calibrated for use between 0 and 200 
µg/l and with a lower detection limit of 0.02 µg/l.  An average reading was taken from 4 
technical replicate measurements for each sample of dosed media; these readings were 
then converted into a concentration (in µg/l) from the calibration graph.  To investigate the 
potential interference of media10 with the measurement of dissolved total silver, two spike 
recovery tests were performed using a sample of the same batch of media10 used in 
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exposures.  The first test using a final spike concentration of 1 ppb gave a return reading of 
1.02 ppb and the second using a final concentration of 10 ppb gave a return reading of 
10.03 ppb, indicating that the media component had no impact on the measurements.  All 
submitted control samples resulted in a total silver content below the limit of detection 
signifying the background Ag content of exposures to be, at the very least, <0.02 µg/l.  
ICP-MS measurements were conducted by Dr Steve Baker (University of Birmingham). 
The concentration of dissolved silver in the exposure vessels at 0 h, 24 h and 48 h was 
calculated using Equation 3.1.  Briefly, the concentration of total silver measured in the top 
fraction of UC samples or the filtrate of UF samples [Ag]dm was multiplied by the total 
factor of dilution (D) that occurred during sample preparation (14.75 fold dilution in total).  
Theoretically, as described above (sections 3.2.6 and 3.2.7), these fractions should contain 
only dissolved Ag species and as such should be representative of the total dissolved silver 
fraction of exposures once dilutions during preparation are taken into account.  The 
concentration of the AgNP fraction is calculated using Equation 3.2.  The total silver 
concentration of the lower UC fraction and UF filtrand should theoretically contain both 
dissolved and concentrated nanoparticle silver.  As such is representative of the total silver 
concentration of the media once dilutions during preparation and concentration of AgNP 
fraction has been taken into account.  The initial concentration of AgNPs [Ag]NP is 
therefore calculated through the multiplication of the measured total silver fraction [Ag]tm 
by the dilution factor (D) of sample preparation.  This resulting figure then has the [Ag]ds 
value calculated earlier subtracted from it before dividing the result by the concentration 
factor (C); the factor by which the nanoparticles have become concentrated from the 
original aliquot.  The mean total Ag concentrations measured following UC and UF 
separation are given in the Appendix (Table 9.1 and Table 9.2 respectively). 
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The percentage dissolution was then calculated by dividing the concentration of the 
dissolved Ag fraction [Ag]d by the total silver concentration of the exposure media 
([Ag]NP+[Ag]I) and multiplying the resulting fraction by 100 (Equation 3.3).  The resulting 
data were compared for each technique across treatment type and dissolution duration by a 
2-way ANOVA followed by a Sidak’s comparison test. 
  
  
61 
 
Equation 3.1 – Calculation of dissolved silver content in spiked exposure media. Where [Ag]ds 
is the concentration of dissolved silver  in the exposure sample, [Ag]I is the measured 
concentration of total silver in the top fraction following UC or the filtrate of UF and D is the 
total dilution factor used in sample preparation. 
[𝐴𝑔]d = [𝐴𝑔]dm × 𝐷 
Equation 3.2 - Calculation of nano-silver content in spiked exposure media. Where [Ag]NP is 
the concentration of the AgNP fraction within the exposure vessel, [Ag]Tm is the measured 
concentration of the  UC bottom fraction or the UF filtrand, D is the dilution factor from 
sample preparation and C is the nanoparticle concentration factor from UC or UF. 
[𝐴𝑔]NP =(([𝐴𝑔]tm × 𝐷) − [𝐴𝑔]d) ÷ 𝐶 
Equation 3.3 - Calculation of nanoparticle dissolution.  The dissolution of each sample (% 
total Ag) is the concentration of the dissolved fraction of the spiked exposure media ([Ag]d) as 
a percentage of the concentration of both the nanoparticle and dissolved silver fractions. 
% dissolution = (
[𝐴𝑔]d
[𝐴𝑔]d+ [𝐴𝑔]NP
) × 100 
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3.3 Results and Discussion 
3.3.1 Importance of media composition in nanoparticle toxicity testing 
The potential impact of the concentration of D. magna culture media on cit-AgNP acute 
immobilisation exposures was assessed in media1 and media10.  Groups of D. magna 
neonates were exposed to increasing concentrations of cit-AgNPs, as well as Ag+ ions to 
control for any non-nanoparticle specific effects in media1 and media10 only.  Under all 
conditions, immobilisation followed a concentration-dependent pattern with an absence of 
adverse effect in both the negative and capping agent controls. For cit-AgNPs in media10 a 
lowest observed adverse effect concentration (LOAEC) of 2.5 μg/l was observed, with 
total immobilisation occurring at 10 μg/l (Figure 3.1). The corresponding LOAEC in 
media1 was 11.25 μg/l and, despite an increased exposure range of up to 20 μg/l, complete 
immobilisation was not achieved (Figure 3.1).  The EC50 for AgNPs was calculated as 
7.70 μg/l in media10 and nominally stated as being 20.00 μg/l in media1.  Due to the 
incomplete dose-response curve in media1, a comparison by sum of squares F-test was not 
possible.  However, in media1 the lowest observed effect is induced at a concentration 
shown to cause total immobilisation in media10.  The non-nanoparticle control exposures 
of AgNO3 in media10 began inducing immobilisation from 0.31 µg/l until total 
immobilisation was observed at 3.15 µg/l. In media1, immobilisation was induced between 
0.63 and 1.12 µg/l until total immobilisation was observed at 1.49 µg/l. Through use of the 
logistic approach EC50s were calculated as being 0.61 µg/l in media10 and 1.10 in media1.  
These two EC50s were deemed as not being significantly different through use of a sum-of-
squares F-test, nevertheless the EC50 of AgNO3 in media1 is greater than in media10.   
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Figure 3.1 - Sigmoidal dose-response curves showing the mean percentage immobilisation of 
D. magna neonates (n=3) ± SEM in response to increasing concentrations of Ag+ ions (a) and 
cit-AgNPs (b) in media1 (grey) and media10 (clear).  The concentration of total Ag has been 
log10-transformed for the application of the logistic model.  Media1 and media10 dose-
response curves for each toxicant were compared by a sum-of-squares F-test. Log EC50 
values of AgNO3 exposures in media1 and media10 were determined as the same for each 
data set (p>0.05) whereas comparison of AgNP exposures was not possible due to incomplete 
characterisation in media1.  
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These results suggest that the toxicity of the cit-AgNPs used in this study is impacted by 
the composition of exposure media.  This potential media-dependant reduction in toxicity 
could occur for two reasons.  Firstly, if AgNP toxicity is mediated by the free silver ion as 
previously hypothesised, the decreased concentration of chloride ions in media10 could 
allow for greater availability of the free silver ion which could also potentially result in an 
increase in AgNP toxicity.  The non-nanoparticle control of AgNO3 does show a slight, yet 
insignificant reduction in toxicity to D. magna when dispersed in media1 compared to 
media10.  This slight change may be due to the higher concentration of Cl- in media1 
driving an increased formation of insoluble AgCl thus reducing the bioavailability of Ag to 
D. magna.  However if the formation of AgCl does reduce the toxicity of AgNO3 it does 
not do so significantly between these two compositions of media (Figure 3.1).   
Secondly, as would be expected from DVLO theory, the reduced concentration of ions in 
media10 could allow for greater dispersal of the citrate-capped nanoparticles, which could 
result in greater nanoparticle toxicity. This second potential explanation was investigated 
through measurement of the size distribution and circularity of the particles in these media 
as well as an additional dilution (media2).  The size distributions of particles were 
measured by TEM and AFM, and the circularity ratio of particles – a measurement of 
particle shape – was measured by TEM.  In media1 and media2, it was not possible to 
determine an accurate distribution of primary particle size due to the presence of large 
polydisperse particles and aggregates (Figure 3.2).  In media10, particle aggregates were 
not observed and as such it was possible to measure an accurate size distribution by both 
TEM (10 ± 5nm) and AFM (7 ± 3nm) of the mono-disperse particles in suspension 
(summarised in Table 3.5).  A statistical comparison of primary particle size distributions 
between media was therefore not possible, but aggregation of particles in media1 and 
media 2 is apparent through observation by TEM (Figure 3.2).   
  
65 
 
 
Figure 3.2: TEM (left) and AFM (right) images of cit-AgNPs suspended in standard OECD 
ISO test water (media1 (A)), as well as a 2-fold (media 2 (B)) and 10-fold dilution of the 
media (media10 (C)). The TEM scale bar represents 100 nm in images A and B, but 20 nm in 
image C. In the two most concentrated media (images A and B), large particle aggregates can 
be seen whereas in media10 (C) particles are evenly dispersed with little observed 
aggregation.  Images are representative of 3 separate dispersions in each media type (adapted 
from Romer et al 2013). 
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Table 3.5 - The size-ranges (nm) of single particles, particle aggregates and circularity ratios of cit-AgNPs suspended in media1, media2 and 
media10 as measured by TEM and AFM.  The mean particle size measurements are calculated from a minimum of 100 observations across 3 
replicate dispersions in each media type.  Accurate particle size distributions could not be made in media1 or media2 due to the presence of large 
polydisperse aggregates.  In these cases the approximate range of single particle sizes is included.  Table adapted from Romer et al., 2013.  A 1-
way ANOVA indicated the circularity of particles in media1 and media2 were not significantly different (p=0.9388), but that particle circularity 
of particles in media 10 were significantly different compared to in media1 and media 2 (p<0.001 in both cases). 
Measurement 
Range of aggregate 
sizes TEM (nm) 
Single particle size 
TEM (nm) 
Single particle size 
AFM (nm) 
Circularity (from 
TEM) 
Media1 50 - 3300 2 - 40 N/A 0.28 ± 0.13 
Media2 60 - 1100 3 - 60 N/A 0.25 ± 0.12 
Media10  N/A 10 ± 5  7 ± 3  0.95 ± 0.06 
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The circularity ratios obtained for media1 and media2 were 0.28 ± 0.13 and 0.25 ± 0.12 
respectively (Table 3.5) suggesting the presence of irregular-shaped particle aggregates 
(Stevenson et al., 2012).  Values for circularity of cit-AgNP suspension in media10 were 
much closer to 1 (0.95 ± 0.06) suggesting the presence of circular structures which were 
confirmed as disperse particles by TEM (Figure 3.2).  Following a 1-way ANOVA and 
Tukey post-hoc test, the circularity of particles suspended in media1 and media2 were not 
shown to be significantly different (p=0.9388).  Conversely, circularity of cit-AgNPs 
suspended in media 10 were seen to be significantly different to suspensions in both 
media1 and media2 (p<0.001).  
These results suggest that dilution of media1 to media10 has resulted in reduced 
aggregation of cit-AgNPs and increased particle dispersion and stability.  This results 
corresponds with data published previously where these same particles were measured in 
media1, media2 and media10 using DLS and Fl-FFF (Römer et al., 2011).  This increased 
stability could be a result of the reduced overall ionic strength of the media.  It has been 
previously noted that the overall concentrations of salts within exposure media can affect 
the stability of AgNPs (Badawy et al., 2010) and induce the formation of aggregates 
(Römer et al., 2011; Tejamaya et al., 2012).  Likewise this increased stability could be the 
result of a reduction in any of the individual ions that are present in the media. It has been 
shown, for example, that millimolar concentrations of Ca have been shown to induce 
aggregation of AgNPs (Badawy et al., 2010; Piccapietra et al., 2012; Behra et al., 2013).  
The nominal concentration of CaCl2 in media1 is 2mM compared to 0.2 mM in media10 
which could explain the decreased aggregation of AgNPs.   
When the cit-AgNP stability data in media1 and media 10 are coupled with the 
corresponding toxicity data, it is possible to infer that when media1 is diluted to media10, 
cit-AgNPs are more dispersed leading to a truer assessment of AgNP toxicity to D. magna. 
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The overall ionic strength of the two dilutions of media were not measured, neither were 
the individual concentrations of the constituent salts.  Therefore the exact route cause of 
this increased stability it cannot be categorically concluded.  Regardless of the initial 
cause, it is apparent that the stability of particles within this media is increased, and 
previous work in this medium has identified an absence of acute and chronic effects on 
D. magna cultured in this media (Römer et al., 2011). This therefore makes media10 an 
adequate candidate for AgNP exposures.  
3.3.2 Characterisation of PVP-AgNP and Ag+ toxicity to D. magna in media10 
In addition to media composition it is possible to reduce the likelihood of particle 
aggregation further by using AgNPs capped with a more stable capping agent.  PVP-
AgNPs have been shown previously to be very stable in the three dilutions of media used 
here (Tejamaya et al., 2012).  In order to ensure that all following exposures are with fully 
dispersed AgNPs, a combination of PVP-AgNPs and media10 was used.  The results of 
initial range-finding studies revealed that the EC50s of PVP-AgNPs at 24 and 48 h lie 
between 1 µg/l and 10 µg/l, respectively, and the AgNO3 EC50s lie between 0.1 µg/l and 1 
µg/l.  Following the results of these studies, exposures were designed within these 
concentration ranges in an attempt to fully characterise the dose-response relationship 
between the exposure concentration of these toxicants and the endpoint of daphniid 
immobilisation (Figure 3.3).  The EC50s for both AgNPs and Ag
+ were calculated at 24 h 
and 48 h post-exposure with the EC50 for Ag
+ calculated from the corrected weight of 
AgNO3 to account for relative weight of Ag
+.  At 24 h, the EC50 values for AgNP and Ag
+ 
are 7.24 μg/l and 0.48 μg/l respectively.  At 48 h the toxicity of both toxicants appears to 
increase slightly, with EC50 values of 4.82 μg/l and 0.40 μg/l for PVP-AgNPs and Ag
+ ions 
respectively. EC50s for PVP-AgNPs and Ag
+ ions were found to be significantly different 
at 24 h (p < 0.0001) and again at 48 h (p < 0.0001).  A full account of EC50s and 95 % 
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confidence intervals for PVP-AgNPs, AgNO3 and the corrected values accounting for 
relative weight of Ag+ from AgNO3 are tabulated in Table 3.6.  It is apparent from these 
results that dissolved silver ions are significantly more toxic to D. magna neonates than the 
nanoparticles used in this study.  The EC50 values obtained here are similar to those 
reported in previous published material (Hoheisel et al., 2012; Asghari et al., 2012; 
Newton et al., 2013; Ribeiro et al., 2014), which all observed dissolved Ag (from AgNO3) 
as being significantly more toxic than AgNP.    
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Figure 3.3: Sigmoidal dose-response curves showing the immobilisation of D. magna neonates 
in response to increasing concentrations of PVP AgNPs (blue squares) and AgNO3 (red 
circles) over 24 h (darker coloured symbols, solid line) and 48 h (lighter coloured symbols, 
dashed line) exposure durations. Concentrations are given as log10 transformations of the 
theoretical total Ag concentration of each exposure group.  Points represent average number 
of immobilised organisms (n=4) ± standard error of the mean. 
  
  
71 
 
Table 3.6: Median effect concentrations (EC50) in µg/l of PVP-AgNPs, and AgNO3 after 24 h 
and 48 h exposures to D. magna neonates.  AgNO3 concentrations are given as theoretical 
total Ag concentration.  Lower (LCI) and upper (UCI) 95% confidence intervals are also 
shown. 
  
Concentration (μg/l) 
Toxicant Time-point EC50 95 % LCI 95 % UCI 
PVP-AgNP 
24 h 7.24 6.80 7.71 
48 h 4.82 4.21 5.53 
Ag 
24 h 0.48 0.44 0.53 
48 h 0.40 0.39 0.41 
 
3.3.3 Measuring dissolution of AgNPs in D. magna exposure media 
The two techniques used to separate the nanoparticle and ionic components of PVP-
AgNPs yielded differing results which are compared in Figure 3.4.  When using UC, it is 
suggested that the majority of total measured silver was in the dissolved form prior to 
acidification.  At 0, 24 and 48 h post-exposure, Ag+ accounted for 89.75 ± 3.49, 82.48 ± 
4.49 and 87.40 ± 3.17 % of the total silver concentration respectively (Figure 3.4 (a)) 
suggesting the nanoparticles almost completely dissolve upon addition to the exposure 
media.  As can be seen from the dose-response characterisations in this chapter (Figure 
3.3, Table 3.6), the dose response curves and EC50 values for PVP-AgNP and Ag
+ (both at 
24 and 48 h) are significantly different from one another.  If the results of the UC study are 
a true reflection of PVP-AgNP dissolution, then this should be reflected in the toxicity 
data; i.e. the nanoparticle EC50 should be much closer to the dissolved Ag EC50 due to the 
presence of high concentrations of dissolved Ag.  Although the two fractions themselves 
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were not checked for the presence of particles by an observational technique, if 80 - 90 % 
of the particles were to dissolve upon addition to media, it would have made 
characterisation by TEM difficult.  This leads me to surmise that these results are 
inaccurate, and that either UC simply does not affect particles of this size (10 nm) or that 
the pellet formed was very unstable and re-suspended before the layers were separated.  In 
contrast to UC, the dissolution study using UF suggests a much lower level of dissolution 
that does not appear to change significantly over the 48 h exposure period (Figure 3.4 (b)).  
It is also apparent that despite repetitive cleaning washes, a minor background of dissolved 
Ag+ is inevitable.  Immediately after addition to exposure media, Ag+ ions accounted for 
4.05 ± 1.15 % (mean ± SD) of the total Ag concentration.  After 24 and 48 h in exposure 
media, the average concentration of the dissolved silver component was 5.68 ± 2.87 and 
8.15 ± 3.60 % of the total concentration of Ag respectively (Figure 3.5).  These values are 
similar to previously reported % dissolution values for PVP-coated AgNPs (Zhao and 
Wang, 2012a; Yang et al., 2012; Groh et al., 2014).  The results of the UF dissolution 
study will therefore be used to control for Ag+ release from the AgNP exposures over the 
defined exposure period. 
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Figure 3.4: Relative mean percentage ± SEM of nanoparticle (white) and dissolved (dark 
grey) silver in terms of total silver as determined by ultracentrifugation (A) and 
ultrafiltration (B) taken at 0, 24 and 48 h post-exposure. Error bars are representative of the 
standard deviation, n=3 per time point.  A 2-way ANOVA followed by Sidak’s multiple 
comparison test determined no significant change in concentration of either form of silver 
over time.  In both cases the technique was deemed to have a significant impact upon the 
proportions of nanoparticle and dissolved silver (p<0.0001)  
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Figure 3.5: Relative mean percentage ± SEM (n=3 per time point) of ionic silver in terms of 
total silver as determined by ultrafiltration 0, 24 and 48 h post-exposure.  The apparent 
increase over time was determined to be not-significant by 1-way ANOVA (p=0.4226). 
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3.4 Conclusions 
TEM and AFM confirm that cit-AgNPs suspended in media10 are dispersed, whereas in 
media1 the formation of aggregates is observed.  This observed increase in stability with 
reduced nominal concentration of salts within culture/exposure media is in accordance 
with DLVO theory, whereby an increased ion concentration shields the surface-charges of 
nanoparticles allowing them to come into sufficiently close contact for aggregation to 
occur.  The observed significant reduction in toxicity of AgNPs dispersed in media1 is not 
seen for AgNO3 in media10 suggesting that this is a consequence of nanoparticle 
aggregation and not increased sequestration of the dissolved component by Cl- ions.  To 
fully assess the toxicity of AgNPs we need them in their dispersed form (Stevenson et al., 
2012). From the results of this and previous studies (Römer et al., 2011; Tejamaya et al., 
2012) it is clear that media10 presents an ideal medium in which to achieve increased 
particle dispersal for toxicity assessment.  In addition to this, the likelihood of particle 
aggregation can be reduced further through use of capping agents that induce stability 
through steric hindrance and not charge-based repulsion.  PVP-AgNPs have been shown 
previously to be very stable in the three dilutions of media used here (Tejamaya et al., 
2012).  In order to ensure that all following exposures, specifically those intended to 
induce a sub-lethal toxic response, are with fully dispersed AgNPs, a combination of PVP-
AgNPs and media10 was used. 
The fully characterised dose-response curves and EC50 values for PVP-AgNPs and AgNO3 
reflect the same comparisons in previously reported studies (Hoheisel et al., 2012; Asghari 
et al., 2012; Newton et al., 2013; Ribeiro et al., 2014) that conclude dissolved silver (from 
AgNO3) is more toxic to D. magna than AgNPs.  This is an observation that has also been 
made in the comparison of other metal or metal-oxide nanoparticles with the EC50’s of 
their respective dissolved forms (Notter et al., 2014).  The dissolution of PVP-AgNPs over 
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24 h and 48 h, measured by ICP-MS following UF, were found to be similar to previously 
reported values (Zhao and Wang, 2012a; Yang et al., 2012; Groh et al., 2014).   
For the planned exposures for omics analyses, the planned concentration of the dissolved-
Ag groups would be 5.68 ± 2.87 % over 24 h or 8.15 ± 3.60 % over 48 h of the AgNP w/v 
concentration.  This would be to ensure animals in the dissolved-Ag control groups were 
exposed to the same concentration of dissolved Ag as animals in the respective AgNP 
groups.  The 48 h exposure duration suggested by the OECD is designed to observe a final 
outcome of immobilisation or organism death whereas the initial transcriptional response 
to toxicant exposure and likewise the resulting impact on metabolism will occur much 
earlier, within the first 24 h. Therefore, an exposure duration of 24 h was selected as the 
optimum window to capture the transcriptional and metabolic response.  This exposure 
duration has been used previously in –omic analyses of D. magna toxicity tests (Poynton 
et al., 2012).  To detect the subtle molecular responses of D. magna to AgNP and AgNP 
exposure, a range of concentrations was selected – thus enabling identification of potential 
concentration dependant responses – which are high enough to induce a subtle response 
but low enough avoid lethality.  The lowest observed adverse effect concentration 
(LOAEC) of PVP-AgNPs was observed to be approximately 4.70 µg/l over 24 h and 
3.08 µg/l over 48 h.  Only three neonates were immobilised at this concentration at 24 h 
suggesting a threshold point between maximum tolerance and immobilisation.  The 
LOAEC for the chosen exposure period was therefore selected as the maximum PVP-
AgNP exposure concentration. Following the results of the UF dissolution test, the Ag 
control concentrations would be 5.68 ± 2.87 % of the AgNP w/v concentration. 
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Chapter 4: Determining the role of Ag+ ions in AgNP toxicity 
4.1 Introduction 
Studies investigating AgNP toxicity often centre on whether dissolved Ag released from 
the nanoparticle surface is the sole cause of nanoparticle toxicity (Lubick, 2008).  From the 
literature (reviewed in section 1.2.3) it is possible to conclude three potential MoAs 
relating to the role of dissolved Ag in AgNP toxicity to D. magna (Figure 4.1).  Firstly, 
AgNPs dissolve within the exposure medium and the resulting dissolved Ag is absorbed 
by D. magna, primarily at the site of ion-exchange, resulting in a toxic response.  
Secondly, both the AgNP and any dissolved Ag are absorbed by D. magna and induce 
independent but potentially synergistic mechanisms of toxicity.  The third possibility is a 
‘Trojan Horse’ mechanism, whereby AgNP dissolve internally following absorption by 
D. magna; this results in a highly-concentrated, localised release of Ag. Toxicity in the 
Trojan horse mechanism is thought to be induced primarily by the dissolved silver, with 
AgNPs being the vehicle for delivery. 
The primary aim of this chapter was to determine which of these potential mechanisms are 
true for AgNP. To that end, using optimal exposure conditions determined in Chapter 3, 
D. magna neonates were simultaneously exposed to AgNPs and to the concentration of the 
dissolved Ag fraction (from AgNO3) measured to be released from these particles into 
media10 over a 24 h exposure period (section 3.3.3).  The impact of these exposures was 
then assessed by a custom Agilent D. magna microarray, and by direct infusion FT-ICR 
MS; the resulting data were analysed by multivariate and univariate statistical analyses.    
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Figure 4.1 The three hypothesised roles of Ag+ in AgNP toxicity to D. magna. (1) AgNPs 
dissolve completely externally to the organism and toxicity is induced by the dissolved silver 
alone. (2) AgNPs are absorbed by the organism and exert toxicity by an independent and 
potentially synergistic mechanism to dissolved Ag. (3) AgNPs are absorbed and dissolve 
internally, resulting in a concentrated release of Ag+ which are then the sole mediators of 
toxicity. 
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Similarities or discrepancies between these exposure profiles measured by this dual-omics 
approach will give an enhanced insight into the role of dissolved Ag in AgNP-induced 
toxicity through a direct comparison of the induced molecular level changes.  Certain 
molecular responses have been shown to occur following exposure to both Ag and AgNP. 
For example, Ag+ is known to impact Na+/Cl- transport and Na+/K+-ATPases, an effect 
which may be reflected in the transcription of their respective genes.  AgNP have been 
also observed to disrupt the transport of Na+ by these enzymes but at a reduced level 
(Stensberg et al., 2013).  Both forms of silver have also been identified as causing an 
increase in protein-thiols (Rainville et al., 2014), such as glutathione, cysteine residues and 
metallothioneins.  Impacts on amino acids and sugars have been measured as being similar 
for both forms of silver (Li et al., 2015a), as has their impact on genes for oxidative 
phosphorylation complexes I, II, III and IV (Aerle et al., 2013). If AgNP toxicity is due 
solely to the dissolved fraction, which would be the case in both mechanism 1 and 3 above 
(Figure 4.1), we would expect to see similar changes in the molecular response of 
D. magna exposed to AgNPs and to the respective dissolved fraction alone. 
Likewise any discrepancies in the MoAs of AgNP and Ag+ ions will be observed.  For 
example, as well as the reduced efficiency for Na+ transport disruption of AgNPs 
mentioned above (Stensberg et al., 2013), other molecular effects have been identified 
which are specific to either AgNP or dissolved Ag exposure.  It is known, for example, 
that AgNPs and Ag+ ions enter cells by differing methods; Ag+ ions through ion-transport 
pumps (Bury and Wood, 1999) and AgNPs primarily by clathryn-mediated endocytosis 
(Asharani et al., 2009). There may be differing levels of expression in the genes associated 
with these processes upon exposure to either dissolved silver or AgNPs.  High-throughput 
superSAGE (serial analysis of gene expression) in zebrafish embryos identified 13 
D. magna genes unique to the response to AgNP exposure and 32 genes unique to 
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dissolved Ag treatment including cyclic AMP-dependent transcription factor ATF-4 (Aerle 
et al., 2013).  If AgNPs induce an independent molecular response, the patterns of gene-
expression and metabolite production will be noticeably different to those induced by 
AgNO3 exposure.   
In this chapter a dual-omics approach is taken to compare the perturbations induced in the 
overall transcriptional and metabolic profiles of D. magna, following exposure to 
increasing concentrations of AgNPs and AgNO3.  As an additional stage of investigation, 
the uptake and elimination of Ag in D. magna at these concentrations was assessed.  By 
confirming the presence of Ag within or on the organisms it will allow the differentiation 
between some of the hypothesised mechanisms. If only dissolved silver is available to 
D. magna neonates then these exposures will result in similar concentrations of Ag 
associated with the exposed neonates.  If the nanoparticle form of silver is ingested, then a 
greater Ag body burden would be expected in those animals exposed to AgNPs.  The 
pattern of Ag elimination from the organisms can give an insight into the extent of Ag 
accumulated within tissues and cells. 
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4.2 Materials and Methods 
4.2.1 Sub-lethal omics exposure studies  
Nominal exposure concentrations of 4.70, 2.35, 1.18 and 0.59 μg/l AgNPs (AgNP High, 
Mid, Low and V. Low respectively) were used alongside nominal concentrations of 0.44, 
0.22, 0.11 and 0.06 µg/l AgNO3 (Ag
+ High, Mid, Low and V. Low respectively). These 
exposure concentrations of AgNO3 equate to 0.28, 0.14, 0.07 and 0.04 μg/l of total Ag 
corresponding to approximately 6 % of the respective AgNP exposures.  Untreated 
(deionised water; no-added silver), capping agent (0.03 % v/v. PVP) and bulk silver 
(4.7 μg/l, 3μm average diameter, Sigma Aldrich) controls were used to account for 
background mortality, any potential impact of the capping agent, and to control for 
potential aggregation effects respectively.  The Ag filtered from the AgNP stock prior to 
use was included as an additional filtrate control.  Each group contained 6 biological 
replicates and all exposures were performed in media10. For each desired control, AgNP 
and AgNO3 exposure concentration to be used, a 250-fold concentrated stock was made.  A 
master sock of PVP-AgNPs was prepared as outlined in section 2.3 and measured by ICP-
MS (section 2.3.3) to have a concentration of 14.7 mg/l. Separately, 117.5, 58.8, 29.4 and 
14.7 µl of this stock were diluted with MilliQ water to a volume of 10 ml to produce 
spiking stocks for the AgNP High, Mid, Low and V Low groups respectively. A AgNO3 
Master-Stock was produced as before (section 3.2.4) by weighing 100.5 mg AgNO3 into 
100 mL MilliQ water to give a nominal concentration of 1 g/l. This stock was 
subsequently diluted 1 in 100 followed by a subsequent 1 in 10 dilution to produce a 
working stock with a nominal concentration of 1 mg/l.  Seperately, 1100, 550, 275 and 150 
µl of this stock were diluted to 10 ml with MilliQ water to produce spiking stocks for the 
Ag+ High, Mid, Low and V Low groups respectively. The exposure groups used and the 
desired nominal exposure concentrations are outlined in (Table 4.1).   
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Table 4.1 Outline of the nominal exposure concentrations for AgNP and AgNO3 exposures 
for omics analysis. All concentrations are in terms of total Ag content with the exception of 
the PVP-control which is % volume/volume. 
 
Each biological replicate consisted of 30 D. magna neonates (<24 h) with 6 biological 
replicates per treatment group. The AgNP High group had an additional 2 replicates (n = 8 
in total) to account for potential mortalities induced by the higher concentration.  Groups 
of 30 D. magna neonates (<24 h) were added to individual exposure vessels (250 ml glass 
beaker, Fisher Scientific) containing 200 ml of media10.  The appropriate spiking stock 
(1 ml) was then used to spike the study medium followed immediately by 49 ml of 
additional media10 to mix.  Exposure vessels were kept as described in section 2.5. Tests 
were only considered valid if no more than 10% of control animals were immobilised 
during the exposure.  Following exposure, animals were filtered from media into a 
precellys homogenization tube (Stretton Scientific Ltd., UK), flash frozen in liquid 
nitrogen and stored at -80 °C prior to extraction. 
4.2.2 Dual-omics extraction protocol 
Frozen animals (30 neonates per sample) were homogenised using a Precellys-24 ceramic 
bead-based homogeniser (Stretton Scientific Ltd., UK) in 448 μl of a 5:2 mix of methanol 
High Mid Low V.Low
AgNP 4.70 2.35 1.18 0.59
AgNO3 
(total Ag)
0.28 0.14 0.07 0.04
No-silver 
control
0.00
PVP-
control
0.03% v/v
Bulk silver 
control
4.70
Nominal concentrations (µg/l)
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(HPLC grade): water (nuclease free, QIAGEN) for two 10 s bursts at 6400 rpm with a 15 s 
intermission then returned to ice.  A 112 μl aliquot of homogenate was then removed into a 
nuclease-free microfuge tube (1.7 ml, Axygen) for RNA extraction and replaced with the 
same volume of 5:2 methanol:water. This aliquot was centrifuged for 5 minutes at 15,000 
rcf in a bench-top microcentrifuge (5415D, Eppendorf) and the supernatant was removed. 
The pellet was then immediately re-suspended vigorously in 350 μl of guanidine-
thiocyanate containing buffer (RLT buffer, QIAGEN) with added β-mercaptoethanol (1 µl 
per ml of buffer) and stored at -80 C for future extraction. 
4.2.3 Bi-phasic extraction of polar metabolites 
Polar metabolites were extracted using a two-step, biphasic method as detailed previously 
(Wu et al., 2008).  Briefly, homogenate was transferred into 1.8 ml glass vials on ice and 
further volumes of nuclease free water (160 µl) and chloroform (320 μl) were added to 
produce a final solvent ratio of 2:2:1.8 methanol:chloroform: water (Wu et al., 2008).  This 
mixture was then vortex-mixed for 30 s and left on ice for 10 minutes before being 
centrifuged (4000 rcf, 4 °C, 10 min) (Biofuge Primo R, Thermo Scientific) yielding a 
biphasic mixture separated by a layer of protein debris.  The upper, polar layer of each 
sample was removed into a single 1.5 ml microfuge tube (Starstedt, Leicester, UK) via 
Hamilton syringe.  The lower, non-polar layer was removed and prepared for FT-ICR 
lipidomic analysis which is not reported in this thesis (White, 2013).  Polar extracts were 
dried under vacuum (Savant Refrigerated Vapour Trap, Thermo Scientific) using a 
centrifugal concentrator (Savant SpeedVac concentrator, Thermo Scientific) without 
application of heat and stored at -80 °C prior to FT-ICR analysis.  Two extract blanks were 
created using the above homogenisation and extraction protocols in the absence of 
biological material.  
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4.2.4 Polar extract re-suspension for MS analysis 
All frozen, dried, polar extracts were re-suspended by addition of 30μl 4:1 mixture of 
methanol:water with 20 mM ammonium acetate followed by vortex-mixing for 30 s for 
negative ion mode analysis. All re-suspended samples were centrifuged at 22,000 rcf, 4 °C 
for 10 minutes to remove particulate matter.  The supernatant of each sample was then 
loaded alongside quality control (QC) samples in a randomly generated order on 384 well 
polymerase chain reaction (PCR) plates (Agilent technologies).  QC samples were created 
from a pool of D. magna polar extract collected from a separately collected group of 
neonates.  Once samples were loaded, wells were immediately covered with self-adhesive 
foil to temporarily prevent contamination or sample evaporation.  Once an entire plate was 
loaded, it was permanently sealed using a single, heat-sealed, foil sheet (ALPS 50V, 
Thermo Fisher Scientific, US). 
4.2.5 Acquisition of mass spectra 
All extracts were analysed in quadruplicate using an LTQ-FT Ultra (Thermo Fisher 
Scientific, Bremen, Germany) hybrid LTQ FT-ICR mass spectrometer with a direct 
infusion, chip-based nano-electrospray ionisation source (Triversa, Advion Biosciences, 
Ithaca, NY). Nanoelectrospray conditions consisted of a 200 nl/min flow rate, 0.3 psi 
backing pressure and an electrospray voltage of either +1.7 kV or -1.7 kV in positive or 
negative ion mode respectively controlled by Chipsoft software (Advion, Ithaca, NY, 
USA).  An automatic gain control setting of 1x106 was used in combination with a mass 
resolution of 100,000 (FWHM at 400 m/z).  Each technical replicate was analysed using 
Xcalibur software (Version, Thermo Scientific).  Data were acquired as transients from 
m/z 70-590 using the selected ion monitoring (SIM) stitching methodology (Southam et 
al., 2007; Payne et al., 2009; Weber et al., 2011) in 7 SIM windows of 100 m/z width and 
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30 m/z overlap.  Samples were analysed in a randomly generated order with QC samples 
spaced evenly throughout to disentangle MS technical drift from biological differences. 
4.2.6 Mass spectral data processing 
Transient data from the FT-ICR were processed, and the SIM stitch algorithm was applied 
as described previously (Southam et al., 2007; Payne et al., 2009).  Briefly, transients were 
averaged and then transformed into spectra with Fast Fourier Transform (Comisarow and 
Melka, 1979) and calibrated using a list of defined peaks for each SIM window (Section 
0).  SIM window spectra were then ‘stitched’ together through the alignment of peaks in 
overlapping regions (30 Da) using the SIM-stitching algorithm (Southam et al., 2007).  All 
peaks with intensities with a signal to noise ratio of less than 3.5 were removed, as were 
areas of ‘mechanical noise’ or ‘high noise regions’ in the m/z ranges of (m/z = (74.05-
74.2); (90.50-90.58), (101.32-101.42); (101.6-102.1); (105.1-105.5); and (116.37 116.5)).  
This process resulted in four stitched spectra per biological sample; the three best quality 
replicates were then selected for further filtering.  Replicate quality was primarily based on 
the variation of relative intensity within SIM windows. The spectra of the three selected 
technical replicates were then aligned and merged, with peaks being retained only if 
present in at least two of the remaining three replicates, thus resulting in one spectrum per 
biological sample.  When aligning replicate spectra, peaks were considered to be the same 
if they occurred within a 1.5 ppm error of one another along the m/z axis.  The spectra of 
all samples were then aligned and filtered with m/z peaks only being retained if they were 
present in at least 80 % of all experimental samples.  Due to the differing origin of the QC 
samples, they were excluded from this process to avoid skewing the filter. When aligning 
sample spectra, peaks were considered to be the same if they occurred within a 2.5 ppm 
error of one another along the m/z axis.  A blank filter was also applied; any of the 
remaining sample peaks which were also detected within the extract blanks were removed 
  
86 
 
from all spectra. All spectral processing steps were completed in MATLAB (student 
version 7, The Math-Works, Natick, MA).  These processing steps yield a matrix of raw 
peak intensity values, with columns corresponding to m/z values and rows corresponding 
to samples, which require further processing before statistical analysis. 
4.2.7 Probable Quotient Normalisation of m/z intensity matrices 
To account for variation arising from differences in sample concentration, the resulting 
filtered matrix was normalised via Probable Quotient Normalisation (PQN) (Dieterle et al., 
2006) using an in-house MATLAB script. Quotients of dilution were calculated by 
dividing the intensity of each peak in a spectrum by the mean intensity for that peak across 
all samples.  The median quotient of the entire spectrum is then selected as the scaling 
factor (most probable quotient) for that spectrum.  Quotients were only calculated for 
peaks that occurred in 100 % of all samples except QCs. 
4.2.8 Missing value imputation by the k-nearest neighbour method 
Due to the nature of the sample filter, some samples within the intensity matrix may not 
have intensity values for peaks which are otherwise detected in the remaining samples. To 
prevent miscalculation of fold changes, missing values were imputed using the k-nearest 
neighbour (KNN) algorithm using an in-house MATLAB script (Hrydziuszko and Viant, 
2011).  Briefly, the top k (in this study k = 5) peaks with the most similar intensity profiles 
across all samples were used to calculate a weighted average (the most similar peaks  
being favoured) for that sample.  This value was then imputed in the place of the missing 
value.   This normalised matrix with imputed missing values was used for the assessment 
of fold changes in peak intensities across groups and for univariate analysis to determine 
significantly changing peaks. 
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4.2.9 Generalised logarithm transformation for multivariate analysis 
Peaks of naturally higher intensities are intrinsically prone to greater technical variation, in 
terms of absolute values, than those which are naturally lower in intensity.  This can skew 
the results of multivariate statistical analysis. To counteract this, the normalised matrix 
was transformed using the generalised logarithm transformation (Parsons et al., 2007). 
This process uses a scaling factor (λ) derived from the QC samples i.e., samples between 
which, theoretically, the only variation is technical and not biological.  This process 
stabilises technical variation and reduces dominance of large intensity peaks, allows for 
better observation of biological differences in subsequent multivariate statistical analyses 
such as PCA (Parsons et al., 2007). 
4.2.10 Generation of calibration lists 
In order to complete the processing workflow, a calibration list of robust peaks is required. 
This list is generated from a preliminary run of the steps outlined above but with the 
following exceptions.  A signal:noise ratio of 10 was used instead of 3.5, only peaks 
occurring within all three technical replicates of a sample were kept, and finally only peaks 
which occurred in 100 % of samples were retained.  This stringent filtering process 
ensured the retention of robust m/z features within the D. magna or D. pulex metabolome.  
Features retained from this process were putatively annotated using MI-Pack as outlined 
below using the single peak search function.  The final calibration lists were created using 
a minimum of one successfully annotated m/z feature within each of the SIM windows.  
The calibrants used in this chapter are listed in the Appendix (Table 9.3). 
4.2.11 Assessment of MS data quality 
The quality of mass spectral data was assessed using two methods.  First the analytical 
reproducibility (or precision) of the data was assessed through calculation of the median 
Relative Standard Deviation (RSD) of QC spectra. Briefly, the RSD was calculated for 
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each peak remaining from MS spectral processing from the respective intensity values 
within the QC sample population.  The median RSD value was then taken as indication of 
analytical reproducibility as outlined previously (Parsons et al., 2009).  A median RSD of 
<20% is deemed to be an acceptable level of reproducibility (Kirwan et al., 2014).  The 
median RSD was also calculated for each control and exposure group as well as for all 
biological samples (not QCs) used within the study. Comparison of these values showed a 
much lower median RSD between the QC samples in comparison to the RSD of all 
biological samples; 12.0 % compared to 33.5 % respectively (Table 4.2) indicating that the 
analytical variation observed in the dataset is much lower than the background biological 
variation between unique replicates..  Next, the quality of the final processed dataset was 
assessed through a multivariate quality assessment as described previously (Sangster et al., 
2006; Kirwan et al., 2014).  Following the method outlined below (section 4.2.17), PCA 
was conducted on all biological samples and QC samples. The degree to which QC 
samples cluster relative to the variation in biological samples was then visualised as first 
outlined by Sangster et al., 2006.  The tight clustering of QC samples observed in Figure 
4.2 relative to the wide spread of the biological samples clearly indicates that the analytical 
variation within the dataset is small relative to the biological variation. 
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Table 4.2. Median Relative Standard Deviation (% RSD) of m/z peak intensities for QC 
samples compared to all control and exposure groups combined (Test samples) and 
seperately.   
Exposure Group Median % RSD 
QC samples 12.0 
Test Samples 33.5 
PVP Control 33.7 
Untreated Control 26.1 
Bulk Ag Control 28.6 
Ag+ Filtrate 29.1 
AgNP Very Low 22.2 
AgNP Low 26.5 
AgNP Mid 25.8 
AgNP High 30.5 
AgNO3 Very Low 25.8 
AgNO3 Low 26.9 
AgNO3 Mid 26.7 
AgNO3 High 25.0 
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Figure 4.2: Principal components analysis comparing scores values on PC1 and PC2 of the 
model for all test organisms (□) and quality control (QC) samples (♦).  The tight clustering of 
QC samples in comparison to the wide spread of the biological replicates indicates and 
absence of technical drift.  
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4.2.12 Extraction of total RNA 
The homogenate aliquot in RLT buffer was thawed on ice and RNA extraction continued 
using a column-based extraction kit (RNeasy Mini Kit, QIAGEN) following 
manufacturer’s instructions, including DNase1 treatment  (RNase-Free DNase kit, 
QIAGEN).  Briefly, 350 µl 70 % v/v ethanol was mixed with thawed aliquots and then 
spun through silica-based spin-columns (30 s, 8000 rcf) to allow RNA binding.  Samples 
were then washed three times in low salt, ethanol buffers before elution in 40 µl nuclease 
free water.  The quantity and quality of RNA was assessed using a spectrophotometer 
(NanoDrop 1000, Thermo Scientific, Waltham, MA) using an analysis constant of 40 for 
RNA. The integrity of all samples was measured using an Agilent RNA 6000 Nano Kit 
and an Agilent 2100 Bioanalyser (Agilent Technologies, Santa Clara, CA).   
4.2.13 Ethanol/Acetate precipitation of RNA 
Any RNA extracts with an A260/A230 ratio (measured by nanodrop (Section 4.2.12) lower 
than 1.5 were cleaned using the ethanol/acetate precipitation method and then re-measured.  
Ethanol (100 %, 2 volumes, -20 °C) and sodium acetate (3 M, 0.1 volumes, pH 5.2) were 
mixed with each extract before incubation at -80 °C for 1 h.  Samples were then 
centrifuged for 30 min at 4 °C and the supernatant was removed.  The pellet was washed 
with ethanol (70 % v/v) and centrifuged before being air dried for 30 min.  Once dry the 
RNA pellet was re-suspended in nuclease free water. 
4.2.14 Amplification and Cy3-labelling of selected RNA samples  
Only samples within the untreated, PVP and bulk control groups, the Ag+ High and Ag+ 
Low exposure groups and the AgNP High and AgNP Low exposure groups were selected 
for microarray analysis.  The One-Color RNA Spike-In Kit (Agilent Technologies) was 
used to account for variation between the arrays as quality control.  This kit contains a 
mixture of 10 positive control transcripts at known concentrations which anneal to 
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complementary probes on the microarray. This kit is an invaluable form of quality 
assurance, controlling for any abnormalities in the labelling and hybridisation procedure 
including the potential interference AgNPs may have with fluorescent dyes in use.  The 
results of the QC probes were comparable across all groups, no differences were observed 
between control groups, AgNP or AgNO3-exposed animals.  One AgNP High failed QC as 
a result of non-specific hybridisation and was removed from future analyses.  Briefly, the 
stock Agilent One Colour RNA Spike Mix concentrate was serially diluted four times 
(1:20, 1:25, 1:20 and finally 1:4) then 2 µl of the final dilution was added to 50 ng of each 
sample of total RNA.  The labelling reaction was prepared using the one-colour Low Input 
QuickAmp Labelling kit (Agilent Technologies), according to manufacturer’s instructions 
using an input of 50 ng of spiked-RNA.  This kit employs a double amplification strategy 
in which the total RNA is first reverse-transcribed to cDNA which is then used to produce 
the fluorescent Cy3-CTP labelled cRNA.  The labelled, amplified cRNA was made up to 
100 µl with nuclease free water and was purified using an RNeasy Mini Kit (QIAGEN).  
Once purified, the labelled cRNA was quantified using the microarray measurement 
function on the NanoDrop with an analysis constant of 40 for RNA. From these 
measurements, the yield of cRNA (µg) and the specific activities of Cy3 per µg cRNA 
were calculated.  All samples were found to have a specific activity above the 
recommended minimum value of 6 pmol Cy3 per µg cRNA. 
4.2.15 Hybridisation and scanning of a custom D. magna microarray  
The hybridisation and scanning of the microarray slides were conducted with supervision 
from the Genomics Facility, University of Birmingham.  Following purification, Cy3-
labelled cRNA samples (600 ng) were fragmented through addition of Agilent gene 
expression blocking agent (5 µl) and fragmentation buffer (1 µl) (Agilent Technologies) in 
a total reaction volume of 25 µl (made up waith nuclease free water) and incubated for 
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30 min at 60 °C.  Fragmented cRNA was then immediately cooled on ice and mixed with 
25 µl hybridisation buffer to stop fragmentation. Samples were hybridised to a custom 
D. magna gene expression microarray (Design ID: 023710, Agilent Technologies) as used 
previously (Poynton et al., 2012; Antczak et al., 2013; Scanlan et al., 2013).  The array is 
constructed from 15,000 unique, best-responding probes from a preliminary microarray 
constructed from a D. magna expressed sequence tag database (Garcia-Reyero et al., 
2009).  The hybridized microarrays were scanned with an Agilent Technologies Scanner 
G2505B at 535 nm for Cy3. Scanned images were processed and results were extracted 
using Feature Extraction software (Agilent Technologies). 
4.2.16 Microarray data processing 
Microarray data processing and analyses were performed within Genespring analytical 
software (version GX7.3.1, Agilent Technologies).  Prior to normalisation, low intensity 
values (< 0.01) were set to a minimum value of 0.01 intensity units.  Each measurement 
was then normalised by the 50th percentile of all measurements within each individual 
sample-array.  Each gene-probe was normalised by the median of its measurements across 
all sample-arrays.  Genes with particularly low expression levels (< 40) were removed 
with background noise, as were genes whose standard deviation exceeded 1.4 in greater 
than 4 of the 7 exposure groups. The normalized microarray dataset were log2 transformed 
prior to multivariate statistical analysis. 
4.2.17 Principal components analysis of multivariate data 
PCA was used to assess the variation of glog-transformed metabolic and log-transformed 
transcriptional matrices in an unbiased manner.  Prior to PCA model creation, glog or log-
transformed intensity values for each variable (m/z peak or gene probe respectively) were 
mean centred.  PCA models were then generated from mean-centred transformed matrices 
with 4 PCs for each model using the PLS_Toolbox (version 6.0.1, Eigenvector Research, 
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Manson, WA) within MATLAB.  The significance of differences between scores values 
for each group was assessed along each PC by analysis of variance (ANOVA) using an in-
house script in MATLAB.  The p-values generated by this test were corrected using a FDR 
of 5 % to account for the multiple-testing of all PC scores (Benjamini and Hochberg, 
1995).  All QC samples were excluded from multivariate analyses.   
4.2.18 Analysis of variance of individual peak intensities between exposure groups 
One-way ANOVAs were used to determine those genes and m/z peaks that changed 
significantly in intensity between exposure groups.  Multivariate and univariate statistical 
analyses indicated no significant differences between the untreated, PVP and bulk control 
groups as outlined in section 4.3.1.  For this analysis samples in the untreated, PVP and 
bulk control groups were treated as a single group to identify only those variables which 
changed significantly in response to Ag exposure.  Briefly, mean intensity values of the 
combined control and all exposure groups were compared by one-way ANOVAs for each 
individual m/z peak or gene.  Due to the large size of metabolomics and transcriptomics 
datasets, the comparison of multiple variables in this manner is likely to induce a large 
number of false positives.  For example, using a significance value of 0.05 for each test 
could potentially mean that of the multiple comparisons taking place, 5 % could be 
incorrectly assigned a significant p-value.  This false discovery rate is accounted for by 
calculating a corrected (or adjusted) p-value (Benjamini and Hochberg, 1995). The p-
values generated from these tests were corrected using an FDR of 5 % to account for the 
multiple testing hypothesis (Benjamini and Hochberg, 1995). QC samples were not 
included in these tests. 
4.2.19 AgNP and AgNO3 uptake and elimination studies 
In a separate set of exposures to the omics-analyses outlined above, D. magna neonates 
were exposed to nominal concentrations of 4.70 and 1.18 μg/l AgNPs as well as 0.44 and 
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0.11 μg/l AgNO3 (theoretically equating to 0.28 and 0.07 μg/l total Ag) as well as 
untreated (no-added silver) conditions in media10.  Spiking stocks were made using the 
AgNP master stock and AgNO3 working stock previously described in section 4.2.1. 
Briefly, 1.6 ml and 100 µl of AgNP master stock (14.7 mg/l) were made to total volumes 
of 20 ml and 5 ml with MilliQ water to produce the AgNP High and AgNP Low spiking 
stocks respectively. Similarly, 2.2 ml and 140 µl of AgNO3 master stock (1 mg/l), were 
made to total volumes of 20 ml and 5 ml in MilliQ water to produce the AgHigh and 
AgLow spiking stocks respectively. The concentrations of these spiking stocks were 
measured by ICP-MS as described in section 4.2.20 and are tabulated below along with 
their intended nominal concentrations (Table 4.3). Due to the limitations of ICP-MS, the 
concentrations of the individual water exposures were not measured. 
Table 4.3: The nominal spiking stock and final exposure concentrations for all AgNP and 
AgNO3 exposure groups alongside the measured stock concentrations and the estimated 
exposure concentrations derived from these values. 
 
Each biological replicate consisted of 30 D. magna neonates (<24 h) with 9 biological 
replicates per treatment group with the exception of the lower AgNP and AgNO3  
concentrations which only contained 3 biological replicates.  Groups of 30 D. magna 
neonates (<24 h) were added to individual exposure vessels (250 ml glass beaker, Fisher 
Scientific) containing 200 ml of media10.  The appropriate exposure stock (1 ml) was then 
used to spike the study medium followed immediately by 49 ml of additional medium10 to 
mix.  Exposure vessels were kept under conditions outlined in section 2.5.  Tests were only 
Group Nominal Measured Nominal Estimated
Ag Low 17.5 30.8 0.07 0.12
Ag High 70 89.4 0.28 0.36
AgNP Low 295 293.2 1.18 1.17
AgNP High 1175 1108.3 4.70 4.43
Stock conc. (µg/l) Exposure conc. (µg/l)
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considered valid if no more than 10 % of control animals were immobilised during the 
exposure.   
After the 24 h exposure period, neonates were filtered and rinsed with Milli-Q water to 
remove any externally bound Ag (Khan et al., 2015). Three biological replicates from all 
treatment conditions (Control, AgNP Low, AgNP High, AgNO3 Low and AgNO3 High) 
were then blotted dry and transferred to pre-weighed, acid-washed 1.5 ml microfuge tubes.  
Tissue wet-weight was then determined by difference before samples were flash frozen in 
liquid nitrogen and stored at -80 °C prior to acid-digestion for ICP-MS analysis to 
determine initial Ag burden. 
The remaining replicates were transferred via an intermediate “wash” beaker of Milli-Q 
water to a clean vessel of media10 with 0.5 ml algal feed to begin clearance of the gut 
contents thus ending internal exposure (Khan et al., 2015).  After 18 h depuration, 3 
biological replicates from the three exposure conditions were filtered, rinsed with Milli-Q 
water and then transferred into pre-weighed, acid-washed 1.5 ml Eppendorf tubes.  Tissue 
wet-weight was determined by difference. Samples were flash-frozen in liquid nitrogen 
and then stored at -80 until needed for ICP-MS analysis.  The exposure media of the 
remaining exposures was replaced at 18 h and then every subsequent 24 h until the end of 
the exposure.  Fresh algal feed was added with every media change.  After a total of 96 h, 
the remaining three replicates of the control, AgNP High and AgNO3 High treatments 
were harvested as described for 0 h and 18 h post-exposure.  
4.2.20 Preparation of samples for ICP-MS analysis of internalised silver 
Frozen neonates (2.4 – 3.5 mg tissue at T=0, 2.9 – 4.8 mg of tissue at T= 18 h and 12.0 – 
17.8 mg tissue at T=96 h) were submerged in 100 µl of concentrated (69 %) trace-metal 
grade nitric acid (Fisher Scientific), mixed by vortexing, and then allowed to digest 
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overnight. Once fully digested, samples were transferred to an acid-washed scintillation 
vial and diluted to approx 1 % acid by addition of ultrapure water to a total volume of 
6.9 ml.  A digestion blank was prepared following the same method but with no Daphnia 
included.  The exposure stocks from section 4.2.19 were prepared for measurement in a 
similar way; 100 µl of stock was digested in 100 µl of trace-metal HNO3 as described for 
Daphnia samples. Once digested these stocks were diluted to a total volume of 6.9 ml.  All 
samples intended for measurement were shipped to the Swiss Federal Institute of Aquatic 
Science and Technology (EAWAG) for ICP-MS analysis by Dr Smitha Pillai (EAWAG, 
Dubendorf, Switzerland).  The concentration of total Ag in all submitted samples was 
measured by high-resolution ICP-MS (ELEMENT 2, Thermo Scientific) with a lower limit 
of detection for Ag of 1 ng/l.  Each sample was measured ten times from which an average 
measurement was taken.  Blanks were measured after every ten samples alongside two 
references containing known concentrations of Ag.  All blanks returned values below the 
1 ng/l of total Ag detection limit.  The results from the reference samples were used in the 
normalisation of sample concentrations. The measured concentrations of the reference 
samples were within acceptable ranges. The measured internal concentrations of silver of 
individual samples were normalised by their individually measured sample wet-weight. A 
1-way ANOVA was used on the same data followed by a Tukey post-hoc test to compare 
the differences in Ag body-burdens between treatment groups.  The uptake and data was 
also analysed by 2-way ANOVA followed by Sidak’s multiple comparison test to compare 
the effects of concentration and treatment type on Daphnid Ag body-burden.  Depuration 
data was analysed using a 2-way ANOVA followed by Sidak’s multiple comparison test to 
compare the impact of total depuration time and treatment type on the body burden of Ag-
exposed Daphnia in terms of % initial body burden.   
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4.3 Result and Discussion 
4.3.1 Exposure to the capping agent and bulk-Ag controls does not induce an adverse 
transcriptional or metabolic response. 
All neonates from the no-added silver, PVP and bulk silver (3 μm average diameter) 
control survived the 24 h exposures indicating a valid experiment (Appendix Table 9.4).  
Prior to analysis of toxicant exposures, the metabolic and transcriptional profiles of these 
control groups were compared using PCA (Figure 4.3).  In total, the 4 PCs that constituted 
either model described approximately 61.24 % of the transcriptomics data and 71.85 % of 
the metabolomics data, representing the greatest trends/patterns in the data.  Scores 
generated for the samples within each condition were compared by a 1-way ANOVA to 
identify potential statistical differences between the groups.  These comparisons were 
performed for each of the 4 PCs within the multivariate model.  Following adjustment for 
multiple testing (Benjamini and Hochberg, 1995) all of the calculated p-values were 
greater than 0.05 indicating no significant separation between the three controls groups 
along any PC (Table 4.4).  A univariate comparison of the relative intensities of genes-
spots or m/z peaks within the three groups of profiles indicated no significant changes in 
expression or concentration.  The results of these analyses indicate no difference between 
the transcriptome and metabolome of these animals, implying that no adverse effects had 
been induced in response to PVP or bulk-Ag exposure.  With this in mind these three 
groups will therefore be classed as a single “combined control” group for statistical 
analyses of Ag exposed profiles to identify only those changes occurring as a result of 
AgNP or AgNO3 exposure. 
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Figure 4.3: PCA scores plot comparing the transcriptional (a) and metabolic (b) profiles of the untreated (○), PVP (▲) and bulk (■) control 
groups along the first two principal components.   
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Table 4.4: p-values following adjustment for multiple testing generated by a 1-way ANOVA 
comparing the scores values for the untreated, PVP and bulk control groups along the four 
principal components of the transcriptomic and metabolomic PCA models. 
 Adjusted p-values 
Method PC1 PC2 PC3 PC4 
Transcriptomics 0.47387 0.42181 0.84116 0.50450 
Metabolomics 0.27220 0.35346 0.34275 0.99008 
 Variance covered (%) 
Metabolomics 41.20 14.53 8.88 7.24 
Transcriptomics 23.17 16.62 11.50 9.94 
 
4.3.2 AgNP and Ag+ exposures and sample processing 
The highest AgNP exposure concentration used in this study was the 24 h LOAEC of 
4.7 μg/l (section 3.3.2) and as such some immobilisation of neonates was expected.  
However the actual number of neonate deaths in this group and in the AgNP Mid group 
was unexpectedly high.  This reduced the number of biological replicates in these groups 
to 4 and 5 respectively (Appendix Table 9.4).   
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Additionally, one biological replicate was lost from the Ag High exposure group due to a 
loose tube cap during sample homogenisation.  During the processing of transcriptomics 
data, two arrays were removed from the study; an untreated control replicate produced a 
“black hole”, whereby only the outer wells hybridised and one AgNP High replicate 
showed substantial variation from the remaining samples in the group resulting from non-
specific hybridisation as indicated by the spike-in QC oligonucleotides.  Both samples 
were removed as the data they provided was considered unreliable and not a true 
representation of the exposed animals’ transcripome.  No samples were removed from the 
metabolomics data during processing.   
4.3.3 Ag NPs induce a dose-dependent perturbation to Daphnia gene transcription 
and metabolism which is not fully accounted for by the Ag+ content of AgNP 
exposures 
After data acquisition and processing, PCA was used to assess the variation of the 
transcriptional and metabolic profiles of all animals used in this study.  Models consisting 
of 4 PCs were created and scores values for PC1 and PC2, the PCs covering the greatest 
variation, were plotted for both transcriptional (Figure 4.4) and metabolic (Figure 4.5) 
profiles.  The untreated, PVP and Bulk controls groups are indicated separately on the 
plots but were treated as a combined control for all statistics.  The raw and transformed 
microarray data matrices produced from this work is available in the ArrayExpress 
database (www.ebi.ac.uk/arrayexpress) using the accession number: E-MTAB-4041.  
Likewise the FT-ICR data is obtainable from the MetaboLights database 
(http://www.ebi.ac.uk/metabolights) using the accession number: MTBLS259.  
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Figure 4.4: PCA scores plot (PC1 Vs PC2) from the 4 PC transcriptomics PCA model 
generated from intensity values of all 8128 detected genes.  Clear symbols represent the 
untreated (○), PVP (Δ) and Bulk (□) control groups.  Blue and red symbols represent AgNP 
and Ag+ exposures respectively with symbols representing the High (■) and Low (▲) 
concentrations.  Separation of the AgNP High and Ag+ High groups is apparent along PC2. 
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Figure 4.5: PCA scores plot (PC1 Vs PC2) from the 4 PC metabolomics PCA model 
generated from intensity values of all 1330 detected m/z peaks.  Clear symbols represent the 
untreated (○), PVP (Δ) and Bulk (□) control groups.  Blue and red symbols represent AgNP 
and Ag+ exposures respectively with symbols representing the High (■), Mid (●), Low (▲), 
and V. Low (▼) concentrations.  No separation is observed between any of the groups along 
PC1 or PC2.  
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As observed from the PCA scores plots, the transcriptional profiles exposed to AgNP High 
and Ag High groups appear to separate along PC2 from the control groups and lower 
exposure concentrations (Figure 4.4).  In contrast, no separation is observed between the 
metabolic profiles of any group along PC1, nor PC2 (Figure 4.5).  To identify the key PCs 
of each model, a one-way ANOVA was implemented between scores values of all samples 
across all 4 PCs.  This test identified significant differences between the scores values of 
groups present in the transcriptomics model on PC2 (p = 4.12x10-7) and the metabolomics 
model on PC3 (p = 3.83x10-4) (Table 4.5).  To allow clearer visualisation of the changes 
described by these significant PCs, each sample is plotted against their respective scores 
value for transcriptomics on PC2 (Figure 4.6) and metabolomics on PC3 (Figure 4.7).  
Tukey-Kramer post-hoc tests identified the metabolic profiles of animals exposed to the 
highest concentration of AgNP as being significantly different from the combined controls, 
and all other groups except the AgNP Mid, the Ag High, and the Ag Filtrate (Figure 4.8).  
This is again true on a transcriptional level, but here animals exposed to the highest 
concentration of Ag ions also show significant separation along the same principal 
component (Figure 4.9)  
Table 4.5: FDR-corrected p-values generated for transcriptomics and metabolomics data, by 
a 1-way ANOVA comparing scores of each exposure group across all four PCs.  PCs along 
which significant separations occur are highlighted in red. 
 Adjusted p-values 
Method PC1 PC2 PC3 PC4 
Transcriptomics 0.58031 0.00000 0.04767 0.18786 
Metabolomics 0.48872 0.66794 0.00008 0.93627 
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Figure 4.6: Plot of PC2 scores from the 4 PC transcriptomics PCA model for each sample 
generated from intensity values of all 8128 detected genes.  Clear symbols represent the 
untreated (○), PVP (Δ) and Bulk (□) control groups, and although they are shown separately 
on the plot, they were combined for statistical analysis.  Blue and red symbols represent 
AgNP and Ag exposures respectively with symbols representing the High (■) and Low (▲) 
concentrations. 
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Figure 4.7: Plot of PC3 scores from the 4 PC metabolomics PCA model for each exposure 
sample generated from intensity values of all 1330 detected m/z peaks.  Clear symbols 
represent the untreated (○), PVP (Δ) and Bulk (□) control groups, and although they are 
shown separately on the plot, they were combined for statistical analysis.  Blue and red 
symbols represent AgNP and Ag exposures respectively with symbols representing the High 
(■), Mid (●), Low (▲), and V. Low (▼) concentrations. 
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Exposure 
groups 
AgNP 
High 
AgNP 
Mid 
AgNP 
Low 
AgNP 
Vlow 
Ag+ High Ag+Mid Ag+ Low Ag+ Vlow 
Ag+ 
Filtrate 
Control 
Control                   N/A 
Ag 
Filtrate 
                N/A  
Ag Vlow               N/A   
Ag Low             N/A    
Ag Mid           N/A     
Ag High         N/A      
AgNP 
Vlow 
      N/A       
AgNP 
Low 
    N/A        
AgNP 
Mid 
  N/A         
AgNP 
High 
N/A          
Figure 4.8: Tukey-Kramer post-hoc results following an ANOVA of PC3 scores generated from metabolomics data (p = 3.83x10-4).  Green squares 
indicate a sgnificant difference between the two groups in question.  The metabolic profiles of animals exposed to the highest concentration of 
AgNP are significantly different from all groups, with the exception of the Ag High, the AgNP Mid and the Ag Filtrate.   
  
  
108 
 
Exposure 
groups 
AgNP 
High 
AgNP 
Low 
Ag High Ag Low Control 
Control         N/A 
Ag Low       N/A  
Ag High     N/A   
AgNP 
Low 
  N/A    
AgNP 
High 
N/A     
 
Figure 4.9: Tukey-Kramer post-hoc results following an ANOVA of PC2 scores generated from transcriptomics data (p = 4.12x10-7).  Green 
squares indicate a sgnificant difference between the two groups in question. The high dose groups (for both Ag and AgNP) are significantly 
different from all other groups. Furthermore, the high dose Ag and high dose AgNP groups are themselves significantly different. 
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In this study, 8128 gene-spots and 1330 m/z peaks were retained following extensive data 
processing prior to the statistical analyses.  To discover which genes and metabolites were 
responsible for the separation observed by PCA, a 1-way ANOVA was used to determine 
those which changed significantly in intensity across exposure groups.  Statistical analysis, 
following correction for multiple testing (Benjamini and Hochberg, 1995), identified 711 
significantly changing genes and 190 significantly changing peaks (p ≤ 0.05) across all 
groups. 
To visualise this molecular change further, matrices of peak intensity or gene-spot 
fluorescence relating specifically to these significantly changing peaks or genes, were 
compiled and PCA scores models were generated (Figure 4.10).  By concentrating solely 
on these variables, the dose-response effect of AgNP exposure to the D. magna 
metabolome is more apparent; both the AgNP Mid and AgNP Low groups begin to 
separate along PC1 with the AgNP High group.  This concentration-dependant separation 
strongly implies that the representative molecular changes are a direct response to AgNP 
exposure.  What is also depicted, in both the metabolic and transcriptional datasets, is that 
these features are perturbed in a similar way in animals exposed to the highest 
concentration of AgNO3 (Figure 4.10).  PC1 scores values for samples in this group are 
positive, separating from controls in the same direction as the AgNP groups along the 
same PC.  This reinforces what was seen previously with the unrefined datasets at a 
transcriptional level (Figure 4.6) and suggests that the list of significantly changing 
variables accurately reflects the impact of both AgNP and AgNO3 exposures. 
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Figure 4.10: PCA scores plots of models generated from significantly changing gene-spots (A) or m/z peaks (B) only. The scores for PC1 only are 
plotted for each biological sample in the model to allow for the comparison of magnitude of affect along this PC between all groups.  Clear 
symbols represent the untreated (○), PVP (Δ) and Bulk (□) control groups, treated as a combined control for statistical tests.  Blue and red 
symbols represent AgNP and AgNO3 exposures respectively with symbols representing the High (■), Mid (●), Low (▲), and V. Low (▼) 
concentrations.  Ellipses and arrows are present to aid in the visualisation of separations between groups along PC1 only.   
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In the case of this study, PCA is analysing all possible related patterns of variance in the 
transcriptional or metabolic profiles of animals; and then ranking these patterns as PCs in 
order of total variance described.  Each PC therefore represents a particular pattern of 
changes in gene expression or metabolite concentration.  Samples that generate similar 
scores values on a particular PC are likely to have similar profiles.  If members of two 
exposure groups separate from the control in the same direction along a principal 
component then it suggests that a similar response is being induced.  This is what is 
observed in the significant molecular response of animals exposed to the highest 
concentrations of both forms of silver (Figure 4.10).  When observing the significant 
changes induced upon the transcriptome and the metabolome, the profiles of animals 
exposed to the highest concentration of either AgNP or AgNO3 in both cases separate from 
controls in the same positive direction along PC1.  This implies that both AgNP and 
dissolved Ag induce a similar transcriptional profile and also a similar metabolic profile, 
though it is not possible at this stage to say if the two omics profiles are related. Along 
with this shared exposure profile, there is a significant difference in the magnitude of 
response between the transcriptional profiles of the AgNP High samples and their 
dissolved Ag counterparts (Figure 4.9). This implies that at these concentrations, AgNPs 
induce a greater level of response than exposures to the dissolved Ag fraction alone, though 
the molecular responses induced by each form appear to be similar.  
It is therefore unlikely that AgNPs and Ag+ induce toxicity by different mechanisms, as 
this would have been represented by separation of the AgNP and AgNO3 exposure groups 
along different PCs (e.g. AgNP on PC1 and AgNO3 on PC2) in PCA scores plots.  The 
similarities in the induced profiles could suggest that Ag+ is the mediator of toxicity for 
AgNP.  This would be consistent with previous studies that have shown a complete 
reduction of AgNP toxicity following chelation of the free-ion form of Ag (Zhao and 
  
112 
 
Wang, 2011).  If this was the case the greater magnitude of response observed for AgNP-
exposed animals could be the result of the Trojan-horse mechanism. This would mean that 
the absorption and subsequent internal dissolution of AgNPs (either in the lumen of the gut 
or within tissues) could result in a large internal concentration of toxic Ag+, with the 
AgNPs themselves remaining relatively non-toxic.  Alternatively this result could mean 
that both AgNP and dissolved Ag induce toxicity independently, but that both forms of Ag 
induce the same molecular profile changes.  This would account for the greater magnitude 
of response observed in AgNP-exposed animals, as the theoretical total Ag concentration 
of AgNP exposures is greater than that of their counterpart AgNO3 exposures. Both 
explanations would conform to the results of previous mechanistic investigations of the 
two forms of silver which concluded that both species of Ag induced a similar molecular 
response (Aerle et al., 2013; Ahn et al., 2014; De Matteis et al., 2015), including an NMR-
based metabolomics investigation in D. magna which showed agreement between the 
overall molecular profiles induced by both forms of silver by PCA (Li et al., 2015a).  
However, it has been observed previously that chelation of Ag+ in AgNP suspensions 
results in a complete reduction of AgNP toxicity to D. magna (Kennedy et al., 2010; Zhao 
and Wang, 2011; Newton et al., 2013) suggesting that AgNPs themselves have little-to-no 
inherent toxicity compared to dissolved Ag.  It is more likely that if AgNPs induced 
toxicity independent of any released Ag+, the changes observed would be unique to those 
induced by Ag+ which would be reflected in the transcriptional and metabolic profiles 
observed by PCA.  These differences were not observed, suggested that dissolved Ag is 
the form responsible for AgNP toxicity.   
4.3.4 AgNP likely enact toxicity via the digestive tract  
The concentration of total Ag associated with D. magna following AgNP and AgNO3 
exposures was investigated using ICP-MS to gain greater insight into the role of Ag uptake 
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in the mechanism of toxicity.  AgNP and AgNO3 stocks used in sub-lethal uptake 
exposures were measured by ICP-MS and the AgNO3 stocks were found to be slightly 
higher than originally intended (Table 4.3).  The Ag+ High stock is 8.06 % of the 
AgNP High stock which is within 1 SD of the mean percentage dissolution at 24 h (5.68 % 
± 2.87).  The Ag+ Low stock is 10.50 % of its AgNP counterpart which is above the 
originally intended range; this must be taken into account when interpreting results. 
After a 24 h exposure, the concentration of associated silver was measured by ICP-MS, 
and body burden was calculated in terms of µg of Ag per g of daphnid wet weight.  
Animals exposed to the lowest concentrations of AgNP (1.17 µg/l) and dissolved Ag 
(0.12 µg/l) were measured to have average body burdens of 0.4316 ± 0.7475 µg/l and 
0.5443 ± 0.0605 µg/l respectively.  Exposure to 4.43 µg/l of AgNP and 0.36 µg/l of 
dissolved silver yielded respective D. magna body-burdens of 3.8402 ± 0.2695 µg/l and 
1.9632 ± 0.3099 µg/l.  The Ag body burden of animals exposed to the lowest 
concentrations of AgNO3 and AgNP (0.12 µg/l and 1.17 µg/l respectively) were deemed as 
not being significantly different to controls by a 1-way ANOVA followed by Dunnett’s 
multiple comparison test.  It is worth noting that two of the three AgNP Low biological 
replicates failed to measure any silver associated with the exposed animals, whereas the 
third measured 1.27 µg/g; this resulted in a SD value larger than the mean.  At the highest 
concentration AgNO3 (0.12 µg/l) AgNP (1.17 µg/l) exposures there is significantly more 
(p < 0.0001) Ag associated with the animals upon exposure compared to control animals.  
The relationship between total Ag exposure concentration and body-burden for AgNP and 
AgNO3 exposed Daphnia is shown in Figure 4.11.  With respect to the total concentration 
of Ag in the exposure media, AgNO3 exposures result in a higher body burden of Ag 
within the exposed animals than AgNPs, highlighting the difference in uptake rate and 
bioavailability between the two species of silver.    
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Figure 4.11: Comparison of the relationship between body burden of Ag following AgNP and 
AgNO3 exposure, and the total Ag concentration of the exposure media.  A 1-way ANOVA 
identified significantly higher body burden in animals exposed to the highest concentration of 
AgNPs when compared with its AgNO3 counterpart (p < 0.0001).  No difference in Ag body 
burden was observed between the low concentration exposures.  N = 3 replicates for each 
group, error bars represent standard error of the mean. 
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The total Ag concentrations of AgNO3 in this experiment were chosen to represent the 
concentration of the dissolved Ag fraction of their respective AgNP exposures.  In theory, 
the AgNO3 Low and AgNP Low should contain the same concentrations of dissolved Ag.  
Likewise this should be the case for the AgNO3 High and AgNP High groups.  When 
analysed by a 2-way ANOVA comparing these nominal treatment and concentration 
goups, it was deemed that concentration of toxicant had a significant impact on the 
resulting body-burden (p = 0.0063) and that animals exposed to AgNP yielded 
significantly greater body-burdens than D. magna exposed to the respective dissolved 
silver fraction alone (p < 0.0001) as depicted in Figure 4.12.  This latter result suggests that 
AgNPs must account for some of the total Ag measured within these organisms, if only 
dissolved Ag was absorbed into or onto the animals (i.e., if the neonates did not or could 
not ingest the nanoparticles), it would be more likely that there would be no significant 
difference between the AgNP High and AgNO3 High exposures.  
The methodology of this experiment included a “rinse” step with Milli-Q water prior to 
measurement by ICP-MS in order to remove any Ag attached to the external surface of the 
organisms.  Because of this, it is likely that any Ag measured within the acid-digested 
Daphnia samples was contained within the organism; however there is still a chance that 
some Ag was attached to the carapace.  The ingestion of AgNP by D. magna has been 
observed previously through measurement of AgNP uptake and efflux using ICP-MS 
(Zhao and Wang, 2010; Khan et al., 2015), and through secondary ion mass spectrometry 
(SIMS), a MS-based imaging technique that successfully detected the presence of silver, 
following AgNP exposure in the digestive tract of D. magna (Audinot et al., 2013).  
However, this data cannot distinguish between the presence of Ag within the gut or 
attached to the carapace of exposed Daphnia, and Ag that has accumulated within the 
animal’s tissues.  
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Figure 4.12: Comparison of body burden of Ag following exposure to Low and High 
concentrations of AgNO3 and AgNPs.  A 2-way ANOVA followed by Sidak’s multiple 
comparison test determined significantly higher body burdens observed in animals exposed 
to AgNPs in comparison to their corresponding dissolved Ag fractions alone (p < 0.0001).  
The concentration of toxicant was also deemed to have a significant impact on Ag body 
burden (p = 0.0063). N = 3 replicates for each group, error bars represent standard deviation. 
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As an addition to the assessment of AgNP uptake into D. magna the elimination of both 
AgNPs and AgNO3 were also measured (Figure 4.13).  Following an exposure to 
AgNP High and to the respective dissolved Ag fraction for 24 h, animals were 
immediately transferred to clean media10 with algal feed to promote gut-clearance.  The 
concentration of silver within animals was measured at 18 h and again at 96 h (4 d) after 
exposures had finished.  Elimination was plotted as a percentage of absorbed total silver 
(0 h) against time (Figure 4.13).  The Ag body burden of animals at 0 h was measured to 
be 3.8402 ± 0.2695 µg/l for AgNPs and 1.9632 ± 0.3099 µg/l for AgNO3.  After an 18 h 
depuration period, the body burden of animals that were exposed to AgNPs has reduced to 
0.8805 ± 0.5645 µg/l, equating to 23.1 % of the 0 h concentration.  Likewise after 18 h the 
body burden of animals that were exposed to AgNO3 has reduced to 2.8 %.  At the final 
96 h time point, AgNP-exposed animals have a body burden of 0.0423 ± 0.0081, which is 
approximately 2.2 % of the original body burden.  The Ag body burden of Daphnia 
exposed to AgNO3 is below the detection limit of the instrument, potentially indicating a 
complete removal of all internal silver at this point. 
The burden of silver within animals exposed to both AgNP and Ag+ ions reduces 
significantly (p < 0.0001) 18 h following the end of exposure, and by 96 h post-exposure 
the internalised silver is nearly completely removed.  Due to the lack of data points, fitting 
the data to a single-step or two-step depuration model was not possible, and the data 
should be considered as preliminary.  However, the resulting plot (Figure 4.13) is similar 
in profile to those plotted previously by studies investigating the influx and efflux of 
AgNP (Zhao and Wang, 2010; Khan et al., 2015) and gold nanoparticles (Khan et al., 
2014) in Daphnia magna.  These previous efflux patterns are typically biphasic, with the 
initial rapid phase describing the passage of NPs through the digestive tract and the 
second, slower phase relating to the elimination of NPs which had either been absorbed 
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from the gut into the surrounding tissue or simply remain in the lumen (Khan et al., 2015).  
In this study, the initial rapid removal of silver observed over the initial 18 h matches 
previously published data (Khan et al., 2015), but 96 h after the end of exposure almost all 
of the silver within the organism over the 24 h exposure period was completely cleared.  
This differs to previous work which see approximately 10 % of the initial Ag content 
remaining within exposed D. magna even as long as 5 days following exposure.  This 
suggests that in this study the silver may not be retained to a substantial degree within the 
tissues of D. magna, but instead passes relatively rapidly through the organism.  
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Figure 4.13: The depuration of absorbed AgNPs (■) and Ag+ (○) from exposed D. magna over 
a 96 h period.  N = 3 replicates per time point, error bars represent the standard error of the 
mean.  Connective lines are for visualisation purposes as fit of the data to a two-step 
depuration model was not possible.  Following a 2-way ANOVA and Sidak’s multiple 
comparison test, it was determined that the body burden of animals decreased significantly 
over time (p < 0.0001) for both AgNP and dissolved Ag.  Mean body burden values for AgNP 
and dissolved Ag at 18 h are significantly different (p = 0.0186). 
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4.4 Conclusion 
The primary aim of this chapter was to determine which of three hypothetical mechanisms 
proposed in the introduction to this chapter (Figure 4.1), if any, best described the role of 
dissolved Ag in AgNP toxicity.  From comparison of the transcriptional and metabolic 
profiles of D. magna neonates exposed to AgNPs and dissolved Ag, the data suggests that 
both forms of Ag induce similar overall molecular responses. These similarities in profiles 
suggest that exposure to AgNPs induce the same molecular perturbations as exposure to 
AgNO3, which would be consistent with dissolved Ag as the mediator of toxicity for 
AgNP. This conclusion would be consistent with previous studies that have shown a 
complete reduction of AgNP toxicity following chelation of the free-ion form of Ag (Zhao 
and Wang, 2011).  It is therefore likely that the dissolved silver fraction is responsible for 
AgNP-induced toxicity as in mechanism 1 and 3 (Figure 4.1).  However, the elevated Ag 
body-burden and omics response observed for AgNP exposed animals compared to that of 
animals exposed to the dissolved fraction alone suggests that although the dissolved silver 
fraction is responsible for AgNP-induced toxicity, it is unlikely to do so following 
dissolution external to the organisms.  This data would therefore disprove hypothesised 
mechanism 1. 
The data presented in this chapter also does not fit fully with the second hypothetical 
mechanism which suggested simultaneous, different, but potentially synergistic 
mechanisms for AgNPs and dissolved Ag (Figure 4.1).  Mechanism 2 hypothesises that 
AgNPs and dissolved Ag ions both induce toxicity upon exposure through separate and 
potentially synergistic mechanism. If the responses induced by the two forms of Ag were 
different this would have been reflected in PCA of transcriptional and metabolic profiles; 
the two forms of silver would have been seen to separate along separate PCs rather than to 
differing magnitudes on the same PC.  Unlike mechanism 1 above however, mechanism 2 
  
121 
 
cannot be ruled out completely.  The limited annotation of the D. magna microarray and 
the limitations in detecting many naturally low-level metabolites means it is still possible 
that some significant differences between the two mechanisms exist but remain largely 
undetected.   
The combination of results from omics analyses and determination of total Ag body 
burden would therefore better suit a Trojan-horse type mechanism (mechanism 3, Figure 
4.1); whereby AgNPs are ingested by D. magna, resulting in a concentrated delivery of 
Ag+ ions following AgNP dissolution within tissues or the lumen of the gut and an 
elevated molecular response.   
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Chapter 5: Elucidating the molecular mode of action of silver 
nanoparticles to Daphnia magna 
5.1 Introduction 
The molecular perturbations induced by Ag and AgNPs are still mostly uncharacterised 
but a number of mechanistic studies in recent years have highlighted some key responses 
and areas for further investigation.  A potential limitation of these studies is their use of a 
targeted, hypothesis-driven approach.  An advantage of omics-technologies is the ability to 
use a non-targeted approach for mechanistic investigation (Keun, 2006); measuring 
hundreds of endpoints rather than focusing on a select few (Viant, 2009).  This alternative 
approach to study-design potentially allows for the generation of new hypotheses and the 
identification of otherwise unconsidered mechanisms for investigation in cases where the 
prior knowledge for the traditional targeted approach is still lacking; as is the case for 
AgNPs.  There are currently three high-thoughput “omics” analyses of AgNP and AgNO3 
toxicity in D. magna; a microarray investigation into the impact of exposure on the 
transcriptome (Poynton et al., 2012), a redox-proteomic approach using two-dimensional 
electrophoresis (2DE) (Rainville et al., 2014), and a 1H-NMR-based analysis comparing 
the overall impact on the metabolic profiles (Li et al., 2015a).   
To investigate the transcriptional impact of AgNP exposures, the transcriptional profiles of 
10 day old D. magna adults exposed to the 1/10 LC50 and the LC25 of citrate and PVP-
stabilised AgNPs, as well as the ¼ LC25 and ½ LC25 of AgNO3 were compared following a 
24 h exposure (Poynton et al., 2012).  Enrichment analysis of these profiles highlighted 
several gene ontology (GO) terms as being enriched or over represented. AgNP were seen 
to induce in increase in protein ubiquitination and proteolysis and in cellular signalling 
processes, whereas AgNO3 exposure resulted in an increase in transcription of genes 
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related to energy production and cellular respiration as well as a decrease in those involved 
in embryonic morphogenesis and segmentation, eye photoreceptor development and 
reproduction and oogenesis  (Poynton et al., 2012). 
The proteomic investigation by Rainville et al. analysed the impact of a 24 h exposure to 5, 
15, 20 and 30 µg/L of AgNPs and 0.4, 1.2 and 2.5 µg/L AgNO3 on the proteome of 
D. magna by 2DE (Rainville et al., 2014). This exposure revealed that both forms of silver 
induced an increase of protein-thiol content, but only AgNPs caused an increase of protein 
carbonyls.  The authors suggest that the increase in protein-thiol content is in response to 
the presence of Ag+ ions within the organisms; to directly chelate the ions and decrease 
their toxicity, or alternatively as a response to reduce toxicity by ROS.  The increased 
carbonyl content induced by AgNPs is thought to be an indication of AgNP-induced 
oxidative stress and oxidation of cellular proteins (Rainville et al., 2014).  Additionally, 
MS/MS following 2D electrophoresis identified 4 of 8 features of interest as vitellogenin 
fused with superoxide dismutase; a key enzyme in the response to reactive oxygen species 
(ROS). 
An NMR investigation into the impact of AgNP and AgNO3 exposure on the metabolic 
profile of D. magna suggested that both forms of Ag induced the same metabolic 
perturbations (Li et al., 2015a).  Exposure to 2 and 10 µg/l of 10 nm AgNP showed 
elevated levels of lactate and phosphocholine and depleted levels of 3-hydroxybutyrate, 
arginine, lysine and choline (Li et al., 2015a). 
By analysing samples using a combination of omics technologies, we can achieve an 
understanding of the genes and metabolites involved in the global response to AgNP and 
Ag+ exposure.  However, lists of genes and metabolites tell us very little without wider 
consideration for how they interact with one another.  Pathway analysis allows a statistical 
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approach to decipher large lists of putative responsive genes or metabolites by putting 
them into the context of known molecular interactions.  Online tools are available for the 
analysis of transcriptomics  (http://david.abcc.ncifcrf.gov/) and metabolomics (Xia et al., 
2012) datasets individually as well as for integrated analysis (Kamburov et al., 2011).  This 
enables an objective, statistical approach to interpret interactions between genes and 
metabolites of interest without having to resort to speculation (Cavill et al., 2011) or 
dependence on prior knowledge.  The results of these analyses can then be used to form 
hypotheses on the response being observed.  However, all current methods of pathway 
analysis are not without their limitations and some prior knowledge is still needed for 
successful interpretation of results. 
The literature surrounding the genes, proteins and metabolites involved in response to 
AgNP toxicity is expanding, following an increase in mechanistic investigations across 
multiple cell lines and test organisms. (Comfort et al., 2014; Verano-Braga et al., 2014; 
McQuillan and Shaw, 2014; Carrola et al., 2015).  Mitotoxicity has been observed through 
use of fluorescent dye-based assays in HeLa and A549 cells (De Matteis et al., 2015) and 
through measurement of the impact of Ag exposure on H+ flux across the mitochondrial 
membrane in D. magna (Stensberg et al., 2013).  A quantitative proteomic analysis of 
AgNP-exposed human colon carcinoma cells observed a down-regulation of mitochondrial 
proteins, including those involved with the electron transport chain (Verano-Braga et al., 
2014).  On a transcriptional level, significant down-regulation of genes encoding 
complexes I, II, III and IV of the oxidative phosphorylation machinery have been observed 
in zebrafish (Aerle et al., 2013).  Studies in cell lines have measured the presence of ROS 
following AgNP and AgNO3 exposure (Arora et al., 2009; Asharani et al., 2009; 
Domingos et al., 2009; Chairuangkitti et al., 2013), potentially suggesting the direct 
induction of oxidative stress by these two forms of silver. In some cases this production of 
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ROS has been linked to the aforementioned disruption of mitochondrial activity (Asharani 
et al., 2009) as well as being linked to the induction of DNA damage and genotoxicity 
(AshaRani et al., 2009).  It has been observed that the principal response to Ag toxicity 
across multiple model organsims is an increase in the production of metallothioneins and 
other thiol-containing peptides (Ferguson et al., 1996; Chae et al., 2009; Meyer et al., 
2010; García-Alonso et al., 2011; Johari et al., 2015).  The inhibition of RNA polymerase 
by AgNP has been measured; Wang and colleagues demonstrated that exposure of 
erythroid progenitor cells to AgNP resulted in the inhibition of RNA polymerase activity 
and RNA transcription through the direct binding of AgNPs to the enzyme (Wang et al., 
2013).  Ag exposure has also been seen to disrupt key cellular processes such as an 
increase in calcium transients (Asharani et al., 2009), cell cycle arrest (De Matteis et al., 
2015) and impacts on transcription factors (Aerle et al., 2013). An NMR-based 
metabolomics study has suggested Ag-induced perturbation to the purine metabolism 
pathway (Hadrup et al., 2012) following detection of an increase in uric acid and allantoin 
excretion in mice.  AgNPs have been seen to exert indirect effects via serine/threonine 
protein kinase (PAK), mitogen-activated protein kinase (MAPK), and phosphatase 2A 
pathways (Verano-Braga et al., 2014). 
In this Chapter, the markers of AgNP and AgNO3 exposure discovered in Chapter 4 
underwent extensive annotation yielding robust putative identities.  To statistically 
interpret interactions between putative annotations, ORA was rigorously applied using 
three online platforms: the Database for Annotation, Visualization and Integrated 
Discovery (DAVID) (Huang et al., 2009), MetaboAnalyst (Xia et al., 2012) and Integrated 
Molecular Pathway-Level Analyses (IMPaLA) (Kamburov et al., 2011) all of which search 
different databases.  This allowed the assessment of key putative interactions or pathways 
that were perturbed in response to AgNP and Ag+ exposures.  Significantly changing 
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putative identities involved in these interactions were then investigated further by RT-
qPCR and MS/MS to confirm gene expression levels and peak identity respectively.  
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5.2 Materials and Methods 
5.2.1 Putative annotation of filtered genes and m/z peaks 
The D. magna microarray was originally designed using a large expressed sequence tag 
(EST) database and annotated by Poynton et al (2012). An initial BLASTX search of these 
EST sequences (http://blast.ncbi.nlm.nih.gov/Blast.cgi) against the entire NCBI non-
redundant protein database gave the closest protein homologues to the microarray targets 
using an e-value filter of 10-6.  Further annotation was acquired through a BLASTX search 
against the Daphnia pulex genome v1.0 (Colbourne et al., 2005).  D. pulex protein 
sequences corresponding with hits from this search were compared with human peptide 
sequences, downloaded from Ensembl (Flicek et al., 2014) using BLASTp to find putative 
human orthologues for pathway analysis.  Gene ontology annotation was achieved using 
Blast2GO (Götz et al., 2008).  This method of annotation was adapted from previously 
published methods (Williams et al., 2011; David et al., 2011; Poynton et al., 2012). 
For FT-ICR mass spectrometry data, all filtered m/z values with corresponding average 
raw intensities (non-normalised) were imputed into MI-Pack (Weber and Viant, 2010) to 
generate possible empirical formulae and putative metabolite names for each m/z peak 
using KEGG.  Briefly, MI-Pack calculates accurate m/z values for common negative ions 
([M-H]-, [M+35Cl]-, [M+37Cl]-, [M+Acetate (Ac)]-, [M+K-2H]- and [M+Na-2H]-) and 
positive ions ([M+H]+, [M+Na]+, [M+39K]+, [M+41K]+) of all compounds within the 
KEGG compounds database.  It then attempts to match these values with the accurate mass 
m/z values detected during the experiment using an error window of 1 ppm.  The 
transformation mapping algorithm (Weber and Viant, 2010) was used to increase 
confidence in assigned putative metabolite names.  
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5.2.2 Over-representation analysis of transcriptomics datasets using DAVID 
ORA was performed with putative orthologous human Ensembl gene IDs using the 
DAVID (version 6.7).  The input list consisted of all Ensemble IDs assigned the gene-
spots that were deemed to change significantly via 1-way ANOVA in the previous chapter 
(Section 4.3.3).  A list of all detected gene-spots with orthologous human Ensemble gene 
IDs, regardless of significance, was used as a background comparison list.  Fisher’s exact 
test was used with a FDR of 0.05 to correct for the multiple-testing hypothesis (Benjamini 
and Hochberg, 1995).  Four pathway databases were used for their respective pathway 
definitions: KEGG-Pathway, Reactome-Pathway, BIOCARTA and the Biological 
Biochemical Image Database (BBID).  Pathways relating to diseased states and first-tier 
Reactome definitions that encompass many smaller pathways (e.g. ‘Metabolism’ or 
‘Signal transduction’) were excluded. Only pathway definitions with a minimum of 3 hits 
from the input list were retained.  
5.2.3 Over-representation analysis of metabolomics datasets using MetaboAnalyst 
ORA was applied using MetaboAnalyst (Version 2.0 (Xia et al. 2012)) to putatively 
assigned KEGG IDs from the metabolomics dataset.  An input list was formed from all 
KEGG IDs that were assigned to m/z peaks deemed to change significantly via 1-way 
ANOVA in the previous chapter (Section 4.3.3).  A list of all putative KEGG IDs assigned 
to any peak regardless of significance was assembled for use as a background reference 
list.  If a particular KEGG ID was assigned to multiple peaks only a single iteration of the 
ID was used.  Fisher’s exact test was used with a FDR of 0.05 to correct for the multiple-
testing hypothesis (Benjamini and Hochberg, 1995).  Pathway definitions used were 
obtained from KEGG.  Only pathway definitions with a minimum of 3 hits from the input 
list were retained. 
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5.2.4 Integrated over-representation pathway analysis of metabolomics and 
transcriptomics datasets using IMPaLA 
IMPaLA is an online analytical software tool that allows the combined pathway analysis of 
transcriptomics and metabolomics datasets (Kamburov et al., 2011).  ORA was performed 
using input lists of the significantly changing Ensembl gene and KEGG compound IDs 
generated in the previous chapter (Section 4.3.3).  Background lists of all detected 
Ensemble and KEGG IDs were used to avoid bias as above.  IMPaLA applies Fisher’s 
exact test independently for transcriptomics and metabolic datasets and then integrates the 
resulting p-values using Fisher’s combined probability test (Cavill et al., 2011).  These 
‘joint-p’ values are then corrected using a FDR of 0.05 to account for the multiple testing 
hypothesis (Benjamini and Hochberg, 1995).  Pathways relating to diseased states and 
first-tier Reactome definitions that encompass many smaller pathways (e.g. ‘Metabolism’ 
or ‘Signal transduction’) were excluded. Only pathway definitions with a minimum of 3 
hits from each input list were retained. 
5.2.5 Confirmation of gene changes in purine metabolism pathway by quantitative, 
reverse transcriptase PCR 
To validate the microarray data, Reverse-Transcriptase quantitative PCR (RT-qPCR) was 
conducted on the four genes from the purine metabolism pathway whose expression was 
discovered to have been altered significantly in response to AgNP exposure.  The same 
samples used for microarray analysis were used for validation by RT-qPCR. 
5.2.6 Synthesis of cDNA  
Prior to primer validation and RT-qPCR, cDNA was synthesised using a Tetro cDNA 
synthesis kit (Bioline Reagents Limited, London, UK) according to manufacturer’s 
instructions.  RNA was first incubated with a mix of random hexamers (1 µl) for 2 minutes 
at 65 °C to denature template RNA.  For primer validation 500 ng of template RNA was 
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used. For cDNA synthesis from omics-samples, the maximum available volume of 12 µl 
was used due to very low sample concentrations.  Once incubation was completed, 5x RT 
Buffer (4 µl), a 10 mM dNTP mix (1 µl), Ribosafe RNase inhibitor (1 µl), and 1 µl Tetro 
reverse transcriptase (200 units/µl) was added to each tube.  For primer validation, 
nuclease free water was added to make a final reaction volume of 20 µl.  Each reaction 
was incubated using a thermocycler (Eppendorf Mastercycler Gradient; Eppendorf, 
Cambridge, UK) according to the temperature cycle outlined below (Table 5.1).  The 
concentration of cDNA was measured after synthesis using a Nanodrop 
spectrophotometer, with an analysis constant of 33 for single-stranded DNA, and stored at 
-20°C. 
Table 5.1: The temperature cycle for synthesis of cDNA using Tetro reverse transcriptase 
Temperature  Duration  Notes 
25 °C 10 min Annealing 
42 °C 90 min cDNA synthesis 
70 °C 15 min Denaturation 
 
5.2.7 Primer design and validation 
Primers were designed using Primer3 (Rozen and Skaletsky, 1999) and synthesised by 
Sigma-Aldrich (Sigma-Aldrich, UK). Primer sequences are presented in Table 5.2 
. 
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Table 5.2: qPCR primer sequences and target information 
Gene ID Ensemble ID 
Human Gene 
Symbol 
Direction Primer Sequence (5' to 3') 
DM00042 ENSG00000185100 ADSSL1 
Forward TAATGGAATCCGCGTTGCTG 
Reverse CCAAGACCATTTTCCCTGCC 
DM00720 ENSG00000185100 ADSSL1 
Forward CTACCGCCATCGCTTATTGG 
Reverse ATCCACAACGTCTTTTCCGC 
DM00278 ENSG00000168002 POLR2G 
Forward ACGAAATTCTGTTGCACCCA 
Reverse TGTCCAGGCTGTATGATTCCA 
DM00814 ENSG00000076685 NT5C2 
Forward CACCTGTGTTCATGGCATCC 
Reverse TGTAGTCCATGTCGAAGCCA 
DM02745 ENSG00000198682 PAPSS2 
Forward AAATCCTCTTTGCGTTCCGG 
Reverse ACATCGTAGGCAGAGATCCG 
 
Primers were validated using BIOTAQ polymerase (Bioline Reagents Limited, London, 
UK).  For each reaction, 100 ng of template cDNA was mixed with forward and reverse 
primers (each at 2 µM final concentration), 3 mM Mg2+ (from MgCl2), 0.2 mM dNTPs and 
1 unit of BIOTAQ polymerase.  Once reactions were mixed, samples were incubated in a 
thermocycler (Eppendorf Mastercycler Gradient; Eppendorf, Cambridge, UK) to the 
temperature cycle outlined in Table 5.3, then prepared for gel electrophoresis to confirm 
the presence of a PCR product. 
Table 5.3: Primer validation temperature cycle using BIOTAQ polymerase. Each stage 
proceeds in order from top to bottom with the middle three stages repeated (in order) 37 
times before the final elongation stage 
Temperature Duration Cycles Notes 
95 °C 5 min 1 Activation of TAQ 
95 °C 30 s 
38 
Primer activation 
60 °C 30 s Annealing 
72 °C 30 s Elongation 
72 °C 15 min 1 Final elongation 
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5.2.8 Agarose gel electrophoresis of PCR products 
Agarose powder  (Bioline Ltd, UK) was added to 1x TBE buffer (89 mM Tris base, 
89 mM boric acid and 2 mM EDTA, adjusted to pH 8.0) with added SYBR Safe DNA gel 
stain (1 µl per 10 ml of dissolved gel,  Invitrogen, Life Technologies, CA, USA) and 
dissolved by heating. Once poured and set in the electrophoresis tank, the gel was 
submerged in 1x TBE Buffer. DNA samples and DNA molecular weight markers (100 bp, 
New England Biolabs, USA) were mixed with loading dye (6x gel loading dye, orange; 
New England Biolabs, USA) and loaded into the wells. Electrophoresis was performed at 
80 V for 20-45 minutes and the gel was visualised by UV trans-illumination (Machine, 
model, manufacturer).  PCR products were confirmed by sequencing, as described in 
section 5.2.9. 
5.2.9 Purification and sequencing of PCR products  
Prior to sequencing, PCR products were purified using a kit (QIAquick PCR purification 
kit, QIAGEN) according to the manufacturer’s guidelines.  Briefly, 5 µl of sodium acetate 
and 250 ml buffer PB were added to the product and filtered through the QIAquick column 
for 1 min at 13,000 rpm in a desk-top microfuge (5415D, Eppendorf).  The column was 
washed with 750 µl of buffer PF, the product was then eluted from the column in 50 µl 
nuclease free water.  Purified samples were sequenced by the Functional Genomics and 
Proteomics Unit, (School of Biosciences, University of Birmingham, Birmingham, UK) 
using an ABI3730 DNA analyser (Applied Biosystems, UK). Each sequencing reaction 
was set up using 10 ng of the purified DNA samples and 0.4 µl of either reverse or forward 
primers (10 pmol). The final volume was adjusted to 10 µl using sterile water.  To 
determine whether the custom primers had amplified the gene of interest, the sequences of 
the amplified DNA fragments were imputed into BLAST 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi).  
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5.2.10 RT-qPCR using omics samples 
Following cDNA synthesis from all selected groups, the three biological replicates with 
the highest concentration and best quality cDNA were selected for RT-qPCR.  
Approximately 100 ng of each sample was mixed with a final concentration of 1 µM 
forward and reverse primers and 10 µl of SensiFAST SYBR Lo-ROX mix (Bioline 
Reagents Limited, London, UK) and made to a total volume of 20 µl per individual 
reaction.  Each of the 21 biological samples was plated in triplicate on a 96-well PCR plate 
(Agilent Technologies).  A separate plate was used for each of the selected genes with a 
functioning pair of primers including 4 log10-fold dilutions of template cDNA as a 
concentration curve, a non-template control and a non-reverse-transcriptase control which 
utilised template RNA instead of cDNA.  Forward and reverse primers for the D. magna 
Actin gene were utilised as a reference gene.  Each plate was scanned for SYBR Green 1 
intensity on an Mx3005P RT-PCR machine and MxPro analysis software (Agilent 
technologies) using a 3-step cycle (Table 5.4) followed melt-profile analysis. 
Amplification efficiencies were calculated from the concentration curve. 
Table 5.4:  RT-qPCR temperature cycle.  Each stage proceeds in order from top to bottom 
with the middle three stages repeated (in order) 39 times before melt-curve determination 
Temperature (°C) Duration  No. cycles 
95 2 min 1 
95 5 s 
40 60 10 s 
72 5 s 
Melt curve   1 
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5.2.11 Relative quantification using the Pfaffl method 
The amplification efficiencies of the reference and target genes were not equal; therefore 
the Pfaffl method (Pfaffl, 2001) was used to calculate relative expression levels of target 
genes. The Pfaffl method follows the equation outlined in Equation 5.1. 
Equation 5.1: The Pfaffl method for relative quantification and calculation of the relative 
expression ratio (R).  Where E represents the amplification efficiency of the target or 
reference gene and ΔCq is the Cq deviation of control – sample of the target of reference 
gene. 
𝑅 =
(𝐸target)∆𝐶𝑞target(𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑠𝑎𝑚𝑝𝑙𝑒)
(𝐸reference)∆𝐶𝑞ref(𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑠𝑎𝑚𝑝𝑙𝑒)
 
5.2.12 Confirming the identities of significantly changing metabolites 
A D. magna QC aliquot was re-suspended in 100 µl of a 4:1 mixture of methanol:water 
with 20 mM ammonium acetate for FT-ICR MS analysis in negative ion mode according 
to protocol outlined earlier (Section 4.2.4).  The use of a smaller re-suspension volume was 
to enhance sensitivity for easier detection of the lower intensity peaks of interest.  Once re-
suspended, 5 µl aliquots were loaded onto a 384 well plate as before, and sealed using a 
single, heat-sealed, foil sheet.  Samples were directly and continuously infused into the MS 
using parameters outlined earlier (Section 4.2.5). Using the FT-ICR-MS, attempts were 
made to manually isolate (1 m/z isolation window) ions at 266.08954 m/z, 267.07354 m/z 
282.08439 m/z and 328.04510 m/z believed to correspond to deoxyadenosine/guanosine, 
inosine, guanosine and cAMP respectively.  Isolated ions were fragmented through 
collision induced dissociation under nitrogen gas at a normalised collision energy of 35%, 
with detection of resulting product ions performed using the LTQ-MS.  Where possible, 
the highest intensity product ion was subsequently isolated (1 m/z) and further fragmented 
(normalised collision energy of 35 %), as above.  The fragmentation patterns of the 
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isolated peaks were compared to those reported in the available literature for purified 
standards (Struck-Lewicka et al., 2014; Stentoft et al., 2014).  
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5.3 Result and Discussion 
5.3.1 Putative annotation of molecular markers of AgNP exposure 
After implementing the annotation processes outlined above (section 5.2.1), 4121 of the 
8128 detected gene spots were identified as putative orthologues of human genes, and 
were assigned human Ensembl gene IDs.  Of these, 313 changed significantly in 
expression upon exposure to AgNPs and a detailed list is available in the Appendix (Table 
9.6).  Despite the genome of D. magna being sequenced the data is not yet published or 
available for public use.  This situation will be partially responsible for the relatively low 
level of annotation observed in this study; the other will be due to the many ‘species 
specific’ genes that have no homologue in other model organisms (Colbourne et al., 2011).  
Of the 1330 detected m/z peaks, only 145 were successfully assigned at least 1 empirical 
formula with a minimum of 1 putative KEGG Compound ID. Of these, 26 had been 
deemed to change significantly in intensity upon exposure to AgNPs.  A full list of all 
putatively annotated significantly changing m/z peaks can be found in the appendix (Table 
9.7).  Although the transformation mapping algorithm improves assignment of putative 
IDs, many of the 145 successfully annotated m/z peaks had been assigned multiple 
potential KEGG IDs.  361 KEGG IDs had been assigned in total, with 68 assigned to 
significantly changing m/z values.  Due to the nature of the data the true identity cannot be 
assigned at this point so, for computational pathway analysis, all putative identities have to 
be assumed to be equally possible. 
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5.3.2 Interpreting annotation: over-representation analysis of annotated variables 
All 313 putative Ensemble IDs were imputed into DAVID for ORA against a background 
of all detected putative Ensemble IDs using Fisher’s exact test.  Pathway definitions from 
KEGG-Pathway, Reactome-Pathway, BIOCARTA and BBID were used in the analysis.  
Similarly, each of the 68 individual putative KEGG IDs assigned to each of the 31 
generated empirical formulae were compiled and imputed into MetaboAnalyst for over-
representation pathway analysis again using Fisher’s exact test (Xia et al., 2012).  
Following correction for multiple testing using a FDR of 0.05 (Benjamini and Hochberg, 
1995), it was determined that none of the tested transcriptional or metabolic pathway 
definitions were significantly enriched.  It is worth noting however, that the galactose 
metabolism pathway as defined by KEGG had an adjusted p-value of 0.0622 following 
ORA via MetaboAnalyst. 
The result of Fisher’s exact test directly depends upon the size of the background list used 
for comparison.  Due to the bottle-neck of metabolite identification, the number of 
detected metabolites that can be putatively annotated is limited, resulting in a truncated 
background list of hundreds of metabolites compared to the potential thousands that exist 
in eukaryotic cells (Bouhifd et al., 2013).  This, along with the limited annotation of the 
D. magna microarray in use, could potentially reduce the efficiency of analysis making it 
less likely for any one pathway to be statistically over-represented.  Despite a lack of 
significant over-representation, the data still holds information as to which pathways are 
impacted by Ag exposure. To isolate potential pathways of interest, disease-related 
pathways and first-tier Reactome pathways were removed, as were any pathway 
definitions with < 4 hits from the input list.  This shortlisted 22 transcriptional pathway 
definitions (Table 5.5) and 6 metabolic pathway definitions (Table 5.6) which were 
involved in the response to Ag toxicity.  
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Table 5.5: Pathways of interest following over-representation analysis of the transcriptomics dataset via DAVID.  For each pathway the number 
of significant and background hits is included as well as the raw and FDR-correct p-values. 
     Input List  Background  Statistics 
Pathway Name 
Pathway 
Source 
 Hits Total  Hits Total  p-value adj p-value 
Amino sugar and nucleotide sugar metabolism KEGG  6 110  20 989  0.0595 0.9998 
Retinol metabolism KEGG  4 110  12 989  0.1371 1.0000 
Cysteine and methionine metabolism KEGG  4 110  13 989  0.1646 0.9998 
Chemokine signaling pathway KEGG  6 110  28 989  0.1871 0.9994 
Processing of Capped Intron-Containing Pre-mRNA REACTOME  7 73  40 730  0.1924 0.9947 
Tyrosine metabolism KEGG  4 110  14 989  0.1936 0.9978 
Signaling by Rho GTPases REACTOME  4 73  21 730  0.3433 0.9838 
Metabolism of amino acids REACTOME  9 73  69 730  0.3682 0.9765 
Biological oxidations REACTOME  4 73  23 730  0.3999 0.9720 
Lysosome KEGG  6 110  38 989  0.4101 0.9981 
Glutathione metabolism KEGG  4 110  21 989  0.4131 0.9970 
Transcription REACTOME  5 73  34 730  0.4368 0.9703 
Pathways in cancer KEGG  7 110  51 989  0.5002 0.9979 
Neurotrophin signaling pathway KEGG  4 110  24 989  0.5039 0.9971 
Focal adhesion KEGG  6 110  43 989  0.5233 0.9948 
Metabolism of carbohydrates REACTOME  5 73  44 730  0.6495 0.9941 
Wnt signaling pathway KEGG  4 110  30 989  0.6610 0.9966 
Metabolism of lipids and lipoproteins REACTOME  5 73  49 730  0.7343 0.9955 
Signalling by NGF REACTOME  4 73  39 730  0.7614 0.9955 
Purine metabolism KEGG  4 110  38 989  0.8104 0.9988 
MAPK signaling pathway KEGG  4 110  42 989  0.8618 0.9993 
Spliceosome KEGG   4 110   43 989   0.8725 0.9992 
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Table 5.6: Pathways of interest following over-representation analysis of the metabolomics dataset via MetaboAnalyst.  For each pathway the 
number of significant and background hits is included as well as the raw and FDR-correct p-values. 
     Input List  Background  Statistics 
Pathway 
Pathway 
Source 
 Hits Total  Hits Total  p-value adj p-value 
Galactose metabolism KEGG  8 47  12 276  0.0008 0.0622 
Starch and sucrose metabolism KEGG  4 47  5 276  0.0088 0.3511 
Fructose and mannose metabolism KEGG  7 47  15 276  0.0248 0.6617 
Butanoate metabolism KEGG  4 47  9 276  0.1092 1.0000 
Purine metabolism KEGG  6 47  16 276  0.1095 1.0000 
Amino sugar and nucleotide sugar metabolism KEGG  4 47  13 276  0.3119 1.0000 
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As outlined in Table 5.5, the genes that were identified as being significantly up or down 
regulated in response to Ag exposure are involved in many varied processes. These include 
the metabolism and transport of small molecules such as hexose sugars and amino acids, 
and signalling cascades involving MAP kinases, nerve growth factor, neurotrophin and 
Rho-GTPases.  The glutathione metabolism and cysteine and methionine metabolism 
pathways both contain four gene products which alter significantly in response to Ag 
exposure.  Both glutathione and cysteine contain thiol groups and can act to both sequester 
free metal ions including Ag+ and to protect against oxidative stress through the reduction 
of ROS.  The metabolic pathways outlined in Table 5.6 are involved in the metabolism of 
dietary sugars as well as purines and amino-sugars and nucleotide sugars.  This may 
suggest an impact on energy metabolism and the production of ATP, processes which have 
been seen to be impacted by Ag exposure previously.   
While robust and informative, these two independent ORA alone do not give a definitive 
image of the extent of overlap and interaction between the transcriptome and metabolome 
of Ag-exposed Daphnia.  It is possible to gain knowledge of these interactions through 
conceptual integration of these lists based on published data, however this approach is 
subjective and may result in potentially novel mechanisms being overlooked (Cavill et al., 
2011).  As a more objective, statistical approach, integrated pathway analysis was used to 
take the interactions between metabolites and genes into account.  The KEGG Compound 
IDs and the Ensembl Gene IDs putatively assigned to the significant, annotated MS peaks 
and gene-probes respectively were compiled for ORA using IMPaLA (Kamburov et al., 
2011).  ORA was implemented using Fisher’s exact test with a reference background of all 
detected Ensembl Gene IDs and KEGG Compound IDs.  After correcting for the multiple 
testing hypothesis (Benjamini and Hochberg, 1995), it was again found that none of the 
molecular-level pathways from the 12 tested databases were significantly over-represented 
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(Table 5.7).  As with the results of DAVID and MetaboAnalyst, the result of ORA via 
IMPaLA is restricted by the limitations in metabolite identification and the current level of 
annotation of the D. magna microarray. 
Despite the lack of significant over-representation, the results are informative as to the 
pathways in which significantly altered metabolites and gene products are involved.  To 
isolate potential pathways of interest, those with ≥ 3 putative metabolites and ≥ 3 putative 
genes were shortlisted.  These parameters yielded 2 pathway definitions from KEGG, 1 
from the Edinburgh Human Metabolic Network (EHMN), and 10 from the Reactome 
database.  To restrict the search further, pathways relating to diseased states were excluded 
as well as first-tier Reactome definitions that encompass many smaller pathways (e.g. 
‘Metabolism’ or ‘Signal transduction’).  This second stage filter resulted in 11 pathway 
definitions which are listed in Table 5.7.  These suggest perturbations to the metabolism of 
lipids, lipoproteins and fatty acids, the transport of small organic molecules, the 
metabolism carbohydrates, signalling via G-protein coupled receptors and the metabolism 
of purines.  
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Table 5.7: Pathways of interest following over-representation analysis.  For each pathway the number of significant and background hits is 
included for transcriptomics and metabolomics analyses.  The p-values and adjusted p-values from the integrated analyses are also included.  
Pathway definitions are from Reactome, KEGG, and the Edinburgh Human Metabolic Network (EHMN). 
   Transcriptomics  Metabolomics  Integrated Statistics 
Pathway Name 
Pathway 
Source 
 Input Hits 
Background 
Hits 
 Input Hits 
Background 
Hits 
 p-value adj p-value 
Metabolism of lipids and lipoproteins Reactome  19 123 (490)  6 15 (443)  0.0234 1 
Amino sugar and nucleotide sugar 
metabolism - Homo sapiens (human) 
KEGG  6 21 (47)  4 13 (99)  0.0314 1 
Fatty acid, triacylglycerol, and ketone body 
metabolism 
Reactome  6 42 (92)  3 6 (90)  0.125 1 
SLC-mediated transmembrane transport Reactome  5 35 (254)  10 35 (164)  0.142 1 
Purine metabolism - Homo sapiens 
(human) 
KEGG  4 41 (172)  6 16 (92)  0.167 1 
Transport of sugars, bile salts, organic 
acids, metal ions and amine compounds 
Reactome  3 14 (97)  6 23 (83)  0.199 1 
Metabolism of carbohydrates Reactome  9 67 (255)  4 12 (120)  0.219 1 
Purine metabolism EHMN  4 55 (224)  5 16 (94)  0.419 1 
Signaling by GPCR Reactome  5 41 (1071)  4 15 (151)  0.436 1 
GPCR downstream signaling Reactome  4 29 (960)  3 14 (124)  0.538 1 
Metabolism of nucleotides Reactome  3 31 (80)  5 20 (135)  0.551 1 
  
143 
 
5.3.3 AgNPs and Ag+ ions induce a significant change in metabolites and gene-
products involved in purine metabolism 
Of the shortlisted pathways, purine metabolism as defined by KEGG showed the greatest 
interaction between the constituent significant gene-products and putative metabolites.  All 
significantly changing gene-probes and m/z peaks found within this pathway are listed in 
Table 5.8..   
Table 5.8: Putative identities of significantly changing metabolites and gene-products in the 
purine metabolism pathway. 
m/z peak KEGG Compound ID Putative name adj p-value 
266.08954 C00330 Deoxyguanosine 0.01044 
266.08954 C00212 Adenosine 0.01044 
267.07354 C00294 Inosine 0.00770 
282.08439 C00387 Guanosine 0.00022 
328.0451 C02353 2',3'-Cyclic AMP 0.01881 
328.0451 C00575 3',5'-Cyclic AMP 0.01881 
Gene ID Ensemble gene ID Predicted function 
Human 
Symbol 
adj p-
value 
DM00042 ENSG00000185100 
adenylosuccinate 
synthase like 1 
ADSSL1 0.03860 
DM00278 ENSG00000168002 
polymerase (RNA) II 
(DNA directed) 
polypeptide G 
POLR2G 0.00167 
DM00720 ENSG00000185100 
adenylosuccinate 
synthase like 1 
ADSSL1 0.00130 
DM00814 ENSG00000076685 
5'-nucleotidase, 
cytosolic II 
NT5C2 0.00822 
DM02745 ENSG00000198682 
3'-phosphoadenosine 
5'-phosphosulfate 
synthase 2 
PAPSS2 0.01880 
DM09437 ENSG00000185100 
adenylosuccinate 
synthase like 1 
ADSSL1 0.04520 
 
  
144 
 
AgNP exposure has been suggested previously to affect the metabolism of purines. 
Specifically, Wistar rats exposed to AgNPs showed elevated excretion of uric acid and 
allantoin which are products of purine breakdown (Hadrup et al., 2012).  What is observed 
in this study is a significant increase in the four peaks putatively annotated as cyclic 
adenosine monophosphate (cAMP), inosine, guanosine and adenosine/deoxyguanosine.  
The relative fold changes of these peaks are at their highest in response to AgNP High 
(Figure 5.2).  Interestingly, these four m/z peaks are all within the top 50 loadings values 
from PCA analysis, indicating their importance in the concentration-dependant response 
observed in the last chapter (Figure 4.10).  The six significantly changing gene-probes 
within this pathway have four predicted functions: adenylosuccinate synthase (ADSSL1), 
polypeptide G of RNA polymerase II (POLR2G), cytosolic II 5’-nucleotidase (NT5C2) 
and 3’-phosphoadenosine 5’-phosphosulfate synthase 2 (PAPSS2).  NT5C2 in particular 
interacts with the four putative purine nucleosides inosine, guanosine, adenosine, and 
deoxyguanosine catalysing the dephosphorylation of their respective monophosphates 
(Figure 5.1). Two of these nucleoside-monophosphates, AMP and dGMP, are putatively 
detected but do not change significantly in intensity.  With the exception of POLR2G 
whose expression putatively decreases in response to AgNP High exposure, the remaining 
target genes show an increase in expression with increasing AgNP or Ag+ concentration 
(Figure 5.3). 
The definitions of metabolic pathways or gene ontology functions used in ORA do not 
accurately reflect the intricate web of interactions that comprise cellular metabolism 
(Khatri et al., 2012).  Many of the constituent genes and metabolites of these definitions 
function in multiple pathways, meaning that there is often overlap between the pathways 
themselves.  This level of interaction and inter-dependence is not reflected in ORA or 
other forms of pathway analysis.  Consequently this may mean that if a particular pathway 
  
145 
 
is affected by Ag exposure, the result following ORA may show multiple pathways to be 
over-represented due to overlapping genes or metabolites between the pathways.  An 
example within this study may be seen following ORA of putative metabolites. Three of 
the pathways in Table 5.6; galactose metabolism, fructose and mannose metabolism and 
starch and sucrose metabolism, contain a large number of overlapping metabolites. It is 
therefore not possible to say that any one of these pathways is or is not over-represented, 
they are therefore treated as being equally likely. 
Likewise any significant constituent of an over-represented pathway may be altered due to 
perturbations in a different pathway.  The putative significantly changing metabolites 
involved in the purine metabolism pathway are also involved in multiple cellular 
processes.  As well as being essential for the production of nucleoside triphosphates and 
therefore the synthesis of RNA, the three nucleosides inosine, guanosine and adenosine 
have alternative roles.  Adenosine is essential for the production of ATP, the primary 
source of energy for all active processes. Guanosine is necessary for the production of 
GDP and GTP which are key for the function of G-protein coupled receptors. These 
membrane proteins trigger cellular signalling through, among others, the cAMP signalling 
pathway which is involved in the regulation of glycogen, sugar and lipid metabolism. 
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Figure 5.1: Map of the key interactions between significantly changing putative metabolites and gene-products in the purine metabolism pathway.  
Circles represent metabolites which are not-detected (white), putatively annotated but unchanged in intensity (yellow) or putatively annotated 
significantly elevated in intensity (green) with directional arrows indicating inter-conversions between metabolites.  Oblongs represent gene 
products that catalyse reactions between metabolites and are either significantly up- (green) or down- regulated. 
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Figure 5.2: Fold changes of the peaks corresponding to the putative IDs of inosine (a), guanosine 
(b), cAMP (c) and adenosine/deoxyguanosine (d) relative to the combined control in response to 
varying concentrations of AgNP and Ag+.  Mean relative fold changes have been Log10 
transformed.  P-values were generated following a 1-way ANOVA and stars have been placed 
over those groups that changed significantly compared to the combined control. Analysis by 2-
way ANOVA indicated no significant difference between AgNPs and dissolved Ag. 
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Figure 5.3: Fold changes of microarray gene spots for ADSSL1 (a), NT5C2 (b), POLR2G (c) 
and PAPSS2 (d) relative to the combined control in response to High and low concentration 
AgNP and Ag+ exposure.  Mean relative fold change values have ben Log10 transformed.  P-
values were generated following a 1-way ANOVA and stars have been placed over those groups 
that changed significantly compared to the combined control.  Analysis by 2-way ANOVA 
indicated no significant difference between AgNPs and dissolved Ag. 
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5.3.4 Attempted confirmation of perturbed gene regulation by qPCR 
RT-qPCR was used to confirm the perturbations of the four genes with predicted functions 
within the KEGG purine metabolism pathway measured to be significantly changing by DNA 
microarray.  During validation, the primers designed for DM02745 (PAPSS2) did not 
produce a product so were excluded from RT-qPCR.  Additionally the primers designed for 
DM00720 were chosen over DM00042 due better alignment of the product sequence with the 
target gene (ADSSL1). The remaining primers were successfully validated and found to 
amplify the correct targets as described above (section 5.2.7).  All target genes measured in 
the test control and exposure groups showed relatively small error between technical 
replicates but large variation between biological replicates.  As a result, when the different 
control and exposure conditions were measured by qPCR and compared by ANOVA, target-
gene expression was not found to be significantly different (Figure 5.4).   
.  
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Figure 5.4 The mean ± SEM relative fold changes of ADSSL1 (a), NT5C2 (b) and POLR2G (c) 
expression following exposure to AgNP, Ag+ and control conditions.  Relative fold change was 
determined by the Pfaffl method.  Expression levels were not found to alter significantly in any 
exposure or control condition. 
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5.3.5 Identification of inosine and guanosine by MS/MS fragmentation 
As stated earlier, the empirical formulae and KEGG Compound names assigned by MI-Pack 
are putative annotations, and may not reflect the true identity of m/z peaks involved.  To 
comprehensively identify peaks of interest they can be isolated and fragmented using 
MS/MS. The fragmentation pattern of the isolated peaks can then be compared with pure 
metabolite standards to confirm their identity.  It was only possible to successfully isolate two 
of the four target peaks; 267.07334 m/z and 282.08422 m/z corresponding to the putative 
KEGG IDs of inosine and guanosine respectively. Upon fragmentation of 267.07334 m/z 
(Figure 5.5) and 282.08422 m/z (Figure 5.6) the main fragments observed were at 134.9 m/z 
and 150.0 m/z respectively which are the approximate m/z values of deprotonated ([M-H]-) 
hypoxanthine and guanine (Stentoft et al., 2014). This purports to a neutral loss of 
approximately 132 Da, corresponding to loss of a deoxyribose sugar in both instances 
(Stentoft et al., 2014).  Subsequent isolation and fragmentation of the ion at 134.9 m/z, 
yielded two additional peaks at 91.9 m/z and 108.0 m/z (Figure 5.5) which have been reported 
previously as corresponding to the loss of –HCNO and –HCN respectively from 
hypoxanthine (Struck-Lewicka et al., 2014).  Further fragmentation of 150.0 m/z produced an 
additional peak at 133.0 m/z (Figure 5.6) potentially corresponding to the neutral loss of NH3 
from the guanine structure (Struck-Lewicka et al., 2014).   
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Figure 5.5: The fragmentation pattern of an isolated precursor ion at 267.07334 m/z.  Shown 
above is the isolated parent peak (MS), the initial fragments (MS2), and the fragments produce 
upon fragmentation of the main MS2 fragment (MS3). 
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Figure 5.6: The fragmentation pattern of an isolated precursor ion at 282.08422 m/z.  Shown 
above is the isolated parent peak (MS), the initial fragments (MS2), and the fragments produce 
upon fragmentation of the main MS2 fragment (MS3). 
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The similarities between the observed fragmentation patterns of these peaks to those 
previously reported from purified standards (Struck-Lewicka et al., 2014; Stentoft et al., 
2014) heavily suggests that m/z 267.07334 and 282.08422 correspond to the [M-H]- ions of 
inosine and guanosine respectively.  As stated above, the peaks corresponding to these two 
compounds, and to the putative identities of cAMP, adenosine and deoxyguanosine, are 
within the top 50 PC3 loadings values generated in the previous chapter.  This emphasizes the 
importance of these compounds in the response induced by AgNP exposure, with inosine 
ranked as the most important variable in the entire model.   
Guanosine is a precursor for the synthesis of GTP; the substrate for G-protein coupled 
receptors.  As seen from ORA (Table 5.7), downstream G-protein coupled receptor signalling 
pathways appeared to be affected following AgNP exposure.  Related to this, the putative 
metabolite cAMP, seen to increase significantly in response to AgNP exposure, is an 
important second messenger molecule.   
Both inosine and guanosine are ribonucleosides and as such are involved in the synthesis of 
RNA.  Guanosine is used in the synthesis of messenger, ribosomal and transfer RNA whereas 
inosine is involved in the biosynthesis of some tRNA molecules (Elliott and Trewyn, 1984).  
Their elevated production in response to AgNP and Ag+ exposure could simply be the result 
of increased transcription and translation of proteins involved in the response to toxicant 
exposure.    The inhibition of RNA polymerase by AgNP has been previously observed; 
Wang and colleagues demonstrated that exposure of erythroid progenitor cells to AgNP 
resulted in the inhibition of RNA polymerase activity and RNA transcription through the 
direct binding of AgNPs to the enzyme (Wang et al., 2013).  This could explain the 
significant increase in inosine and guanosine with respect to combined control groups; 
inhibition of RNA polymerase could indirectly result in an accumulation of these metabolites 
due to reduced RNA synthesis. 
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Alternatively inosine, guanosine and also adenosine have been previously reported to act as 
cyto-protective compounds by combating oxidative stress (Jurkowitz et al., 1998; Módis et 
al., 2009; Li et al., 2011; Cipriani et al., 2014).  These compounds have been suggested to 
have both anti-oxidant properties and induce the expression of DNA repair genes and the 
production of antioxidants (Gudkov et al., 2006; Dal-Cim et al., 2012).  It is therefore 
possible that the increased production of inosine and guanosine is the result of AgNP or Ag+ 
induced oxidative stress.   
 
5.4 Conclusions 
The work presented in this chapter represents the first attempt to identify the molecular 
response of D. magna to AgNP and Ag+ exposure using a combination of metabolomics and 
transcriptomics techniques.  In the previous chapter, microarray gene-spots and m/z peaks 
that changed significantly in intensity were shortlisted, giving a list of the most important 
variables in the molecular response to AgNP and Ag+ exposure.  Here, those features were 
successfully assigned putative identities, and pathway analysis was applied to identify 
molecular pathways which had been putatively perturbed.  Through use of IMPaLA, ORA 
was simultaneously applied to the transcriptomics and metabolomics shortlists to statistically 
integrate both levels of observation.  The results of this analysis showed perturbation of genes 
and metabolites involved in the metabolism of lipids and fatty acids, the transport of small 
organic compounds, the metabolism of carbohydrates, G-protein coupled receptor signalling 
and the metabolism of purines.  Further investigation of these pathways showed substantial 
interaction between the components on the purine metabolism pathway, with one enzyme in 
particular (NT5C2) being responsible for the production of 4 putative compounds.  Due to the 
large variation of gene-expression between biological replicates, confirmation of significantly 
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altered expression for these genes by PCR was not successful.  However, MS/MS 
fragmentation gave greater confidence in the identity of m/z 267.07334 and m/z 282.08422 as 
the purine nucleosides inosine and guanosine respectively.  The remaining significant peaks 
in this pathway could not be successfully isolated. 
These two metabolites and the putative compounds adenosine and cAMP are within the top 
50 PC3 loadings of the metabolomics PCA model produced in the last chapter.  This indicates 
that these compounds play an important role in the metabolic response of D. magna to AgNP 
and Ag+ exposure.  Exactly what role these two compounds play cannot be identified by this 
study, but both compounds are involved in the synthesis of RNA and have also been reported 
to have properties that protect cells from oxidative stress (Jurkowitz et al., 1998; Módis et al., 
2009).  The latter role links with mechanisms of AgNP (AshaRani et al., 2009; Chairuangkitti 
et al., 2013) and Ag+ (Yoshimaru et al., 2006; Cortese-Krott et al., 2009) toxicity suggested 
in the literature involving the induction of oxidative stress.  It could be possible that the 
production of these compounds is increased for their signalling roles in an effort to increase 
production of DNA damage repair and antioxidant enzymes (Dal-Cim et al., 2012).  
However, it is possible the significant increase in these two metabolites is the result of RNA 
polymerase inhibition, which is consistent with previously published findings (Wang et al., 
2013).  In summary these two compounds represent good targets for future work 
investigating the mechanism of AgNP-induced toxicity. 
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Chapter 6: Exploring the role of reactive oxygen species and oxidative 
stress in Ag toxicity to D. magna 
6.1 Introduction 
Reactive oxygen species (ROS) are a group of short-lived chemically reactive oxygen-
containing molecules which include the superoxide radical (.O2
-), hydroxyl radical (.OH), 
hydrogen peroxide (H2O2) and singlet oxygen (
1O2) (He et al., 2011).  ROS are produced 
naturally within mitochondria as a by-product of oxidative phosphorylation.  During this 
process some electrons can “leak” from the electron transport chain and interact with oxygen 
leading to the formation of the superoxide radical (.O2
-) (Campian et al., 2004).  This process 
is relatively infrequent under normal physiological conditions, with only 1-3% of oxygen 
molecules within the mitochondria being converted into .O2
- (Boveris and Chance, 1973; He 
et al., 2011).  Although .O2
- has a relatively low reactivity, its presence propagates the 
formation of other oxygen-containing radicals such as the hydroxyl radical (.OH) which 
possesses the highest reduction potential of all biologically relevant ROS (Fu et al., 2014).   
Normally, the production of this highly reactive and damaging species is kept in check by 
endogenous antioxidant enzymes and molecules.  The superoxide radical for example, is 
converted to hydrogen peroxide and molecular oxygen by the anti-oxidant enzyme 
superoxide dismutase (SOD) (Liochev and Fridovich, 2000).  The resulting hydrogen 
peroxide is then readily converted into water and molecular oxygen by the enzyme catalase 
(Finkel and Holbrook, 2000).  Antioxidants are small molecules which participate in redox 
reactions to remove ROS and prevent their propagation and interaction with cellular 
components.  The most important antioxidant in eukaryotic cells is glutathione (GSH), a 
tripeptide comprised of glutamic acid, cysteine and glycine (γ-glutamylcysteinylglycine) 
which acts as a defence against ROS, reactive xenobiotics or other electrophiles such as Ag+.  
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Glutathione can reduce ROS directly through the thiol group of its cysteine residue resulting 
in the removal of free ROS and the production of reduced glutathione (GSSG).  Glutathione 
is regenerated through the enzyme glutathione reductase which produces two molecules of 
GSH from one molecule of GSSG.  Glutathione can also sequester reactive species through 
the actions of glutathione-S-transferase (GST), which catalyses the conjugation of GSH to 
molecules such as such as peroxidised lipids and oxidises proteins (Strange et al., 2001). If 
the production of ROS becomes excessive, cellular anti-oxidant systems can become 
overwhelmed resulting in a state of oxidative stress (Finkel and Holbrook, 2000). Common 
consequences of oxidative stress include damage to DNA, the oxidation of polyunsaturated 
fatty acids in lipids (lipid peroxidation) and oxidation of amino acids in cellular proteins.  
This can result in genotoxicity and mutations, as well as membrane and enzyme dysfunction 
potentially leading to cytotoxicity and cell death. 
Heavy metals induce the production of ROS through either the Fenton or Fenton-like 
reactions (Equation 6.1) or the Haber-Weiss reaction (Equation 6.2) whereby the metal 
catalyses the production of hydroxyl radicals from cellular hydrogen peroxide (Jomova and 
Valko, 2011; Fu et al., 2014).   
Equation 6.1: The Fenton reaction  
𝐴𝑔0 + 𝐻2𝑂2  →  𝐴𝑔
+ + ∙ 𝑂𝐻 + 𝑂𝐻− 
Equation 6.2: The Haber-Weiss reaction 
∙ 𝑂2
− + 𝐻2𝑂2  
𝐴𝑔0
→  𝑂2 + 𝑂𝐻
− + ∙ 𝑂𝐻 
Ag is thought to induce the formation of ROS through a Fenton-like reaction such as that 
outlined in Equation 6.1 resulting in the formation of Ag+ from Ag0 (He et al., 2011).  The 
Ag+ ion can then react with O2 causing the formation 
.O2
- and reformation of Ag0.  This Ag-
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induced generation of ROS and oxidative stress has been measured in vitro and in vivo both 
directly, through the detection of ROS via fluorescence-based biochemical assays (De 
Matteis et al., 2015) and indirectly through measurement of down-stream effects such as 
DNA damage (Asharani et al., 2009; De Matteis et al., 2015), protein oxidation (Rainville et 
al., 2014) and the expression of antioxidant enzymes (Asharani et al., 2009; Poynton et al., 
2012).  In vitro, exposure to AgNPs has been shown to cause a significant increase in 
glutathione content and SOD activity within mouse hepatocytes (Arora et al., 2009).  AgNP-
induced genotoxicity has also been detected via the comet assay following exposures to 
human lung fibroblasts (AshaRani et al., 2009), human cervix carcinoma cells and human 
lung carcinoma cells (De Matteis et al., 2015).  Heme-oxygenase-1 (HMOX) has also been 
measured to increase significantly in response to AgNP exposure by RT-qPCR (Asharani et 
al., 2009) in human lung fibroblasts.  In vivo, the disruption of mitochondrial activity and 
oxidative phosphorylation has been observed following Ag exposure in C. elegans (Ahn et 
al., 2014), D. magna (Stensberg et al., 2013; Scanlan et al., 2013) and D. rerio (Aerle et al., 
2013).  The mitochondria are the principal location of oxygen within cells and as such are 
often the primary site of ROS generation (Finkel and Holbrook, 2000).  The presence of 
AgNPs within these organelles is thought to result in an increased production of ROS that 
ultimately leads to the disruption of energy production (Asharani et al., 2009; Verano-Braga 
et al., 2014). 
It is thought that exposure to Ag species induces oxidative stress in D. magna. Exposure to 
AgNP was found to result in an increase of protein carbonylation (Rainville et al., 2014) 
which the authors surmised as indicating protein oxidation caused by oxidative stress.  
However the same study indicated that exposure to AgNPs and AgNO3 did not result in a 
significant change of GST, catalase or GAPDH activity, which are known enzymatic 
responses to excessive ROS production (Rainville et al., 2014).  Targeted RT-qPCR also 
  
160 
 
failed to identify a significant increase in GST mRNA expression. However, AgNP and 
AgNO3 exposed D. magna demonstrated a significant increase in the expression of a DNA 
repair gene (REV1) in response to exposure to 1/10th of the LC50 and the LC25 of PVP-coated 
AgNPs over 24 h (Poynton et al., 2012).  A 1H NMR-based metabolomics investigation into 
the response of D. magna to AgNP and AgNO3 exposure identified similar response profiles 
in the metabolome of animals exposed to both forms of Ag (Li et al., 2015a).  The response 
included an increase in lactate and phosphocholine concentrations and a decrease in the 
concentrations of glucose and certain amino acids, which the authors surmised as being an 
indication of a disruption of energy metabolism and consequential oxidative stress (Li et al., 
2015a).  Whether or not oxidative stress is induced by Ag species in D. magna is therefore 
still a contested issue, it also remains unclear whether any previously detected indications of 
oxidative stress are the direct result of the presence of Ag, or an inevitable consequence of 
Ag-induced cell death. 
In this chapter, D. magna neonates were exposed to the Low and Mid concentrations of 
AgNP and AgNO3 used in Chapter 4, then subjected to targeted RT-qPCR analysis for three 
biomarkers of oxidative stress: GST, SOD and HMOX.  The expression of MT 
(metallothionein) was also monitored as a positive control to confirm exposure and 
internalisation of Ag, as an increase in MT transcription and protein abundance is a well-
documented response to both nanoparticle and dissolved Ag species exposure (see section 
1.2).  To confirm exposure to the intended concentrations of dissolved Ag and AgNP, the 
total silver concentration of each individual exposure was measured by ICP-MS.  DLS was 
also used in an attempt to confirm the presence of particles in AgNP exposures, and absence 
of particles in AgNO3 and control exposures.  The aim of the work in this chapter was to test 
the hypothesis proposed in Chapter 5 (section 5.4), that the observed increase in adenosine 
and inosine production following Ag exposure is in response to oxidative stress. Particular 
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interest is given to HMOX, as its expression has been previously documented as being 
elevated in response to guanosine exposure (Quincozes-Santos et al., 2014).   
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6.2 Methods 
6.2.1 AgNP and AgNO3 toxicity exposures to D. magna neonates 
PVP-coated AgNPs were prepared as outlined in section 2.3 and the final concentration was 
measured as 23.98 mg/l by ICP-MS using methods outlined below (section 6.2.3).  This 
AgNP Master Stock was then diluted 10-fold through the addition of 2 ml of Master Stock to 
a total volume of 20 ml MilliQ water to produce the AgNP Spiking Stock.  A Master Stock of 
AgNO3 was prepared through the addition of 89.1 mg of AgNO3 (Sigma Aldrich) to 200 ml 
MilliQ water giving a nominal concentration of 44.55 mg/l.  A 1 in 20 dilution of this master 
stock, followed by two serial 1 in 10 dilutions was made to yield a Spiking Stock with a 
nominal concentration of 222.75 µg/l AgNO3.  The total Ag concentration of both the AgNP 
and AgNO3 Master and Spiking Stocks was measured by ICP-MS using methods outlined in 
section 6.2.3.  To initiate toxicant exposures, 10 neonates (<24 h old) were added using a 
plastic Pasteur pipette to 100 ml of media10 in 25 x 250 ml glass beakers.  In groups of five, 
these vessels were spiked with either 100 µl or 200 µl of the AgNP or AgNO3 spiking stock 
to produce the Low or High concentration exposures of AgNP or AgNO3 respectively 
(nominal concentrations outlined in Table 6.1).   
Table 6.1: The intended concentration of total silver within the Spiking Stocks and exposure 
vessels (µg/l) 
  Total silver concentration (µg/l) 
  
Spike stock 
(nominal) 
Volume (µl) 
into 200ml 
Nominal 
exposure conc. 
AgNP Low 2398 100 1.18 
AgNP Mid 2398 200 2.35 
AgNO3 Low 140 100 0.07 
AgNO3 Mid 140 200 0.14 
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A no-added silver control was created through the addition of 200 µl MilliQ water to five 
exposure vessels.  Immediately following the addition of toxicant or MilliQ water, an 
additional 100 ml of media10 was added to each vessel to mix and to bring the final 
concentration to the intended nominal value (Table 6.1).  Vessels were then covered with 
Clingfilm and left for 24 h in the environmental conditions outlined above (section 2.5).  
After 24 h, the exposures were terminated; the numbers of living and immobilised animals 
per exposure vessel were counted, then the remaining living neonates were removed onto 
gauze and transferred into a 2 ml Precellys homogenisation tube and flash-frozen in liquid 
nitrogen.  Precellys tubes were then stored at -80°C until required for the extraction of RNA. 
6.2.2 Dynamic light scattering (DLS) 
Immediately after exposure initiation, 1ml aliquots of dosed exposure media from three, 
randomly selected vessels from the control, AgNP High and AgNO3 High groups were 
transferred into a plastic cuvette for analysis by DLS.  Particle size was measured using a 
Zetasizer 5000 (Malvern Instruments, UK) at 20°C following a 120 s period to allow for 
equilibration of temperature.  The refractive index (0.54) and adsorption coefficient (3.99) for 
silver samples were used to create the standard operating procedure for analysis using 
Zetasizer software (Version 7.11, Malvern Instruments, UK).  
The DLS technique shines a laser onto particles in suspension and determines their size from 
the fluctuations in the intensity of scattered light.  In this study DLS was used to measure 
three parameters of particles within each solution: the z-average size (nm), the count rate and 
the polydispersity index.  The z-average size represents the average hydrodynamic diameter 
of the particles in suspension; this value is most accurate with suspensions of spherical, 
monodisperse particles.  The count rate (or photon count rate) is simply the number of 
detected photons which are reflected from the disperse particles. Particles with a particularly 
low count rate (for example <100) could be of too low a concentration for successful 
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analysis.  The polydispersity index ranges from 0 to 1 and is an indication of the size-
distribution of particles within the sample; a PDI greater than 0.7 is considered to have a very 
broad particle size distribution and is probably unsuitable for measurement by DLS (Malvern 
Instruments Ltd, 2011).  Briefly, 5 replicate measurements were taken of each sample to 
allow the calculation of mean values for the 3 measured parameters.  The mean and standard 
deviation for these parameters was calculated for the three biological replicates in each group 
and differences between groups were compared by a 1-way ANOVA using a Tukey-Kramer 
post-hoc test for multiple comparisons. 
6.2.3 ICP-MS 
After the exposure vessels were filled with dosed media, 500 µl of exposure water was 
removed into a 40 ml glass vial (acid-washed) and digested in an additional 500 µl 
concentrated, trace-metal grade HNO3 overnight in preparation for ICP-MS analysis. 
Following digestion, samples were diluted to approximately 2 % (v/v) nitric acid through the 
addition of 16 ml MilliQ water.  The total Ag concentration of each water sample was 
measured using an Agilent 7500ce with an Octopole Reaction system.  Calibration was 
performed between 0 – 50 ppb of Ag using 0, 1, 5, 10, 20 and 50 ppb standards.  Silver 
standards were prepared from a 1000 mg/l stock solution (VWR) in 2% nitric acid.  A 
calibration graph of counts (number) against concentration (µg/l) gave a correlation 
coefficient (R2) of 1.000.  An average was taken from 4 technical replicate measurements (in 
ppb) for each sample of dosed media; these readings were then converted into a concentration 
(in µg/l) from the calibration graph.  The limit of detection for silver on this instrument was 
0.02 ppb.  To investigate the potential interference of media10 within the samples with the 
measurement of dissolved total silver, two spike recovery tests were performed using aliquots 
of a control replicate after it had first been measured.  The first test using a final spike 
concentration of 1 ppb gave a return reading of 1.05 ppb and the second using a final 
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concentration of 10 ppb gave a return reading of 10.07 ppb, indicating that the media 
component had no impact on the measurements. 
6.2.4 Extraction of RNA 
RNA extractions were performed using the Absolutely RNA minprep kit (Agilent) to 
manufacturer’s instructions for animal tissue samples. Briefly, frozen animals (10 neonates 
per sample) were homogenised using a Precellys-24 ceramic bead-based homogeniser 
(Stretton Scientific Ltd., UK) in 250 μl of guanidine-thiocyanate containing lysis buffer for 
two 10 s bursts at 6400 rpm with a 15 s intermission.  Homogenate was then transferred into 
a nuclease-free 1.5 ml microfuge tube containing a further 250 µl of 70% ethanol and vortex 
mixed.  This mixture was then transferred to silica-based RNA-binding spin-columns and 
spun in a centrifuge for 60 s at 8000 rcf to allow RNA binding.  The spin-columns were then 
washed with 600 µl of Low-salt buffer (60 s at 8000 rcf) and treated with DNase1 according 
to manufacturer’s instructions.  Once DNase treatment was completed the columns were 
washed with 600 µl High-salt buffer then 600 µl of Low-salt buffer (each for 60 s at 
8000 rcf).  Finally samples were washed with 300 µl Low salt buffer (8000 rcf for 2 minutes) 
and then dried by spinning (8000 rcf for 1 minute) without any additional buffer.  Spin 
columns were transferred to a 1.5 ml nuclease-free microfuge tube and RNA was eluted using 
30 µl of elution buffer (10 mM Tris-HCl (pH 7.5) and 0.1 mM EDTA). The quantity and 
quality of RNA was assessed using a spectrophotometer (NanoDrop 1000, Thermo Scientific, 
Waltham, MA) with an analysis constant of 40 for RNA.  
6.2.5 Synthesis of cDNA 
Prior to primer validation and RT-qPCR, cDNA was synthesised using a Tetro cDNA 
synthesis kit (Bioline Reagents Limited, London, UK) according to manufacturer’s 
instructions.  RNA was first incubated with a mix of random hexamers (1 µl) for 2 minutes at 
65 °C to denature template RNA.  Due to the relatively low yields of RNA extracted from 
  
166 
 
samples, the maximum available volume of 12 µl was used for cDNA synthesis.  Once 
incubation was completed, 5x RT Buffer (4 µl), a 10 mM dNTP mix (1 µl), Ribosafe RNase 
inhibitor (1 µl), and 1 µl Tetro reverse transcriptase (200 units/µl) was added to each tube.  
Each reaction was incubated using a thermocycler (Eppendorf Mastercycler Gradient; 
Eppendorf, Cambridge, UK) according to the temperature cycle outlined below (Table 6.2).  
The concentration of cDNA was measured after synthesis using a Nanodrop 
spectrophotometer (NanoDrop 1000, Thermo Scientific, Waltham, MA), with an analysis 
constant of 33 for single-stranded DNA, and stored at -20°C prior to analysis by RT-qPCR. 
Table 6.2: The temperature cycle for synthesis of cDNA using Tetro reverse transcriptase 
Temperature  Duration  Notes 
25 °C 10 min Annealing 
42 °C 90 min cDNA synthesis 
70 °C 15 min Denaturation 
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6.2.6 Primer design 
Validated forward and reverse primers for five D. magna target genes (sequences outlined in 
Table 6.3) were ordered from and synthesised by Integrated DNA Technologies (IDT, 
Belgium).  
Table 6.3: qPCR primer sequences and target information.   
Gene Name Genbank ID Direction 
Primer 
Efficiency 
Primer Sequence (5' to 3') 
Actin CAB72313.2 
Forward 
94.8 % 
GGTATGTGCAAGGCTGGATT 
Reverse GGTGTGGTGCCAGATCTTTT 
Heme-oxygenase-1 EFX85559.1 
Forward 
98.6 % 
TATGGAGCACAATGGCTTGA 
Reverse GGATTTGACCTCCCGAAAAT 
Superoxide dismutase EFX79040.1 
Forward 
N/A 
GTAAGGGTGGGCATGAACTG 
Reverse ATCTGCCAACATAAATGCCATA 
Glutathione-S-
Transferase 
EFX81636.1 
Forward 
97.9 % 
ACATGGCCGGAGTAGACATC 
Reverse GTCAATGACTGCACGTTGCT 
Metallothionein DV437826.1 
Forward 
94.7 % 
ACGTGGAGAAACGGTCAGAG 
Reverse ACAAATGCAAGCGGAATTTT 
 
6.2.7 RT-qPCR 
Approximately 100 ng of cDNA from each sample was mixed with a final concentration of 1 
µM forward and reverse primers and 10 µl of SensiFAST SYBR Lo-ROX mix (Bioline 
Reagents Limited, London, UK) and made to a total volume of 20 µl per individual reaction.  
Each biological sample was plated in triplicate on a 96-well PCR plate (Agilent 
Technologies).  A separate plate was used for each of the selected genes with a functioning 
pair of primers including 4 x log10-fold dilutions of template cDNA as a concentration curve, 
a non-template control and a non-reverse-transcriptase control which utilised template RNA 
instead of cDNA.  Forward and reverse primers for the D. magna Actin gene were utilised as 
a reference gene.  Each plate was scanned for SYBR Green 1 intensity on an AriaMx RT-
PCR machine and AriaMx PC analysis software (Agilent technologies) using a 2 minute, 95C 
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hot start, a 3-step amplification cycle (Table 6.4). Melt-profile analysis was plotted for each 
sample to ensure only a single product was amplified and primer dimers were not formed.  
Table 6.4: RT-qPCR temperature cycle.  Each stage proceeds in order from top to bottom with 
the middle three stages repeated (in order) 39 times before melt-curve determination 
Temperature (°C) Duration  No. cycles  
95 2 min 1 Hot start 
95 5 s 
40 
3-step 
amplification 
60 10 s 
72 5 s 
95 30 s 1 
Melt curve 65 30 s 1 
95 30 s 1 
 
The amplification efficiencies of the reference and target genes were not equal (Table 6.3); 
therefore the Pfaffl method (Pfaffl, 2001) was used to calculate relative expression levels of 
target genes. The Pfaffl method allows relative quantification of the expression of a target 
gene in comparison to a reference gene (often called a housekeeping gene) and follows the 
equation outlined in Equation 5.1.  Briefly, the quantification cycle (Cq) of treated samples 
was subtracted from the average background Cq taken from control samples to produce a ΔCq 
for both the target and reference genes.  The primer efficiency value for the target gene raised 
to the power of its ΔCq is then divided by the primer efficiency value for the reference gene 
raised to the power of its ΔCq.  The result is a relative fold change of a target gene in treated 
samples compared to control samples normalised by a reference gene. Differences between 
groups were compared by a 1-way ANOVA using a Tukey-Kramer post-hoc test for multiple 
comparisons.  Any set of technical replicates with a standard deviation greater than 2 was 
considered unreliable and as such was removed from statistical analysis. 
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Equation 6.3: The Pfaffl method for relative quantification and calculation of the relative 
expression ratio (R).  Where E represents the amplification efficiency of the target or reference 
gene and ΔCq is the Cq deviation of control – sample of the target of reference gene. 
𝑅 =
(𝐸target)∆𝐶𝑞target(𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑠𝑎𝑚𝑝𝑙𝑒)
(𝐸reference)∆𝐶𝑞ref(𝑐𝑜𝑛𝑡𝑟𝑜𝑙−𝑠𝑎𝑚𝑝𝑙𝑒)
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6.3 Results and Discussion 
6.3.1 Characterisation of dosed exposure media using DLS and ICP-MS 
On preparation of the dosed exposure media, samples were taken for characterisation by DLS 
and ICP-MS.  DLS was used to characterise the size and presence of Ag particles within 
dosed media and to confirm the presence of particles in AgNP exposures as well as the 
absence of particles in AgNO3 and control exposures.  ICP-MS was selected for its high 
sensitivity and was used to determine the total Ag concentration within each exposure beaker 
in order to confirm that animals were exposed to the intended concentration of Ag. 
Low levels of large polydisperse particles were detected in every sample including the no-
added silver control.  The z-average particle sizes were measured to be 976.00 ± 407.4 nm in 
control samples, 722.20 ± 22.37 nm in the AgNP High group and 994.47 ± 371.09 nm in 
AgNO3 High group (Figure 6.1 A).  All samples gave similarly large PDI values; 0.6 ± 0.1, 
0.7 ± 0.1 and 0.6 ± 0.2 for the control, AgNP High and AgNO3 High groups respectively 
(Figure 6.1 B).  The final measured parameter, the average photon count rate, was low in 
each group; 138.83 ± 84.28 nm, 79.12 ± 16.25 nm and 146.00 ± 95.17 for the control, AgNP 
and AgNO3 groups respectively (Figure 6.1 C). Following statistical analysis by 1-way 
ANOVA, it was determined that there were no statistically significant differences between 
mean values for particle size (p = 0.5396), PDI (p = 0.4895) or count rate (p = 0.5167).    
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Figure 6.1: Characterisation of particles within control, AgNO3 and AgNP exposure media by 
DLS.  Depicted are the mean z-average particle size (A), the mean polydispersity index (B) and 
the mean photon count rate (C).  Error bars represent the standard deviation (n = 3), 
differences between each of the three parameters were deemed as not significant following a 1-
way ANOVA and Tukey-Kramer post hoc test.  
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The concentration of total Ag within dosed exposure media and spiking stocks was measured 
by ICP-MS following digestion with HNO3.  The mean total silver concentration of the 
AgNP Low and AgNP Mid groups were measured to be 1.24 ± 0.05 µg/l and 2.29 ± 0.11 µg/l 
respectively which are both within 10 % of their respective nominal concentrations of 1.18 
µg/l and 2.35 µg/l (Table 6.5).  Despite the increased sensitivity of ICP-MS compared to 
other techniques such as GF-AAS and ICP-OES, the concentration of total silver within the 
AgNO3 Low and Mid groups was below the limit of detection following dilution to 2 % 
HNO3, and as such could not be measured directly (Table 6.5).  However, the concentration 
of AgNO3 spiking solution was measured to be 129 µg/l which, assuming accurate dilutions, 
would equate to a total silver concentration of 0.06 µg/l and 0.13 µg/l for the AgNO3 Low 
and AgNO3 High groups.  The total silver concentrations for the AgNP groups measured 
directly from spiked-media and the concentration values for dissolved silver groups derived 
from the AgNO3 spiking stocks will be taken as the actual concentrations; all of which are 
within 10 % of the intended nominal concentrations (Table 6.5). 
Table 6.5: The average measured concentrations of total Ag within AgNP exposure media with 
standard deviation (n = 5) for each group compared to the intended nominal concentrations.  
The control samples gave results below the < 0.02 µg/l detection limit of the instrument. The 
concentration of AgNO3 dosed media have been derived from the measured concentration of the 
AgNO3 spiking stock, as the true concentration was below the detection limit of the instrument. 
 
Total silver concentration (µg/l) 
  
Nominal  
Measured  
(mean) 
Standard 
deviation 
Control 0.00 < 0.02 N/A 
AgNP Low 1.18 1.24 0.05 
AgNP Mid 2.35 2.29 0.11 
AgNO3 Low 0.07 0.06 N/A 
AgNO3 Mid 0.14 0.13 N/A 
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Across all three parameters measured by DLS, there were no significant differences in 
particle content between the control and highest concentration AgNO3 and AgNP exposures.  
The large average polydispersity indices measured for all three groups as well as the low 
photon count rates give an indication that the samples are not suitable for measurement by 
DLS (Malvern Instruments Ltd, 2011). However, the apparent detection of large polydisperse 
particles could be caused by the genuine presence of particles within all groups.  These 
particles could be common to all three groups or different for each group.  For example, 
particles detected in the AgNP high group could be the result of particle aggregation between 
the PVP-AgNPs present within the media.  Particles detected in the AgNO3 exposure may be 
the precipitation of insoluble AgCl formed by the reaction of Ag+ with Cl- present within 
media10.  Finally, particles present within the control group could be small dust particles or 
natural organic matter transferred into the media with the animals.  Alternatively, the 
readings could be an artefact of the exposure medium, induced by light scattered by the 
dissolved salts present within media10 and not by dissolved or nanoparticle silver.  
Regardless, the absence of significant differences between the three measured parameters 
indicates that DLS cannot distinguish between the particles present within the AgNP High 
group and the control group.  As such it is apparent that DLS is an inappropriate technique to 
use at such low concentrations of Ag within media10 to confirm the presence or absence of 
particles.  A more appropriate method may be the use of an imaging technique such as 
confocal microscopy or TEM to directly visualise the presence or absence of particles or 
aggregates in exposure media. 
The results of ICP-MS analysis confirm the presence of Ag within spiked exposure media.  
The successful measurement of spike-recovery tests (Section 6.2.3) indicated that 
measurements of Ag-spiked samples returning values less than the limit of detection are not 
the result of interaction between the Ag and the exposure media.  Therefore particles that are 
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present within the AgNP High group are likely either to be of too low a concentration to 
accurately detect by DLS, as suggested by the low photon count rate, or are potentially 
masked by the presence of naturally occurring particles common to all exposure groups. 
6.3.2 Targeted analysis of antioxidant enzyme expression by RT-qPCR 
Following a 24 h exposure period, no neonates were immobilised in the control, AgNO3 Low 
and AgNO3 High groups.  Both concentrations of AgNP exposure induced neonate 
immobilisation; the lowest concentration induced partial immobilisation (44 % of the total 
starting population) whereas the highest concentration induced total immobilisation of the 
starting population, resulting in that group’s removal from the study (see Appendix Table 
9.5).  Surviving neonates from the AgNP Low group were still collected for extraction of 
RNA and analysis by RT-qPCR alongside the other remaining three groups. 
During analysis, no amplification was observed for reactions using primers for superoxide 
dismutase (SOD). SYBR green melt-curve data for each sample showed a complete absence 
of product; this remained true even with the highest amount of template used in the 
concentration curve, suggesting the primers for this target gene were not viable.  As such, the 
expression of this particular target gene was not measured as was originally intended.  The 
primers for the remaining three target genes; glutathione-S-transferase (GST), 
metallothionein (MT) and heme-oxygenase 1 (HMOX), were viable and measurement of 
their expression was successful (Figure 6.2).  During synthesis of cDNA, one replicate of the 
AgNO3 Low group yielded 10 fold less cDNA than all other replicates.  As such there was an 
insufficient quantity for qPCR of this sample, reducing the replicate number for AgNO3 Low 
to four for all three target genes.  Equally, 2 biological replicates in the MT analysis (one 
from AgNP Low and one from AgNO3 Mid) and one from HMOX analysis (AgNO3 Mid) 
were excluded from statistical analyses for having standard deviations amongst technical 
replicates greater than 2.0.  Following log10 transformation, the fold-change of GST and 
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HMOX relative to control expression was deemed as statistically insignificant between all 
groups by 1-way ANOVA and Tukey-Kramer post-hoc test (p = 0.7674 and p = 0.7913 
respectively).  Metallothionein expression however was seen to increase significantly relative 
to control (p = 0.0287) upon exposure to the lowest concentration of AgNP (1.24 µg/l) 
(Figure 6.2).  The change in expression upon exposure to 0.06 and 0.13 µg/l AgNO3 was not 
significant relative to control samples.  
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Figure 6.2: Relative gene expression of glutathione-S-transferase (GST), metallothionein (MT) and heme-oxygenase 1 (HMOX) in D. magna 
following exposure to 1.19 µg/l of AgNP (AgNP Low), 0.06 µg/l and 0.13 µg/l of AgNO3 (AgNO3 Low and AgNO3 High respectively).  Relative fold 
changes calculated by the Pfaffl method have been log10 transformed prior to analysis ANOVA.  Error bars represent the standard deviation of each 
group (n = 3 for AgNP Low, n = 4 for AgNO3 Low and n = 4 for AgNO3).  The * denotes a significant increase in MT expression relative to the 
control group (p = 0.0287). 
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The significant increase in MT expression observed here conforms to previously reported 
results in D. magna (Poynton et al., 2012; Rainville et al., 2014) and other in vivo models 
(Ferguson et al., 1996; Chae et al., 2009; Meyer et al., 2010; García-Alonso et al., 2011; 
Yang et al., 2012; Johari et al., 2015).  This result suggests the successful internalisation of 
Ag into D. magna cells upon exposure to AgNP.  MT expression will be increased in 
response to the presence of Ag within these cells in order to sequester Ag and Ag+ and 
remove from the cell.  The mean relative expression of MT in animals exposed to AgNO3 
was increased when compared to control animals but deemed not to be significant 
following a 1-way ANOVA (Figure 6.2).  This result was unexpected as increased MT 
expression and activity is a well-documented response to dissolved Ag exposure (Poynton 
et al., 2012; Rainville et al., 2014; De Matteis et al., 2015; Arai et al., 2015). It should be 
noted that the error on both mean values was large (Figure 6.2) and the non-significant 
result may simply be caused by insufficient biological replicates and therefore be a false 
negative.  However in 2012, Poynton et al. also saw a significant increase in the 
transcription of MT in response to commercial PVP-coated AgNPs (8.14 µg/l, 35 nm core 
diameter), a result which again was not reciprocated upon exposure to 0.16 µg/l or 0.32 
µg/l AgNO3. (Poynton et al., 2012). 
The expression of both GST and HMOX was also observed to not change significantly 
following exposure to both AgNPs and AgNO3.  The role of GST in D. magna response to 
Ag exposure has been measured previously by RT-qPCR (Poynton et al., 2012) and 
through measurement of GST enzyme activity (Rainville et al., 2014).  In both instances 
GST was also seen to not increase significantly in response to Ag silver exposure.  This is 
in spite of evidence of oxidative stress being identified in the latter study (Rainville et al., 
2014).  Despite being part of the response of certain cell lines to Ag exposure (Asharani et 
al., 2009) HMOX expression does not appear to be a part of the response to Ag exposure 
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in D. magna  (Figure 6.2). The lack of response observed from these two biomarkers of 
oxidative stress suggests that this state is not induced by exposure to dissolved or 
nanoparticle Ag.  However, Ag-induced oxidative stress has been observed across multiple 
bacterial (Lok et al., 2007; Choi and Hu, 2008; Hwang et al., 2008; Park et al., 2009) and 
eukaryotic (Arora et al., 2009; Asharani et al., 2009; Domingos et al., 2009; Chairuangkitti 
et al., 2013) cell lines as well as in multiple model organisms (Chae et al., 2009; Meyer et 
al., 2010; García-Alonso et al., 2011; Yang et al., 2012; Johari et al., 2015).  It is therefore 
more likely that if oxidative stress is induced in D. magna, as has been reported (Poynton 
et al., 2012; Rainville et al., 2014; Li et al., 2015a), GST and HOX transcription plays no 
part in the response mechanism.   
6.4 Conclusions 
The targeted RT-qPCR conducted in this study suggests that although Ag is successfully 
internalised, transcription of GST and HMOX are not involved in the response of 
D. magna to Ag exposure.  Despite the observation that two well-defined biomarkers of 
cellular oxidative stress do not increase significantly in response to Ag exposure, the result 
of this work does not categorically confirm that ROS generation plays no part in Ag 
toxicity.  The production of ROS by AgNP has been observed in many previous 
publications, either through the direct catalysis of H2O2 degradation (He et al., 2011), 
direct measurement of ROS production in vitro (Asharani et al., 2009; De Matteis et al., 
2015), or analysis of the damaging consequences of oxidative stress across multiple model 
organisms (Chae et al., 2009; Meyer et al., 2010; García-Alonso et al., 2011; Yang et al., 
2012; Johari et al., 2015).  The presence of ROS was not measured directly within this 
study so it is still possible, as reported by previous publications, that Ag that is internalised 
within the cells of D. magna induces the formation of ROS.  MT is known to respond to 
the presence of ROS, so it is possible that the significant increase of MT in this chapter is 
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instead in response to ROS generation and not solely the presence of Ag within the 
organism’s cells.  However with the other target genes in this chapter (HOX and GST) 
remaining unresponsive to Ag exposure, it seems more likely that the significant response 
of MT is metal-responsive and not in in response to oxidative stress.   
One specific aim of this work was to investigate a hypothesis formed from the results of 
Chapter 5 (section 5.4) that an observed significant increase in two purine nucleosides was 
in response to oxidative stress.  It had been previously documented that guanosine protects 
against oxidative damage through the induction of HMOX (Quincozes-Santos et al., 2014).  
The results from this chapter have shown that HMOX expression is not significantly 
altered following exposure to both AgNPs and AgNO3.  This means the observed 
significant increase in purine nucleoside concentration does not result in elevated HMOX 
expression, suggesting an alternate cause for their accumulation.  
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Chapter 7: General Discussion and future work 
The aims set out at the start of this research (Section 1.5) were designed to investigate the 
unknown mechanism of AgNP toxicity in the freshwater crustacean D. magna using a 
dual-omics platform.  The investigation took a non-targeted approach to help drive the 
formation of hypotheses concerning the molecular perturbations and responses induced by 
exposure to AgNP in comparison to AgNO3.  This approach would allow the comparison 
of the global molecular profiles of animals exposed to both forms of silver, allowing for 
the determination of the role of dissolution in AgNP toxicity, and the elucidation of their 
mechanisms of action.  In addition, this thesis allowed the exploration of the possibility of 
using non-targeted omics analyses as part of nanoparticle risk assessment. 
7.1  The role of dissolution in AgNP toxicity 
Although the exact role of AgNP dissolution in toxicity is still unconfirmed, there is 
growing consensus among studies that would suggest a Trojan-horse like mechanism to be 
the most applicable to AgNP induced toxicity.  The Trojan-horse mechanism hypothesis 
suggests AgNPs enact toxicity through the release of toxic Ag+ ions following uptake of 
AgNP into the exposed cells or organisms.  In D. magna, the presence of silver within 
whole-body digests of exposed animals has been previously measured by ICP-MS (Khan 
et al., 2015) and through use of radioisotopes (Zhao and Wang, 2012b). Secondary ion 
mass spectrometry imaging techniques have identified the presence of Ag within the 
lumen of the gut of AgNP-exposed animals which was seen to distribute into the 
surrounding tissues over time (Audinot et al., 2013).  ICP-MS measurements in Chapter 4 
(section 4.3.4) supported this literature base by indicating a significantly greater 
concentration of silver within AgNP exposed animals than those exposed to theoretical 
concentration of the dissolved Ag fraction of AgNP exposures on its own.  This result 
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potentially indicated the delivery of greater internal concentrations of dissolved silver than 
would be if AgNPs only dissolved externally to the animals. 
What has not been observed in the in vivo investigations mentioned above is the relative 
proportions of the nanoparticle and dissolved species of the measured total Ag within 
exposed D. magna.  These proportions of Ag speciation would help towards showing that 
AgNPs are adsorbed within D. magna then dissolve internally into Ag+, showing that 
aspect of the Trojan-horse hypothesis to be possible.  This type of investigation has been 
examined in vitro, leading to the detection of AgNPs within endo-lysosomal structures 
(Greulich et al., 2011; Arai et al., 2015; De Matteis et al., 2015) and the time-dependent 
release of Ag+ following exposure to the acidic environment of these structures (De 
Matteis et al., 2015).  These observations indicate, at least in vitro, that the Trojan-horse 
mechanism, in terms of uptake and dissolution, is possible.   
The relative proportion of AgNP and dissolved Ag within AgNP-exposed D. magna could 
be investigated through use of a combination of separation and measurement techniques as 
have been implemented previously on D. magna exposure media (Shen et al., 2015).  The 
ICP-MS analysis of acid-digested D. magna exposed to AgNPs and AgNO3 presented in 
Chapter 4 could be taken further through additional determination of the internal 
concentration of total dissolved Ag by ICP-MS of acid-digested animals following 
centrifugal ultrafiltration using a 30-kDa filter (Shen et al., 2015). The respective internal 
AgNP concentration would be the resulting difference between these two total 
measurements. Combination of these techniques with visualisation techniques such as 
TEM or SIMS would be necessary to aid interpretation of whether any observed 
dissolution would occur within the lumen of the gut or in the surrounding tissues.  
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What is still lacking from the literature, both in vitro and in vivo, is evidence of which of 
the many forms of Ag is directly responsible for Ag-induced toxicity.  The work in 
Chapter 4 of this thesis adds to this body of literature, identifying similar molecular 
profiles induced by both AgNP and dissolved Ag, which would agree with the hypothesis 
that AgNPs induce toxicity through the internal or intracellular release of dissolved Ag.  
This work suggests the involvement of dissolved Ag in AgNP toxicity.  Also observed was 
a significant difference in the magnitude of the perturbations induced by AgNPs and 
AgNO3, which is a potential indication that the nanoparticle fraction has an additional 
affect.  Measurement of total Ag body burden in D. magna neonates exposed to AgNPs 
and the respective dissolved Ag fraction alone showed a significantly elevated body 
burden in AgNP-exposed animals. This potentially indicates the adsorption and possible 
ingestion of AgNPs into the organism. Targeted RT-qPCR for the expression of 
metallothionein indicated a significant increase in the gene’s expression following 
exposure to the highest concentration of AgNP (Section 6.3.2).  In the work described in 
Chapter 6, this gene was targeted as a positive control for successful Ag cellular uptake, as 
MT expression and activity is known to increase in response to Ag exposure to sequester 
and remove the Ag from the cells  This, coupled with the observation that both species of 
Ag induce similar overall molecular responses, potentially indicates presence of Ag with 
D.  magna cells.  This would be consistent with previously published findings in D. magna 
(Zhao and Wang, 2012b; Stensberg et al., 2013), and in vitro (Park et al., 2010; Wang et 
al., 2013) which conclude that AgNPs work through a Trojan-horse type mechanism by 
acting as a vehicle for the delivery of the toxic Ag+ ion following cellular uptake.  
It is probable that the observed difference in magnitude between molecular profiles 
induced by AgNP and AgNO3 exposure is due to differences in the sites of absorption and 
subsequent distribution of these forms of Ag.  The relationship between total Ag exposure 
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concentration and the resulting body burden in D. magna potentially indicated a higher 
rate of uptake when animals were exposed to AgNO3 compared to AgNPs (section 4.3.4).  
This is not unexpected, as dissolved Ag is known to be more bioavailable than AgNPs due 
to its more rapid method of cellular uptake.  It is possible however that this potential 
difference in uptake rate is the result of the different species of Ag targeting different sites. 
It has been shown previously that dissolved Ag are absorbed by D. magna through the site 
of gaseous exchange (Bianchini and Wood, 2003), and that AgNPs are thought to enter the 
organism through the digestive tract (Zhao and Wang, 2010; Audinot et al., 2013). An 
obvious direction in which to take this line of investigation further is through the use of 
imaging techniques to identify and compared these sites of AgNP and dissolved Ag 
absorption.  Micro-proton induced X-ray emission (MicroPIXE) has been used previously 
to observe and quantify the distribution of AgNPs ingested by the woodlouse Pocellio 
scaber (Tkalec et al., 2011).  An alternative technique would be SIMS imaging, which has 
been used previously to visualise AgNPs, TiO2 NPs and SiO2 NPs within D. magna, 
identifying the presence of AgNPs in the lumen of the digestive tract (Audinot et al., 
2013).  Exposures identical to those outlined in Chapter 4 would allow the comparison of 
the distribution of silver following AgNP exposure, or exposure to the dissolved Ag 
fraction alone. 
7.2 The molecular response of D. magna to Ag exposure 
The background knowledge of the molecular perturbations induced by AgNPs is 
comparatively low.  AgNPs along with other nanomaterials therefore represent an ideal 
opportunity to utilise omics-technologies for a non-targeted approach to determining their 
mechanism of toxicity.  Some studies to date have focused on biochemical interactions 
known to be perturbed by Ag+; such as disruption of Na+ transport (Stensberg et al., 2013), 
mitochondrial disruption (Almofti et al., 2003; Stensberg et al., 2013; Ahn et al., 2014) and 
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the formation of ROS with the subsequent induction of oxidative stress (Park et al., 2009; 
Hsiao et al., 2015). This strategy, while a sensible start point, potentially provides only a 
narrow scope on the molecular mechanism, leaving potential novel changes undiscovered.  
Many omics investigations into AgNP toxicity have also centred their conclusions on the 
mechanisms mentioned above (Poynton et al., 2012; Aerle et al., 2013; Rainville et al., 
2014; Verano-Braga et al., 2014; Li et al., 2015a; 2015b; Carrola et al., 2015), but several 
have identified other components or pathways involved in the toxic response to AgNPs 
that were previously unrecognised (Hadrup et al., 2012; Aerle et al., 2013; Verano-Braga 
et al., 2014). 
A quantitative proteomics investigation identified up-regulation of serine/threonine protein 
kinase (PAK), mitogen-activated protein kinase (MAPK) and protein phosphatase 2A 
(PP2A) subunits following exposure of human colon carcinoma cells to 100 nm citrate-
coated AgNPs (Verano-Braga et al., 2014). PAK and MAPK are both involved in 
signalling cascades that result in caspase-dependent and caspase-independent apoptosis 
respectively, and PP2A is involved in the regulation of the cell cycle.  This study also 
implied an increase in degradation of proteins by the ubiquitin-proteasome system, 
possibly damage proteins, followed by the synthesis of replacement proteins (Verano-
Braga et al., 2014).  In addition to concluding that both AgNPs and dissolved silver impact 
oxidative phosphorylation and mitochondrial activity, Van Aerle et al. (2013) identified 
significant down-regulation of proteasome subunit beta type-1 and up-regulation of 
ribosomal protein S6 modification-like protein B, the authors suggested that together these 
alterations imply an increased level of protein turnover due to oxidative damage (Aerle et 
al., 2013).  An NMR-based metabolomics study in rats measured an increased excretion of 
uric acid and allantoin in urine following AgNP exposure, suggesting a disruption of 
purine metabolism (Hadrup et al., 2012). 
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In Chapter 5, pathway analyses of the Ag-exposed D. magna identified perturbations in 
transcription pathways involved in G-protein coupled receptor (GPCR) signalling and 
signalling cascades involving MAP kinases, nerve growth factor, neurotrophin and Rho-
GTPases.  This supports previous observations of MAPK up-regulation in AgNP-exposed 
human colon carcinoma cells (Verano-Braga et al., 2014). GPCRs initiate cellular 
signalling cascades through MAPKs that result in the regulation of genes involved in cell 
growth and differentiation, as well as inflammation and apoptosis.  The pathways involved 
in the metabolism of dietary sugars as well as purines and amino-sugars and nucleotide 
sugars were identified as being perturbed, potentially indicating the disruption of energy 
production that has been repeatedly reported following AgNP exposure.  The hypothesis-
generating ability of omics-technologies highlighted these pathways as potential 
candidates for further investigation.   
Integrated pathway analysis indicated the metabolic and transcriptional perturbations of 
components within the purine metabolism pathway to be the most interconnected in 
comparison to other impacted pathways.  This was therefore chosen as the next line of 
investigation within Chapter 5.  The purine nucleosides inosine and guanosine were 
identified as increasing significantly in D. magna in response to Ag exposure.  A previous 
NMR-based metabolomics study in rats measured an increased excretion of uric acid and 
allantoin in urine following AgNP exposure, suggesting a disruption in the metabolism of 
purine nucleosides (Hadrup et al., 2012).  Besides this study, there have been few others  
to focus on or identify this metabolic pathway in the AgNP response.  The exact cause of 
this increased production is unknown but seems unlikely to be in response to oxidative 
stress as investigated in Chapter 6.  Increasing guanosine production has been observed 
previously to indirectly combat oxidative stress through stimulation of Heme-oxygenase1 
(Quincozes-Santos et al., 2014).  RT-qPCR performed as part of Chapter 6 showed no 
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significant change in the expression of HMOX or GST, two markers of oxidative stress, 
following exposure of D. magna to AgNPs and AgNO3.  The transcription (Poynton et al., 
2012) and enzyme activity (Rainville et al., 2014) of GST in D. magna has been measured 
to be unchanged in response to AgNP exposure before, as have the activities of other well-
characterised markers of oxidative stress such as catalase and GAPDH (Rainville et al., 
2014).  These results disprove the hypothesis proposed at the conclusion of Chapter 5 that 
the observed increase in guanosine content is in response to Ag-induced oxidative stress 
ultimately resulting in the stimulation of HMOX activity.   
The production of ROS and induction of oxidative stress by AgNP is becoming a well-
established mechanism in mammalian cell lines and some model organisms, though the 
evidence for oxidative stress in D. magna is somewhat conflicting and contradictory. 
Oxidative stress has been suggested as a mechanism of AgNP toxicity in D. magna before, 
but the direct measurement of Ag-induced ROS has only been attempted very recently 
(Ulm et al., 2015).  The result of this measurement was unclear, with no significant 
production of ROS observed, though the author surmised that this may be the result of the 
significant increase in GSH production observed alongside the ROS assay (Ulm et al., 
2015).  It could be possible that the observed increased production of GSH may be in 
response to the presence of Ag+ rather than ROS, as GSH non-specifically sequesters 
electrophiles which include heavy metals.  Additionally, due to the relatively low EC50 of 
Ag species, any measurements of oxidative stress may not be caused directly by Ag, but 
potentially as a by-product of Ag-induced hypoxia or the latter stages of cell death.  It may 
be the case that in D. magna, oxidative stress is not a primary mechanism of Ag toxicity; if 
ROS are generated they may be dealt with through species specific enzymes which are 
currently unknown.  
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It is also possible that the enzymes targeted in Chapter 6 might be involved in the response 
to Ag exposure, but that no significant transcriptional change was seen after a 24 h 
exposure.  It could be that the transcriptional response of these enzymes occurs rapidly and 
the altered transcription is missed 24 h after exposure.  A time-course would be required to 
rule out any transcriptional response from GST & HMOX entirely.  Additional enzymes to 
investigate would be catalase and SOD using alternative primers.  Transcriptomics 
analyses give no indication of protein activity and production, only the level of 
transcription of their corresponding genes.  Quantitative measurement of the presence and 
activity of these enzymes would give a more direct indication of their roles in the response 
of D. magna to Ag exposure. 
It is possible that the significant increase in purine nucleosides observed in Chapter 5 are 
not elevated as a result of increased anabolism, but rather decreased catabolism. For 
example, many of these metabolites are involved in the production of nucleoside 
triphosphates through oxidative phosphorylation, a process which has been seen to be 
inhibited by Ag exposure (Li et al., 2015a; Carrola et al., 2015).  These purine nucleosides 
are all ultimately involved in the synthesis of RNA by RNA polymerase, which is 
inhibited directly through the actions of AgNPs (Wang et al., 2013). A disruption of purine 
metabolism has also been indicated before in rats (Hadrup et al., 2012) suggesting that this 
particular response to Ag exposure may be conserved across multiple species, making it a 
potential biomarker for screening in other organisms.  
To investigate this mechanism further, a targeted approach by LC-MS could be used to 
accurately quantify the production of inosine and guanosine as well as other putative 
purine nucleosides which could not be isolated by FT-ICR MS.  Coupled with ICP-MS 
analysis of the same samples, the production of these metabolites could be correlated with 
respect to silver body-burden, thus cementing their role in the MoA of AgNP toxicity.  To 
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test the hypothesis that AgNP and AgNO3 exposure does not lead to excessive ROS 
production in D. magna, the presence of ROS could be measured directly through use of 
fluorescence-based assays as previously used in vitro (Chairuangkitti et al., 2013) and in 
D. magna (Ma et al., 2012).  This assay would need the use of a comparative positive 
control for ROS production such as H2O2 for interpretation of results.  The hypothesis 
stated by Wang and colleagues (Wang et al., 2013) could be investigated further through 
measurement of the expression and activity of RNA polymerase II.  Correlation of this 
activity over time with the concentration of purine nucleosides measured by LC-MS would 
go further to confirming this mechanism of toxicity in D. magna.  
7.3 The use of omics-technologies in nanoparticle risk assessment 
Due to a relative absence of background knowledge with regards to the molecular changes 
they induce, nanomaterials represent an ideal opportunity to utilise the high-throughput, 
non-targeted approach of omics technologies for the investigation of mechanisms of 
toxicity.  This approach allows the capture of the entire molecular response providing a 
solid basis of knowledge from which to create hypotheses and direct further testing.   
This approach may result in the discovery in molecular perturbations that would go 
potentially unnoticed by the traditional hypothesis-driven research.  As discussed in 
section 1.3.5, there are previous omics investigations into AgNP toxicity which have 
discovered significant perturbations that are not traditionally associated with the toxicity of 
dissolved Ag.  The observations made in this thesis that Ag exposure results in an 
accumulation of purine nucleosides that is not likely to be related to oxidative stress is 
another example of the power of omics in molecular toxicity investigations.  Although the 
exact cause of the significant increase in guanosine and inosine requires further 
investigation, these two metabolites have been highlighted as potential markers of Ag 
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exposure in D. magna.  An ideal biomarker is considered to be a molecule that is 
indicative of early toxicant exposure that can be detected in individual organisms and used 
to predict population-level effects.  A true success story of biomarkers in regulatory 
ecotoxicology includes the discovery of vitellogenin as a biomarker of feminisation of 
male fish following exposure to oestrogen-like compounds (Jobling et al. 1998). 
Understanding of the exact mechanism of inosine and guanosine elevation following Ag 
exposure will be required to cement these two metabolites as specific markers of Ag 
exposure, as opposed to non-specific markers common to multiple mechanisms of toxicity. 
Although useful for mechanistic investigations and the potential identification of 
biomarkers, the routine application of omics technologies, as they stand, to environmental 
risk assessment of new chemicals is an unlikely prospect.  In order for it to become a 
reality there are several technological obstacles that need to be surpassed.  Firstly, a major 
limitation of microarray transcriptomics is that they require a fully sequenced and 
annotated genome for effective use in toxicogenomics.  For example, the D. magna 
microarray used in Chapter 4 only covers just under half of the total D. magna genome; 
15,000 genes compared to approximately 31,000 genes (Colbourne et al., 2011).  This 
means that over half the genome remains unmeasured, which could include genes that alter 
significantly and uniquely in expression following toxicant exposure to either AgNP or 
AgNO3.  Microarray transcriptomics, therefore, are not readily accessible for use with non-
model organisms.  This particular limitation could potentially be overcome through the use 
of the relatively new technology of RNA sequencing (RNA-seq).  This technique converts 
extracted RNA into a library of cDNA fragments which are sequenced in a high-
throughput manner (Wang et al 2009).  A major advantage to this technique is that it is not 
limited to the detection of transcripts that correspond to existing sequenced genomes, and 
can therefore be used in non-model organisms.  
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Despite the increased sensitivity of FT-ICR MS compared to other metabolomics 
techniques, many important naturally low-level metabolites may go undetected due to the 
relatively low available biomass obtained from D. magna neonates.  These limitations, 
though unavoidable, mean that the possibility of an independant AgNP-toxicity 
mechanism cannot be entirely ruled out, though from the data presented in Chapter 4 and 
the literature discussed above (section 1.2.3) the observations made in this thesis support 
the Trojan-horse mechanism.  Untargeted, direct infusion FT-ICR metabolomics allows for 
the detection of 1000’s of metabolites from biological samples.  However, the major 
limitation of this and all available metabolomics technologies is the subsequent 
identification of these metabolites which remains a labour-intensive step (Dunn et al., 
2012).  For example, there are a number of biological metabolites which have the same 
molecular mass and potentially the same empirical formulae.  Currently it is difficult to 
discriminate between metabolites, making biological interpretation of some metabolic 
profiles difficult.  There have been developments in the automatic annotation of detected 
metabolites in recent years (Weber and Viant, 2010; Xia et al., 2012) though there is still a 
lack of metabolite information present in online libraries available for automated searches 
(Dunn et al., 2012). 
Despite the limitations in the available technologies, the high throughput analytical 
methods present an opportunity in obtaining large quantities of toxicology data with 
relatively low input.  They also, as has been demonstrated in this thesis, can provide 
unique insights into mechanisms of toxicity. 
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7.4 Concluding remarks 
The data collected in this thesis suggests that although ultimately AgNP toxicity towards 
D. magna is most likely induced by released Ag ions, there is a potential “nanostructure-
dependant biological activity” (Oberdörster et al., 2005a) relating to the Trojan-horse 
mechanism.  In a regulatory context this data could potentially be used in the argument for 
separate regulatory framework for AgNPs.  Ultimately however, it is suggested from this 
work that the mechanisms of AgNP and AgNO3 toxicity are unlikely to be so different to 
warrant different levels of regulation. 
  
  
192 
 
Chapter 8: References  
Ackermann, M. and Strimmer, K. (2009) A general modular framework for gene set 
enrichment analysis. BMC bioinformatics, 10: 47–66 
Adam, N., Schmitt, C., Galceran, J., Companys, E., Vakurov, A., Wallace, R., Knapen, D., 
Blust, R. (2014) The chronic toxicity of ZnO nanoparticles and ZnCl2 to Daphnia magna 
and the use of different methods to assess nanoparticle aggregation and dissolution. 
Nanotoxicology, 8 (7): 709–17 
Adams, N. and Kramer, J. (1998) Reactivity of Ag+ ion with thiol ligands in the presence 
of iron sulfide. Environmental Toxicology and Chemistry, 17 (4): 625–629 
Aerle, R., Lange, A., Moorhouse, A., Paszkiewicz, K., Ball, K., Johnston, B., de-Bastos, 
E., Booth, T., Tyler, C., Santos, E. (2013) Molecular mechanisms of toxicity of silver 
nanoparticles in zebrafish embryos. Environmental Science & Technology, 47: 8005–8014 
Ahn, J.-M., Eom, H.-J., Yang, X., Meyer, J., Choi, J. (2014) Comparative toxicity of silver 
nanoparticles on oxidative stress and DNA damage in the nematode, Caenorhabditis 
elegans. Chemosphere, 108: 343–52 
Allen, H., Impellitteri, C., Macke, D., Heckman, D., Poynton, H., Lazorchak, J., 
Govindaswamy, S., Roose, D., Nadagouda, M. (2010) Effects from filtration, capping 
agents, and presence/absence of food on the toxicity of silver nanoparticles to Daphnia 
magna. Environmental Toxicology and Chemistry, 29 (12): 2742–50 
Allwood, J. and Goodacre, R. (2010) An introduction to liquid chromatography-mass 
spectrometry instrumentation applied in plant metabolomic analyses. Phytochemical 
Analysis : PCA, 21 (1): 33–47 
  
193 
 
Almofti, M., Ichikawa, T., Yamashita, K., Terada, H., Shinohara, Y. (2003) Silver ion 
induces a cyclosporine A-insensitive permeability transition in rat liver mitochondria and 
release of apoptogenic cytochrome c. Journal of Biochemistry, 134 (1): 43–49 
Altshuler, I., Demiri, B., Xu, S., Constantin, A., Yan, N., Cristescu, M. (2011) An 
integrated multi-disciplinary approach for studying multiple stressors in freshwater 
ecosystems: Daphnia as a model organism. Integrative and Comparative Biology, 51 (4): 
623–33 
Antczak, P., Jo, H., Woo, S., Scanlan, L., Poynton, H., Loguinov, A., Chan, S., Falciani, 
F., Vulpe, C. (2013) Molecular toxicity identification evaluation (mTIE) approach predicts 
chemical exposure in Daphnia magna. Environmental Science and Technology, 47 (20): 
11747–11756 
Arai, Y., Miyayama, T. and Hirano, S. (2015) Difference in the toxicity mechanism 
between ion and nanoparticle forms of silver in the mouse lung and in macrophages. 
Toxicology, 328: 84–92 
Arakawa, H., Neault, J. and Tajmir-Riahi, H. (2001) Silver(I) complexes with DNA and 
RNA studied by Fourier transform infrared spectroscopy and capillary electrophoresis. 
Biophysical Journal, 81 (3): 1580–1587 
Arora, S., Jain, J., Rajwade, J., Paknikar, K. (2009) Interactions of silver nanoparticles 
with primary mouse fibroblasts and liver cells. Toxicology and Applied Pharmacology, 
236 (3): 310–8 
Asghari, S., Johari, S., Lee, J., Kim, Y., Jeon, Y., Choi, H., Moon, M., Yu, I. (2012) 
Toxicity of various silver nanoparticles compared to silver ions in Daphnia magna. 
Journal of Nanobiotechnology, 10: 14 
  
194 
 
Asharani, P, Hande, M., and Valiyaveettil, S. (2009a) Anti-proliferative activity of silver 
nanoparticles. BMC Cell Biology, 10: 65 
Asharani, P. V, Mun, G., Hande, M., Valiyaveettil, S. (2009b) Cytotoxicity and 
Genotoxicity of Silver., ACS Nano, 3 (2): 279–290 
Audinot, J., Georgantzopoulou, A., Piret, J., Gutleb, A., Dowsett, D., Migeon, H., 
Hoffmann, L. (2013) Identification and localization of nanoparticles in tissues by mass 
spectrometry. Surface and Interface Analysis, 45 (1): 230–233 
Baalousha, M. and Lead, J. (2012) Rationalizing nanomaterial sizes measured by atomic 
force microscopy, flow field-flow fractionation, and dynamic light scattering: sample 
preparation, polydispersity, and particle structure. Environmental Science & Technology, 
46 (11): 6134–6142 
Badawy, A., Luxton, T., Silva, R., Scheckel, K., Suidan, M., Tolaymat, T. (2010) Impact 
of environmental conditions (pH, ionic strength, and electrolyte type) on the surface 
charge and aggregation of silver nanoparticles suspensions. Environmental Science & 
Technology, 44 (4): 1260–1266 
Behra, R., Sigg, L., Clift, M., Herzog, F., Minghetti, M., Johnston, B., Petri-Fink, A. 
Rothen-Rutishauser, B. (2013) Bioavailability of silver nanoparticles and ions: from a 
chemical and biochemical perspective. Journal of The Royal Society Interface, 10(87),. 
Bekyarova, E., Fornasiero, P., Kaspar, J., Graziani, M. (1998) CO oxidation on Pd/CeO2-
ZrO2 Catalysis Today., 45: 179–183 
Benjamini, Y. and Hochberg, Y. (1995) Controlling the false discovery rate: a practical 
and powerful approach to multiple testing. Journal of the Royal Statistical Society. Series 
B 57 (1): 289–300 
  
195 
 
Benn, T. and Westerhoff, P. (2008) Nanoparticle Silver Released into Water from 
Commercially Available Sock Fabrics. Environmental Science & Technology, 42 (11): 
4133–4139 
Bhabra, G., Sood, A., Fisher, B., Cartwright, L., Saunders, M., Evans, W., Surprenant, A., 
Lopez-Castejon, G., Mann, S., Davis, S., Hails, L., Ingham, E., Verkade, P., Lane, J., 
Heesom, K., Newson, R., Case, C.(2009) Nanoparticles can cause DNA damage across a 
cellular barrier. Nature Nanotechnology, 4 (12): 876–83 
Bianchini, A. and Wood, C. (2003) Mechanism of acute silver toxicity in Daphnia magna. 
Environmental Toxicology and Chemistry, 22 (6): 1361–1367 
Bianchini, A. and Wood, C. (2008) Does sulfide or water hardness protect against chronic 
silver toxicity in Daphnia magna? A critical assessment of the acute-to-chronic toxicity 
ratio for silver. Ecotoxicology and Environmental Safety, 71 (1): 32–40 
Bleeker, E., Jong, W., Geertsma, R., Groenewold, E., Heugens, E., Koer-Jacquemijns, M., 
Meent, D., Popma, J., Rietveld, A., Wijnhoven, S., Cassee, F., Oomen, A. (2013) 
Considerations on the EU definition of a nanomaterial: science to support policy making. 
Regulatory Toxicology and Pharmacology : RTP, 65 (1): 119–25 
Bouhifd, M., Hartung, T., Hogberg, H., Kleensang, A., Zhao, L. (2013) Review: 
toxicometabolomics. Journal of Applied Toxicology, 33 (12): 1365–83 
Boveris, A. and Chance, B. (1973) The mitochondrial generation of hydrogen peroxide. 
General properties and effect of hyperbaric oxygen. The Biochemical Journal, 134 (3): 
707–16 
  
196 
 
Bradford, A., Handy, R., Readman, J., Atfield, A., Muhling, M. (2009) Impact of silver 
nanoparticle contamination on the genetic diversity of natural bacterial assemblages in 
estuarine sediments. Environmental Science and Technology, 43 (12): 4530–4536 
Bragg, P. and Rainnie, D. (1974) The effect of silver ions on the respiratory chain of 
Escherichia coli. Canadian Journal of Microbiology, 20 (6): 883–9 
British Standards Institution (2007) Terminology for nanomaterials. PAS 136:2007. Text, 
p. 16 
Bruins, A. (1998) Mechanistic aspects of electrospray ionization. Journal of 
Chromatography A, 794 (1-2): 345–357 
Bunescu, A., Garric, J., Vollat, B., Canet-Soulas, E., Graveron-Demilly, D., Fauvelle, F. 
(2010) In vivo proton HR-MAS NMR metabolic profile of the freshwater cladoceran 
Daphnia magna. Molecular bioSystems, 6 (1): 121–5 
Bury, N. and Wood, C., 1999. Mechanism of branchial apical silver uptake by rainbow 
trout is via the proton-coupled Na+ channel. American Journal of Physiology-Regulatory, 
Integrative and Comparative Physiology,277(5), pp.R1385-R1391. 
Campian, J., Qian, M., Gao, X., Eaton, J. (2004) Oxygen tolerance and coupling of 
mitochondrial electron transport. Journal of Biological Chemistry, 279 (45): 46580–46587 
Campos, B., Garcia-Reyero, N., Rivetti, C., Escalon, L., Habib, T., Tauler, R., Tsakovski, 
S., Pina, B., Barata, C. (2013) Identification of metabolic pathways in Daphnia magna 
explaining hormetic effects of selective serotonin reuptake inhibitors and 4-nonylphenol 
using transcriptomic and phenotypic responses. Environmental Science & Technology, 47 
(16): 9434–43 
  
197 
 
Carrola, J., Bastos, V., Ferreira de Oliveira, J. , Oliveira, H., Santos, C., Gil, A., Duarte, I. 
(2015) Insights into the impact of silver nanoparticles on human keratinocytes metabolism 
through NMR metabolomics. Archives of Biochemistry and Biophysics, pp. 1–9 
Cavill, R., Kamburov, A., Ellis, J., Athersuch, T., Blagrove, M., Herwig, R., Ebbels, T., 
Keun, H. (2011) Consensus-phenotype integration of transcriptomic and metabolomic data 
implies a role for metabolism in the chemosensitivity of tumour cells. PLoS 
Computational Biology, 7 (3): e1001113 
Chae, Y., Pham, C., Lee, J., Bae, E., Yi, J., Gu, M. (2009) Evaluation of the toxic impact 
of silver nanoparticles on Japanese medaka (Oryzias latipes). Aquatic Toxicology, 94 (4): 
320–7 
Chairuangkitti, P., Lawanprasert, S., Roytrakul, S., Aueviriyavit, S., Phummiratch, D., 
Kulthong, K., Chanvorachote, P., Maniratanachote, R. (2013) Silver nanoparticles induce 
toxicity in A549 cells via ROS-dependent and ROS-independent pathways. Toxicology in 
Vitro, 27 (1): 330–8 
Chaloupka, K., Malam, Y. and Seifalian, A. (2010) Nanosilver as a new generation of 
nanoproduct in biomedical applications. Trends in Biotechnology, 28 (11): 580–588 
Chambers, C., Proctor, C. and Kabler, P. (1962) Bactericidal effect of low concentrations 
of silver. American Water Works Association, 54 (2): 208–216 
Chaudhry, Q., Scotter, M., Blackburn, J., Ross, B., Boxall, A., Castle, L., Aitken, R., 
Watkins, R. (2008) Applications and implications of nanotechnologies for the food sector. 
Food Additives & Contaminants. 25 (3): 241–58 
Chen, X. and Schluesener, H. (2008) Nanosilver: A nanoproduct in medical application. 
Toxicology Letters, 176 (1): 1–12 
  
198 
 
Chladek, G., Mertas, A., Barszczewska-Rybarek, I., Nalewajek, T., Zmudzki, J., Krol, W., 
Lukaszczyk, J. (2011) Antifungal activity of denture soft lining material modified by silver 
nanoparticles-a pilot study. International Journal of Molecular Sciences, 12 (7): 4735–44 
Choi, O. and Hu, Z. (2008) Size dependent and reactive oxygen species related nanosilver 
toxicity to nitrifying bacteria. Environmental Science & Technology, 42 (12): 4583–4588 
Christian, P., Von der Kammer, F., Baalousha, M.,Hofmann, T. (2008) Nanoparticles: 
structure, properties, preparation and behaviour in environmental media. Ecotoxicology, 17 
(5): 326–43 
Cipriani, S., Bakshi, R. and Schwarzschild, M. (2014) Protection by inosine in a cellular 
model of Parkinson’s disease. Neuroscience, 274: 242–9 
Colbourne, J., Pfrender, M. and Gilbert, D. (2011) The ecoresponsive genome of Daphnia 
pulex. Science, 331 (6017): 555–561 
Colbourne, J., Singan, V.. and Gilbert, D. (2005) wFleaBase: the Daphnia genome 
database. BMC Bioinformatics, 6 (1): 45 
Comfort, K., Maurer, E. and Hussain, S. (2014) Slow release of ions from internalized 
silver nanoparticles modifies the epidermal growth factor signalling response. Colloids and 
Surfaces B: Biointerfaces, 123: 136–142 
Comisarow, M. and Melka, J. (1979) Error estimates for finite zero-filling in Fourier 
transform spectrometry. Analytical Chemistry, 51 (13): 2198–2203 
Cortese-Krott, M., Münchow, M., Pirev, E., Heßner, F., Bozkut, A., Uciechowski, P., 
Pallua, N., Kroncke, K., Suschek, C. (2009) Silver ions induce oxidative stress and 
  
199 
 
intracellular zinc release in human skin fibroblasts. Free Radical Biology and Medicine, 47 
(11): 1570–7 
Couvreur, P. (2013) Nanoparticles in drug delivery: past, present and future. Advanced 
Drug Delivery Reviews, 65 (1): 21–3 
Dal-Cim, T., Molz, S., Egea, J., Parada, E., Romero, A., Budni, J., Martin de Saavedra, M., 
Barrio, L., Tasca, C., López, M. (2012) Guanosine protects human neuroblastoma SH-
SY5Y cells against mitochondrial oxidative stress by inducing heme oxigenase-1 via 
PI3K/Akt/GSK-3β pathway. Neurochemistry International, 61 (3): 397–404 
David, R., Dakic, V., Williams, T., Winter, M., Chipman, J. (2011) Transcriptional 
responses in neonate and adult Daphnia magna in relation to relative susceptibility to 
genotoxicants. Aquatic Toxicology, 104 (3-4): 192–204 
Dettmer, K., Aronov, P. and Hammock, B. (2007) Mass spectrometry-based 
metabolomics. Mass Spectrometry Reviews, 26 (1): 51–78 
Dieterle, F., Ross, A., Schlotterbeck, G., Senn, H. (2006) Probabilistic quotient 
normalization as robust method to account for dilution of complex biological mixtures. 
Application in 1H NMR metabonomics. Analytical Chemistry, 78 (13): 4281–90 
Domingos, R., Baalousha, M., Ju-Nam, Y., Reid, M., Tufenkji, N., Lead, J., Leppard, G., 
Wilkinson, K. (2009) Characterizing manufactured nanoparticles in the environment: 
multimethod determination of particle sizes. Environmental Science & Technology, 43 
(19): 7277–7284 
Donaldson, K., Stone, V., Tran, C., Kreyling, W., Borm, P. (2004) Nanotoxicology. 
Occupational and Environmental Medicine, 61 (9): 727–8 
  
200 
 
Dunn, W., Erban, A., Weber, R., Creek, D., Brown, M., Breitling, R., Hankemeier, T., 
Goodacre, R., Neumann, S., Kopka, J., Viant, M. (2012) Mass appeal: metabolite 
identification in mass spectrometry-focused untargeted metabolomics. Metabolomics, 9 
(S1): 44–66 
Ebert, D. (2005) Ecology, epidemiology and evolution of parasitism in Daphnia. Bethesda 
(MD): National Center for Biotechnology Information  
Elliott, M. and Trewyn, R. (1984) Inosine biosynthesis in transfer RNA by an enzymatic 
insertion of hypoxanthine. The Journal of Biological Chemistry, 259 (4): 2407–10 
Erickson, R., Brooke, L., Kahl, M.., Venter, F., Harting, S., Markee, T., Spehar, R. (1998) 
Effects of laboratory test conditions on the toxicity of silver to aquatic organisms. 
Enviromental Toxicology and Chemistry, 17 (4): 572–578 
EU, (2011). Commission recommendation of 18 October 2011 on the definition of 
nanomaterial (2011/696/EU). Official Journal of the European Union, L 275, 38–40. 
Fabrega, J., Luoma, S., Tyler, C., Galloway, T., Lead, J. (2011) Silver nanoparticles: 
behaviour and effects in the aquatic environment. Environment International, 37 (2): 517–
531 
Ferguson, E., Leach, D. and Hogstrand, C. (1996) August. Metallothionein protects against 
silver blockage of the Na+/K+-ATPase. Proceedings of the fourth International 
Conference, Transport, Fate and Effects of Silver in the Environment (pp. 191-200). 
Madison, WI: University of Wisconsin-Madison.  
Fiehn, O. (2002) Metabolomics--the link between genotypes and phenotypes. Plant 
Molecular Biology, 48 (1-2): 155–71 
  
201 
 
Finkel, T. and Holbrook, N. (2000) Oxidants, oxidative stress and the biology of ageing. 
Nature, 408 (6809): 239–247 
Flicek, P., Amode, M., Barrell, D., Beal, K., Billis, K., Brent, S., Varvalho-Silva, D., 
Clapham, P., Coates, G., Fitzgerald, S., Gil, L., Giron, C., Gordon, L., Hourlier, T., Hunt, 
S., Johnson, N., Juettemann, T., Kahari, A., Keenan, S., Kulesha, E., Martin, F., Maurel, 
T., McLaren, W., Murphy, D., Nag, R., Overduin, B., Pignatelli, M., Pritchard, B., 
Pritchard, E., Riat, H., Ruffier, M., Sheppard, D., Taylor, K., Thormann, A., Trevanion, S., 
Vullo, A., Wilder, S., Wilson, M., Zadissa, A., Aken, B., Birney, E., Cunningham, F., 
Harrow, J., Herrero, J., Hubbard, T., Kinsella, R., Muffato, M., Parker, A., Spudich, G., 
Yates, A., Zerbino, D., Searle, S. (2014) Ensembl 2014. Nucleic Acids Research, 42 
(Database issue): D749–55 
Fu, P., Xia, Q., Hwang, H.-M., Ray, P., Yu, H. (2014) Mechanisms of nanotoxicity: 
generation of reactive oxygen species. Journal of Food and Drug Analysis, 22 (1): 64–75 
Gaiser, B., Biswas, A., Rosenkranz, P., Jepson, M., Lead, J., Stone, V., Tyler, C., 
Fernandes, T. (2011) Effects of silver and cerium dioxide micro-and nano-sized particles 
on Daphnia magna. Journal of Environmental Monitoring, 13 (5): 1227–1235 
García-Alonso, J., Khan, F., Misra, S., Turmaine, M., Smith, B., Rainbow, P., Luoma, S., 
Valsami-Jones, E. (2011) Cellular internalization of silver nanoparticles in gut epithelia of 
the estuarine polychaete Nereis diversicolor. Environmental Science & Technology, 45 
(10): 4630–6 
Garcia-Reyero, N., Poynton, H., Kennedy, A., Guan, X., Escalon, B., Chang, B., 
Varshavsky, J., Loguinov, A., Vulpe, C., Perkins, E. (2009) Biomarker discovery and 
  
202 
 
transcriptomic responses in Daphnia magna exposed to munitions constituents. 
Environmental Science & Technology, 43 (11): 4188–93 
Geiser, M., Rothen-Rutishauser, B., Kapp, N., Schurch, S., Kreyling, W., Schulz, H., 
Semmler, M., Hof, V., Heyder, J., Gehr, P. (2005) Ultrafine particles cross cellular 
membranes by nonphagocytic mechanisms in lungs and in cultured cells. Environmental 
Health Perspectives, 113 (11): 1555–1560 
Geranio, L., Heuberger, M. and Nowack, B. (2009) The behavior of silver nanotextiles 
during washing. Environmental Science & Technology, 43 (21): 8113–8118 
Gottschalk, F., Sun, T. and Nowack, B. (2013) Environmental concentrations of 
engineered nanomaterials: Review of modelling and analytical studies. Environmental 
Pollution, 181: 287–300 
Götz, S., García-Gómez, J.., Terol, J., Williams, T., Nagaraj, S., Nueda, M., Robles, M., 
Talon, M., Dopazo, J., Conesa, A. (2008) High-throughput functional annotation and data 
mining with the Blast2GO suite. Nucleic Acids Research, 36 (10): 3420–35 
Greulich, C., Diendorf, J., Simon, T., Eggeler, G., Epple, M., Koller, M. (2011) Uptake 
and intracellular distribution of silver nanoparticles in human mesenchymal stem cells. 
Acta Biomaterialia, 7 (1): 347–354 
Groh, K., Dalkvist, T., Piccapietra, F., Behra, R., Suter, M., Schirmer, K. (2014) Critical 
influence of chloride ions on silver ion-mediated acute toxicity of silver nanoparticles to 
zebrafish embryos. Nanotoxicology, 5390: 1–11 
Gudkov, S. , Shtarkman, I., Smirnova, V., Chernikov, A., Bruskov, V. (2006) Guanosine 
and inosine as natural antioxidants and radioprotectors for mice exposed to lethal doses of 
γ-radiation. Biochemistry, Biophysics, and Molecular Biology 407 (1): 47–50 
  
203 
 
De Gusseme, B., Hennebel, T., Christiaens, E., Saveyn, H., Verbeken, K., Fitts, J., Boon, 
N., Verstraete, W. (2011) Virus disinfection in water by biogenic silver immobilized in 
polyvinylidene fluoride membranes. Water Research, 45 (4): 1856–64 
Hadrup, N., Lam, H., Loeschner, K., Mortensen, A., Larsen, E., Frandsen, H. (2012) 
Nanoparticulate silver increases uric acid and allantoin excretion in rats, as identified by 
metabolomics. Journal of Applied Toxicology, 32 (11): 929–33 
He, D., Jones, A., Garg, S., Pham, N., Waite, T. (2011) Silver nanoparticle− reactive 
oxygen species interactions: application of a charging− discharging model. The Journal of 
Physical Chemistry C, 115: 5461–5468 
Heckmann, L.-H., Sibly, R., Connon, R., Hooper, H., Hutchinson, T., Maund, S., Hill, C., 
Bouetard, A., Callaghan, A. (2008) Systems biology meets stress ecology: linking 
molecular and organismal stress responses in Daphnia magna. Genome Biology, 9 (2): 
R40 
Hogstrand, C. and Wood, C. (1998) Toward a better understanding of the bioavailability, 
physiology, and toxicity of silver in fish: Implications for water quality criteria. 
Environmental Toxicology and Chemistry, 17 (4): 547–561 
Hoheisel, S., Diamond, S. and Mount, D. (2012) Comparison of nanosilver and ionic silver 
toxicity in Daphnia magna and Pimephales promelas. Environmental Toxicology and 
Chemistry, 31 (11): 2557–63 
Horbach, G., Van Den Brule, S., Magkoufopoulou, C., Vietti, G., Papoutsi, D., Leyns, L., 
Kirsch-Volders, M. (2014) The safety of nanomaterials: translation from academic 
research to industrial and regulatory applications. Journal of Translational Toxicology, 1 
(1): 40–45 
  
204 
 
Hrydziuszko, O. and Viant, M. (2011) Missing values in mass spectrometry based 
metabolomics: an undervalued step in the data processing pipeline. Metabolomics, 8 (S1): 
161–174 
Hsiao, I.-L., Hsieh, Y.-K., Wang, C.-F., Chen, I.-C., Huang, Y.-J.. (2015) Trojan-horse 
mechanism in the cellular uptake of silver nanoparticles verified by direct intra- and 
extracellular silver speciation analysis. Enviromental Science and Technology, 49 (6): 
3813–21 
Huang, D., Sherman, B. and Lempicki, R. (2009) Systematic and integrative analysis of 
large gene lists using DAVID bioinformatics resources. Nature Protocols, 4: 44–57 
Hwang, E., Lee, J., Chae, Y., Kim, Y., Kim, B., Sang, B.-I., Gu, M. (2008) Analysis of the 
toxic mode of action of silver nanoparticles using stress-specific bioluminescent bacteria. 
Small, 4 (6): 746–750 
ISO, Nanotechnologies – Terminology and definitions for nano-objects – Nanoparticle, 
nanofibre and nanoplate. International Organisation for Standardisation (ISO), Genève, 
Switserland, 2008. 
Jiang, J., Oberdörster, G. and Biswas, P. (2008) Characterization of size, surface charge, 
and agglomeration state of nanoparticle dispersions for toxicological studies. Journal of 
Nanoparticle Research, 11 (1): 77–89 
Johari, S., Kalbassi, M., Lee, S., Dong, M., Yu, I. (2015) Silver nanoparticles affects the 
expression of biomarker genes mRNA in rainbow trout (Oncorhynchus mykiss). 
Comparative Clinical Pathology 
Johnson, A., Bowes, M., Crossley, A., Jarvie, H., Jurkschat, K., Jurgens, M., Lawlor, A., 
Park, B., Rowland, P., Spurgeon, D., Svensden, C., Thompson, I., Barnes, R., Williams, 
  
205 
 
R., Xu, N. (2011) An assessment of the fate, behaviour and environmental risk associated 
with sunscreen TiO₂ nanoparticles in UK field scenarios. Science of the Total 
Environment, 409 (13): 2503–10 
Jomova, K. and Valko, M. (2011) Advances in metal-induced oxidative stress and human 
disease. Toxicology, 283 (2-3): 65–87 
Jung, W., Koo, H., Kim, K., Shin, S., Kim, S., Park, Y. (2008) Antibacterial activity and 
mechanism of action of the silver ion in Staphylococcus aureus and Escherichia coli. 
Applied and Environmental Microbiology, 74 (7): 2171–2178 
Jurkowitz, M., Litsky, M., Browning, M., Hohl, C. (1998) Adenosine, inosine, and 
guanosine protect glial cells during glucose deprivation and mitochondrial inhibition: 
correlation between protection and ATP preservation. Journal of Neurochemistry, 71 (2): 
535–48 
Kaegi, R., Sinnet, B., Zuleeg, S., Hagendorfer, H., Mueller, E., Vonbank, R., Boller, M., 
Burkhardt, M. (2010) Release of silver nanoparticles from outdoor facades. Environmental 
Pollution, 158 (9): 2900–2905 
Kamburov, A., Cavill, R., Ebbels, T., Herwig, R., Keun, H. (2011) Integrated pathway-
level analysis of transcriptomics and metabolomics data with IMPaLA. Bioinformatics, 27 
(20): 2917–8 
Keating, K. and Dagbusan, B. (1984) Effect of selenium deficiency on cuticle integrity in 
the Cladocera (Crustacea). Proceedings of the National Academy of Sciences of the United 
States of America, 81 (11): 3433–7 
  
206 
 
Kennedy, A., Hull, M., Bednar, A., Goss, J., Gunter, J., Bouldin, J., Vikesland, P., 
Steevens, J. (2010) Fractionating nanosilver: importance for determining toxicity to 
aquatic test organisms. Environmental Science & Technology, 44 (24): 9571–9577 
Keun, H. (2006) Metabonomic modeling of drug toxicity. Pharmacology & Therapeutics, 
109 (1-2): 92–106 
Khan, F., Kennaway, G., Croteau, M.-N., Dybowska, A., Smith, B., Nogueira, A., 
Rainbow, P., Luoma, S., Valsami-Jones, E. (2014) In vivo retention of ingested Au NPs by 
Daphnia magna: no evidence for trans-epithelial alimentary uptake. Chemosphere, 100: 
97–104 
Khan, F., Paul, K., Dybowska, A., Valsami-Jones, E., Lead, J., Stone, V., Fernandes, T. 
(2015) Accumulation dynamics and acute toxicity of silver nanoparticles to Daphnia 
magna and Lumbriculus variegatus: Implications for metal modelling approaches. 
Environmental Science & Technology, pp. 4389–4397 
Khatri, P., Sirota, M. and Butte, A. (2012) Ten years of pathway analysis: current 
approaches and outstanding challenges. PLoS Computational Biology, 8 (2): e1002375 
Kim, J., Kim, S. and Lee, S. (2011) Differentiation of the toxicities of silver nanoparticles 
and silver ions to the Japanese medaka (Oryzias latipes) and the cladoceran Daphnia 
magna. Nanotoxicology, 5 (2): 208–14 
Kind, T. and Fiehn, O. (2006) Metabolomic database annotations via query of elemental 
compositions: mass accuracy is insufficient even at less than 1 ppm. BMC Bioinformatics, 
7: 234 
  
207 
 
Kirwan, J., Weber, R., Broadhurst, D., Viant, M. (2014) Direct infusion mass spectrometry 
metabolomics dataset: a benchmark for data processing and quality control. Scientific 
Data, 1: 1–13 
Kreyling, W., Semmler-Behnke, M. and Chaudhry, Q. (2010) A complementary definition 
of nanomaterial. Nano Today, 5 (3): 165–168 
Lampert, W. (2011) Daphnia: Development of a Model Organism in Ecology and 
Evolution.  
Le, T.-H., Lim, E.-S., Hong, N.-H., Lee, S.-K., Shim, Y., Hwang, J., Kim, Y.-H., Min, J. 
(2013) Proteomic analysis in Daphnia magna exposed to As(III), As(V) and Cd heavy 
metals and their binary mixtures for screening potential biomarkers. Chemosphere, 93 
(10): 2341–8 
Leblanc, G., Mastone, J., Paradice, A., Wilson, B., Haines Jr, B. Robillard, K., (1984). The 
influence of speciation on the toxicity of silver to fathead minnow (Pimephales 
promelas). Environmental Toxicology and Chemistry, 3(1), pp.37-46. 
Lenz, E. and Wilson, I. (2007) Analytical strategies in metabonomics. Journal of Proteome 
Research, 6 (2): 443–58 
Li, H., Yan, Z., Zhu, J., Yang, J., He, J. (2011) Neuroprotective effects of resveratrol on 
ischemic injury mediated by improving brain energy metabolism and alleviating oxidative 
stress in rats. Neuropharmacology, 60 (2-3): 252–8 
Li, L., Wu, H., Ji, C., Gestel, C., Allen, H., Peijnenburg, W. (2015a) A metabolomic study 
on the responses of Daphnia magna exposed to silver nitrate and coated silver 
nanoparticles. Ecotoxicology and Environmental Safety, 119: 66–73 
  
208 
 
Li, L., Wu, H., Peijnenburg, W., Gestel, C. (2015b) Both released silver ions and 
particulate Ag contribute to the toxicity of AgNPs to earthworm Eisenia fetida. 
Nanotoxicology, 9 (6): 792–801 
Liau, S., Read, D., Pugh, W., Furr, J., Russell, A. (1997) Interaction of silver nitrate with 
readily identifiable groups: relationship to the antibacterial action of silver ions. Letters in 
Applied Microbiology, 25 (4): 279–83 
Liochev, S. and Fridovich, I. (2000) Copper- and zinc-containing superoxide dismutase 
can act as a superoxide reductase and a superoxide oxidase. The Journal of Biological 
Chemistry, 275 (49): 38482–5 
Lok, C.-N., Ho, C.-M., Chen, R., He, Q.-Y., Yu, W.-Y., Sun, H., Kwong-Hang, P., Chiu, 
J.-F., Che, C.-M. (2007) Silver nanoparticles: partial oxidation and antibacterial activities. 
Journal of Biological Inorganic Chemistry, 12 (4): 527–34 
Lubick, N. (2008) Nanosilver toxicity: ions, nanoparticlessor both. Environmental Science 
& Technology, 42 (23): 8959–8964 
Luoma, S. (2008) Silver nanotechnologies and the environment. The Project on Emerging 
Nanotechnologies Report, (15) 
Ma, H., Brennan, A. and Diamond, S. (2012) Photocatalytic reactive oxygen species 
production and phototoxicity of titanium dioxide nanoparticles are dependent on the solar 
ultraviolet radiation spectrum. Environmental Toxicology and Chemistry, 31 (9): 2099–
107 
Malvern Instruments Ltd (2011) Inform white paper dynamic light scattering. Malvern 
Guides, pp. 1–6 
  
209 
 
Martins, J., Oliva Teles, L. and Vasconcelos, V. (2007) Assays with Daphnia magna and 
Danio rerio as alert systems in aquatic toxicology. Environment International, 33 (3): 
414–25 
De Matteis, V., Malvindi, M., Galeone, A., Brunetti, V., Luca, E., Kote, S., Kshirsagar, P., 
Sabella, S., Bardi, G., Pompa, P. (2015) Negligible particle-specific toxicity mechanism of 
silver nanoparticles: The role of Ag+ ion release in the cytosol. Nanomedicine: 
Nanotechnology, Biology and Medicine, 11 (3): 731–739 
McQuillan, J. and Shaw, A.. (2014) Differential gene regulation in the Ag nanoparticle and 
Ag+-induced silver stress response in Escherichia coli: A full transcriptomic profile. 
Nanotoxicology, 5390 (I): 1–8 
Meyer, J., Lord, C., Yang, X., Turner, E., Badireddy, A., Marinakos, S., Chilkoti, A., 
Wiesner, M., Auffan, M. (2010) Intracellular uptake and associated toxicity of silver 
nanoparticles in Caenorhabditis elegans. Aquatic Toxicology, 100 (2): 140–50 
Mijnendonckx, K., Leys, N., Mahillon, J., Silver, S., Houdt, R. (2013) Antimicrobial 
silver: uses, toxicity and potential for resistance. Biometals, 26 (4): 609–21 
Módis, K., Gero, D., Nagy, N., Szoleczky, P., Toth, Z., Szabo, C. (2009) Cytoprotective 
effects of adenosine and inosine in an in vitro model of acute tubular necrosis. British 
Journal of Pharmacology, 158 (6): 1565–78 
Moore, M. (2006) Do nanoparticles present ecotoxicological risks for the health of the 
aquatic environment? Environment International, 32 (8): 967–76 
Morgan, I., Henryb, P. and Wood, C. (1997) The mechanism of acute silver nitrate toxicity 
in freshwater rainbow trout (Oncorhynchus mykiss) is inhibition of gill Na+ and Cl- 
transport. Aquatic Toxicology, 38: 145–163 
  
210 
 
Mueller, N. and Nowack, B. (2008) Exposure modeling of engineered nanoparticles in the 
environment. Environmental Science & Technology, 42 (12): 4447–53 
Nagato, E., D’eon, J., Lankadurai, B., Poirier, D., Reiner, E., Simpson, A., Simpson, M. 
(2013) 1H NMR-based metabolomics investigation of Daphnia magna responses to sub-
lethal exposure to arsenic, copper and lithium. Chemosphere, 93 (2): 331–7 
Nam, H., Kwon, S., Chung, H., Lee, S.-Y., Kwon, S.-H., Jeon, H., Kim, Y., Park, J., Kim, 
J., Her, S., Oh, Y.-K., Kwon, I., Kim, K., Jeong, S. (2009) Cellular uptake mechanism and 
intracellular fate of hydrophobically modified glycol chitosan nanoparticles. Journal of 
Controlled Release, 135 (3): 259–267 
Newton, K., Puppala, H., Kitchens, C., Colvin, V., Klaine, S. (2013) Silver nanoparticle 
toxicity to Daphnia magna is a function of dissolved silver concentration. Environmental 
Toxicology and Chemistry, 32 (10): 2356–64 
Nguyen, D., Arpat, B., Wang, N., Carroll, R. (2002) DNA microarray experiments: 
biological and technological aspects. Biometrics, 58 (4): 701–17 
Notter, D. a., Mitrano, D. and Nowack, B. (2014) Are nanosized or dissolved metals more 
toxic in the environment? A meta-analysis. Environmental Toxicology and Chemistry, 33 
(12): 2733–2739 
Nowack, B., Krug, H. and Height, M. (2011) 120 Years of nanosilver history: Implications 
for policy makers. Environmental Science & Technology, 45 (4): 1177–83 
Nuwaysir, E., Bittner, M., Trent, J., Barret, C., Afshari, C. (1999) Microarrays and 
toxicology: the advent of toxicogenomics. Molecular Carcinogenesis, 24 (3): 153–9 
  
211 
 
Oberdörster, G., Maynard, A., Donaldson, K., Castranova, V., Fitzpatrick, J., Ausman, K., 
Carter, J., Karn, B., Kreyling, W., Lai, D., Olin, S., Monterio-Riviere, N., Warheit, D., 
Yang, H. (2005a) Principles for characterizing the potential human health effects from 
exposure to nanomaterials: elements of a screening strategy. Particle and Fibre 
Toxicology, 2 (1): 8 
Oberdörster, G., Oberdörster, E. and Oberdörster, J. (2005b) Nanotoxicology: an emerging 
discipline evolving from studies of ultrafine particles. Environmental Health Perspectives, 
113 (7): 823–839 
OECD (2004), Test No. 202: Daphnia sp. Acute Immobilisation Test, OECD Guidelines 
for the Testing of Chemicals, Section 2, OECD Publishing, Paris.  
Otte, K., Fröhlich, T., Arnold, G., Laforsch, C. (2014) Proteomic analysis of Daphnia 
magna hints at molecular pathways involved in defensive plastic responses. BMC 
Genomics, 15: 306 
Park, E.-J., Yi, J., Kim, Y., Choi, K., Park, K. (2010) Silver nanoparticles induce 
cytotoxicity by a Trojan-horse type mechanism. Toxicology in Vitro, 24 (3): 872–8 
Park, H.-J., Kim, J., Kim, J., Lee, J.-H., Hahn, J.-S., Gu, M., Yoon, J. (2009) Silver-ion-
mediated reactive oxygen species generation affecting bactericidal activity. Water 
Research, 43 (4): 1027–1032 
Parkin, I. and Palgrave, R. (2005) Self-cleaning coatings. Journal of Materials Chemistry, 
15 (17): 1689 
Parsons, H., Ekman, D., Collette, T., Viant, M. (2009) Spectral relative standard deviation: 
a practical benchmark in metabolomics. The Analyst, 134 (3): 478–85 
  
212 
 
Parsons, H., Ludwig, C., Günther, U., Viant, M. (2007) Improved classification accuracy 
in 1- and 2-dimensional NMR metabolomics data using the variance stabilising generalised 
logarithm transformation. BMC Bioinformatics, 8: 234 
Payne, T., Southam, A., Arvanitis, T., Viant, M. (2009) A signal filtering method for 
improved quantification and noise discrimination in fourier transform ion cyclotron 
resonance mass spectrometry-based metabolomics data. Journal of the American Society 
for Mass Spectrometry, 20 (6): 1087–95 
Pfaffl, M.W. (2001) A new mathematical model for relative quantification in real-time RT-
PCR. Nucleic Acids Research, 29 (9): e45 
Piccapietra, F. (2012) Colloidal stability of silver nanoparticles and their interactions with 
the alga Chlamydomonas reinhardtii (Doctoral dissertation, Diss., Eidgenössische 
Technische Hochschule ETH Zürich, Nr. 20365, 2012). 
Piña, B. and Barata, C. (2011) A genomic and ecotoxicological perspective of DNA array 
studies in aquatic environmental risk assessment. Aquatic Toxicology, 105 (3-4 Suppl): 
40–9 
Poynton, H.C., Lazorchak, J.M., Impellitteri, C. a, et al. (2011a) Differential gene 
expression in Daphnia magna suggests distinct modes of action and bioavailability for 
ZnO nanoparticles and Zn ions. Environmental Science & Technology, 45 (2): 762–8 
Poynton, H., Lazorchak, J., Impellitteri, C., Smith, M., Rogers, K., Patra, M., Hammer, K., 
Allen, H., Vulpe, C. (2012) Toxicogenomic responses of nanotoxicity in Daphnia magna 
exposed to silver nitrate and coated silver nanoparticles. Environmental Science & 
Technology, 46 (11): 6288–96 
  
213 
 
Poynton, H., Taylor, N., Hicks, J., Colson, K., Chan, S., Clark, C., Scanlan, L., Loguinov, 
A., Vulpe, C., Viant, M. (2011b) Metabolomics of microliter hemolymph samples enables 
an improved understanding of the combined metabolic and transcriptional responses of 
Daphnia magna to cadmium. Environmental Science & Technology, 45 (8): 3710–7 
Purcell, T. and Peters, J. (1998) Sources of silver in the environment. Environmental 
Toxicology and Chemistry, 17 (4): 539–546 
Quincozes-Santos, A., Bobermin, L., Souza, D., Bellaver, B., Goncalves, C.-A., Souza, D. 
(2014) Guanosine protects C6 astroglial cells against azide-induced oxidative damage: A 
putative role of heme oxygenase 1. Journal of Neurochemistry, 130 (1): 61–74 
Rai, M., Yadav, A. and Gade, A. (2009) Silver nanoparticles as a new generation of 
antimicrobials. Biotechnology Advances, 27 (1): 76–83 
Rai, M., Deshmukh, S., Ingle, P., Gade, A. (2012) Silver nanoparticles: the powerful 
nanoweapon against multidrug-resistant bacteria. Journal of Applied Microbiology, 112 
(5): 841–52 
Rainville, L.-C., Carolan, D., Varela, A., Doyle, H., Sheehan, D. (2014) Proteomic 
evaluation of citrate-coated silver nanoparticles toxicity in Daphnia magna. The Analyst, 
139 (7): 1678–86 
Ratte, H. (1999) Bioaccumulation and toxicity of silver compounds: A review. 
Environmental Toxicology and Chemistry, 18 (1): 89–108 
Ribeiro, F., Gallego-Urrea, J., Jurkschat, K., Crossley, A., Hassellov, M., Taylor, C., 
Soares, A., Loureiro, S. (2014) Silver nanoparticles and silver nitrate induce high toxicity 
to Pseudokirchneriella subcapitata, Daphnia magna and Danio rerio. The Science of the 
Total Environment, 466-467: 232–41 
  
214 
 
Rivetti, C., Campos, B., Faria, M., Catala, N., Malik, A., Munoz, I., Tauler, R., Soares, A., 
Osorio, V., Perez, S., Gorga, M., Petrovic, M., Mastroianni, N., Alda, M., Masia, A., 
Campo, J., Pico, Y., Guasc, H., Barcelo, D., Barata, C. (2014) Transcriptomic, biochemical 
and individual markers in transplanted Daphnia magna to characterize impacts in the field. 
The Science of the Total Environment 
Robertson, D. (2005) Metabonomics in toxicology: A review. Toxicological Sciences, 85 
(2): 809–822 
Robertson, D., Reily, M. and Baker, J. (2007) Metabonomics in pharmaceutical discovery 
and development. Journal of Proteome Research, 6 (2): 526–39 
Rogers, J., Parkinson, C., Choi, Y., Speshock, J., Hussain, S. (2008) A preliminary 
assessment of silver nanoparticle inhibition of monkeypox virus plaque formation. 
Nanoscale Research Letters, 3 (4): 129–133 
Römer, I., Gavin, A., White, T., Merrifield, R., Chipman, J., Viant, M., Lead, J. (2013) 
The critical importance of defined media conditions in Daphnia magna nanotoxicity 
studies. Toxicology Letters, 223 (1): 103–8 
Römer, I., White, T., Baalousha, M., Chipman, K., Viant, M., Lead, J. (2011) Aggregation 
and dispersion of silver nanoparticles in exposure media for aquatic toxicity tests. Journal 
of Chromatography. A, 1218 (27): 4226–33 
Roy, I. and Vij, N. (2010) Nanodelivery in airway diseases: challenges and therapeutic 
applications. Nanomedicine : Nanotechnology, Biology, and Medicine, 6 (2): 237–44 
Rozen, S. and Skaletsky, H. (1999) Primer3 on the WWW for general users and for 
biologist programmers. Bioinformatics Methods and Protocols 
  
215 
 
Russell, A. and Hugo, W. (1994) Antimicrobial activity and action of silver. Progress in 
medicinal chemistry, 31, p.351. 
Ryman-Rasmussen, J., Cesta, M., Brody, A., Shipley-Phillips, J., Everitt, J., Tewksbury, 
E., Moss, O., Wong, B., Dodd, D., Andersen, M., Bonner, J. (2009) Inhaled carbon 
nanotubes reach the subpleural tissue in mice. Nature Nanotechnology, 4 (11): 747–51 
Sangster, T., Major, H., Plumb, R., Wilson, A., Wilson, I. (2006) A pragmatic and readily 
implemented quality control strategy for HPLC-MS and GC-MS-based metabonomic 
analysis. The Analyst, 131 (10): 1075–1078 
Scanlan, L., Reed, R., Loguinov, A., Antczak, P., Tagmount, A., Aloni, S., Nowinski, D., 
Luong, P., Tran, C., Karunaratne, N., Pham, D., Lin, X., Falciani, F., Higging, C., 
Ranville, J., Vulpe, C., Gilbert, B. (2013) Silver nanowire exposure results in 
internalization and toxicity to Daphnia magna. ACS Nano, 7 (12): 10681–94 
SCENIHR, Opinion on the scientific basis for the definition of the term ‘‘nanomaterial’’. 
Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), 
European Commission Brussels, Belgium, 2010 
Schirmer, K., Fischer, B., Madureira, D., Pillai, S. (2010) Transcriptomics in 
ecotoxicology. Analytical and Bioanalytical Chemistry, 397 (3): 917–23 
Scown, T., Santos, E., Johnston, B., Gaiser, B., Baalousha, M., Mitov, S., Lead, J., Stone, 
V., Fernandes, T., Jepson, M., Aerle, R., Tyler, C. (2010) Effects of aqueous exposure to 
silver nanoparticles of different sizes in rainbow trout. Toxicological Sciences, 115 (2): 
521–34 
  
216 
 
Seaton, A., Tran, L., Aitken, R., Donaldson, K. (2010) Nanoparticles, human health hazard 
and regulation. Journal of the Royal Society, Interface, 7 Suppl 1 (September 2009): 
S119–29 
Shen, M.-H., Zhou, X.-X., Yang, X.-Y., Chao, J.-B., Liu, R., Liu, J.-F. (2015) Exposure 
medium: key in identifying free Ag+ as the exclusive species of silver nanoparticles with 
acute toxicity to Daphnia magna. Scientific Reports, 5: 9674 
Skjolding, L., Kern, K., Hjorth, R., Hartmann, N., Overgaard, S., Ma, G., Veinot, J., Baun, 
A. (2014) Uptake and depuration of gold nanoparticles in Daphnia magna. Ecotoxicology, 
23 (7): 1172–83 
Southam, A., Payne, T., Cooper, H., Arvanitis, T., Viant, M. (2007) Dynamic range and 
mass accuracy of wide-scan direct infusion nanoelectrospray fourier transform ion 
cyclotron resonance mass spectrometry-based metabolomics increased by the spectral 
stitching method. Analytical Chemistry, 79 (12): 4595–4602 
Stebounova, L., Guio, E. and Grassian, V. (2011) Silver nanoparticles in simulated 
biological media: A study of aggregation, sedimentation, and dissolution. Journal of 
Nanoparticle Research, 13 (1): 233–244 
Stensberg, M., Madangopal, R., Yale, G., Wei, W., Ochoa-Acuna, H., Wei, A. Mclamore, 
E., Rickus, J., Porterfield, D., Sepulveda, M. (2013) Silver nanoparticle-specific 
mitotoxicity in Daphnia magna. Nanotoxicology, (April): 1–10 
Stentoft, C., Vestergaard, M., Løvendahl, P., Kristensen, N., Moorby, J., Jensen, S. (2014) 
Simultaneous quantification of purine and pyrimidine bases, nucleosides and their 
degradation products in bovine blood plasma by high performance liquid chromatography 
tandem mass spectrometry. Journal of Chromatography. A, 1356: 197–210 
  
217 
 
Stevenson, A., Bea, D., Civit, S., Contera, S., Cerveto, A., Trigueros, S. (2012) Three 
strategies to stabilise nearly monodispersed silver nanoparticles in aqueous solution. 
Nanoscale Research Letters, 7 (1): 151 
Strange, R., Spiteri, M., Ramachandran, S., Fryer, A. (2001) Glutathione-S-transferase 
family of enzymes. Mutation Research, 482 (1-2): 21–26 
Struck-Lewicka, W., Kaliszan, R. and Markuszewski, M. (2014) Analysis of urinary 
nucleosides as potential cancer markers determined using LC-MS technique. Journal of 
Pharmaceutical and Biomedical Analysis 
Tatarazako, N. and Oda, S. (2007) The water flea Daphnia magna (Crustacea, Cladocera) 
as a test species for screening and evaluation of chemicals with endocrine disrupting 
effects on crustaceans. Ecotoxicology, 16 (1): 197–203 
Taylor, N., Weber, R., Southam, A., Payne, T., Hrydziuszko, O., Arvanitis, T., Viant, M. 
(2009) A new approach to toxicity testing in Daphnia magna: application of high 
throughput FT-ICR mass spectrometry metabolomics. Metabolomics, 5 (1): 44–58 
Taylor, N., Weber, R., White, T., Viant, M. (2010) Discriminating between different acute 
chemical toxicities via changes in the daphnid metabolome. Toxicological Sciences, 118 
(1): 307–17 
Tejamaya, M., Römer, I., Merrifield, R., Lead, J. (2012) Stability of citrate, PVP, and PEG 
coated silver nanoparticles in ecotoxicology media. Environmental Science & Technology, 
46 (13): 7011–7017 
Tkalec, Ž., Drobne, D., Vogel-Mikuš, K., Pongrac, P., Regvar, M., Strus, J., Pelicon, P., 
Vavpetic, P., Grlj, N., Remskar, M. (2011) Micro-PIXE study of Ag in digestive glands of 
  
218 
 
a nano-Ag fed arthropod (Porcellio scaber, Isopoda, Crustacea). Nuclear Instruments and 
Methods in Physics Research B, 269 (20): 2286–2291 
Ulm, L., Krivohlavek, A., Jurašin, D., Ljubojevic, M., Sinko, G., Crnkovic, T., Zuntar, I., 
Sikic, S., Vrcek, I., (2015) Response of biochemical biomarkers in the aquatic crustacean 
Daphnia magna exposed to silver nanoparticles. Environmental Science and Pollution 
Research 
Vance, M., Kuiken, T., Vejerano, E., McGinnis, S., Hochella, M., Rejeski, D., Hull, M. 
(2015) Nanotechnology in the real world: Redeveloping the nanomaterial consumer 
products inventory. Beilstein Journal of Nanotechnology, 6 (October 2013): 1769–1780 
Verano-Braga, T., Miethling-Graff, R., Wojdyla, K., Rogowska-Wrzesinska, A., Brewer, 
J., Erdmann, H., Kjeldsen, F. (2014) Insights into the cellular response triggered by silver 
nanoparticles using quantitative proteomics. ACS Nano, 8 (3): 2161–75 
Viant, M. (2008) Recent developments in environmental metabolomics. Molecular 
BioSystems, 4 (10): 980–6 
Viant, M. (2009) Applications of metabolomics to the environmental sciences. 
Metabolomics, 5 (1): 1–2 
Viant, M., Bearden, D., Bundy, J., Burton, I., Collette, T., Ekman, D., Ezernieks, V., 
Karakach, T., Lin, C., Rochfort, S., De Ropp, J., Teng, Q., Tjeerdema, R., Walter, J., Wu, 
H. (2009) International NMR-based environmental metabolomics intercomparison 
exercise. Environmental Science & Technology, 43 (1): 219–25 
Viant, M. and Sommer, U. (2012) Mass spectrometry based environmental metabolomics: 
a primer and review. Metabolomics, 9 (S1): 144–158 
  
219 
 
Wang, Z., Liu, S., Ma, J., Qu, G., Wang, X., Yu, S., He, J., Liu, J., Xia, T., Jiang, G.-B. 
(2013) Silver nanoparticles induced RNA polymerase-silver binding and RNA 
transcription inhibition in erythroid progenitor cells. ACS Nano, 7 (5): 4171–86 
Wardak, A., Gorman, M., Swami, N., Rejeski, D. (2007) Environmental regulation of 
nanotechnology and the TSCA. IEEE Technology and Society Magazine, 26 (2): 48–56 
Watanabe, H., Takahashi, E., Nakamura, Y., Oda, S., Tatarazako, N., Iguchi, T. (2007) 
Development of a Daphnia magna DNA microarray for evaluating the toxicity of 
environmental chemicals. Environmental Toxicology and Chemistry, 26 (4): 669–76 
Weber, R., Southam, A., Sommer, U., Viant, M. (2011) Characterization of isotopic 
abundance measurements in high resolution FT-ICR and Orbitrap mass spectra for 
improved confidence of metabolite identification. Analytical Chemistry, 83 (10): 3737–
3743 
Weber, R. and Viant, M. (2010) MI-Pack: Increased confidence of metabolite 
identification in mass spectra by integrating accurate masses and metabolic pathways. 
Chemometrics and Intelligent Laboratory Systems, 104 (1): 75–82 
White, T. (2013) Assessing toxicity in Daphnia magna : an oxidative lipidomic approach. 
Doctoral thesis, University of Birmingham. 
Williams, T., Turan, N., Diab, A., Wu, H., Mackenzie, C., Bartie, K., Hrydziuszko, O., 
Lyons, B., Stentiford, G., Herbert, J., Abraham, J., Katsiadaki, I., Leaver, M., Taggart, J., 
George, S., Viant, M., Chipman, K., Falciani, F. (2011) Towards a system level 
understanding of non-model organisms sampled from the environment: a network biology 
approach. PLoS Computational Biology, 7 (8): e1002126 
  
220 
 
Wise, B., Gallagher, N., Bro, R., Shaver, J., Windig, W. and Koch, R. (2007) PLS Toolbox 
4.0. Eigenvector Research Incorporated, 3905. 
Wood, C. (1999) Physiology and modeling of mechanisms of silver uptake and toxicity in 
fish. Environmental Toxicology and Chemistry, 18 (1): 71–83 
Wu, H., Southam, A., Hines, A., Viant, M. (2008) High-throughput tissue extraction 
protocol for NMR- and MS-based metabolomics. Analytical Biochemistry, 372 (2): 204–
12 
Xia, J., Mandal, R., Sinelnikov, I., Broadhurst, D., Wishart, D. (2012) MetaboAnalyst 2.0-
-a comprehensive server for metabolomic data analysis. Nucleic Acids Research, 40 (Web 
Server issue): W127–33 
Xia, J. and Wishart, D. (2010) MetPA: a web-based metabolomics tool for pathway 
analysis and visualization. Bioinformatics, 26 (18): 2342–4 
Yang, X., Gondikas, A., Marinakos, S., Auffan, M., Liu, J., Hsu-Kim, H., Meyer, J. (2012) 
Mechanism of silver nanoparticle toxicity is dependent on dissolved silver and surface 
coating in Caenorhabditis elegans. Environmental Science & Technology, 46 (2): 1119–27 
Yoshimaru, T., Suzuki, Y., Inoue, T., Niide, O., Ra, C. (2006) Silver activates mast cells 
through reactive oxygen species production and a thiol-sensitive store-independent Ca2+ 
influx. Free Radical Biology and Medicine, 40 (11): 1949–1959 
Yudkin, J. (1937) The effect of silver ions on some enzymes of Bacterium coli. 
Enzymologia, 2: 161–170 
Zhao, C.-M. and Wang, W.-X. (2010) Biokinetic uptake and efflux of silver nanoparticles 
in Daphnia magna. Environmental Science & Technology, 44 (19): 7699–704 
  
221 
 
Zhao, C.-M. and Wang, W.-X. (2011) Comparison of acute and chronic toxicity of silver 
nanoparticles and silver nitrate to Daphnia magna. Environmental Toxicology and 
Chemistry, 30 (4): 885–92 
Zhao, C.-M. and Wang, W.-X. (2012a) Importance of surface coatings and soluble silver 
in silver nanoparticles toxicity to Daphnia magna. Nanotoxicology, 6 (4): 361–70 
Zhao, C.-M. and Wang, W.-X. (2012b) Size-dependent uptake of silver nanoparticles in 
Daphnia magna. Environmental Science & Technology, 46 (20): 11345–51 
Zhao, C.-M. and Wang, W.-X. (2013) Regulation of sodium and calcium in Daphnia 
magna exposed to silver nanoparticles. Environmental Toxicology and Chemistry, 32 (4): 
913–9 
Zhao, F., Zhao, Y., Liu, Y., Chang, X., Chen, C., Zhao, Y. (2011) Cellular uptake, 
intracellular trafficking, and cytotoxicity of nanomaterials. Small, 7 (10): 1322–1337 
  
222 
 
Chapter 9: Appendix 
9.1 Mean measured total Ag concentrations following separation of dissolved Ag 
and AgNP 
Data in this section is relevant to data reported in Chapter 3, Section 3.3.3.   
Table 9.1: Mean total Ag concentrations ± SD following separation of AgNP suspensions into 
the dissolved and nanoparticle fractions by ultracentrifugation at 0 h, 24 h and 48 h after initial 
dispersal.  A two-way ANOVA with Sidak’s comparison test determined that total silver 
concentration was significantly different (p<0.0001) between the dissolved and nanoparticle 
fractions, but did not change significantly over time (p=0.2101).  
  Total Ag conc. (µg/l) 
Time point (h) 0 24 48 
Dissolved Ag 2.51 ± 0.42 2.15 ± 0.19 1.96 ± 0.13 
AgNP 0.28 ± 0.14 0.46 ± 0.22 0.29 ± 0.15 
 
Table 9.2: Mean total Ag concentrations ± SD following separation of AgNP suspensions into 
the dissolved and nanoparticle fractions by ultrafiltration at 0 h, 24 h and 48 h after initial 
dispersal. A two-way ANOVA with Sidak’s comparison test determined that total silver 
concentration was significantly different (p<0.0001) between the dissolved and nanoparticle 
fractions, and the AgNP fraction only was deemed to change significantly over time (p=0.0089). 
  Total Ag conc. (µg/l) 
Time point (h) 0 24 48 
Dissolved Ag 0.15 ± 0.04 0.19 ± 0.11 0.26 ± 0.23 
AgNP 3.52 ± 0.19 3.07 ± 0.1 2.70 ± 0.18 
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9.2 Lists of m/z peaks and putative IDs used for calibration in negative ion mode 
Table 9.3: List of m/z values and putative annotation used for calibration of D. magna polar MS 
spectra in negative ion mode reported in Chapter 4. 
Empirical 
Formula 
Ion form m/z 
C3H6O3 [M+Cl]
- 125.0010 
H3O4P [M+Cl]
- 132.9463 
H3O4P [M+(
37Cl)]- 134.9434 
C6H14N4O2 [M-H]
- 173.1045 
C5H10O5 [M+Hac-H]
- 209.0669 
C6H14N4O2 [M+Cl]
- 209.0814 
C6H13NO5 [M+Cl]
- 214.0489 
C6H12O6 [M+Cl]
- 215.0330 
C18H32O16 [M+Cl]
- 539.1387 
C18H32O16 [M+(
37Cl)]- 541.1358 
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9.3 Mortality data for sub-lethal toxicity exposures  
Table 9.4: Number of mortalities occurring in each treatment group over the 24 h exposure period prior to transcriptomics and metabolomic 
analyses in Chapter 4. 
Treatment group 
Nominal total 
Ag conc. (µg/l) 
Neonates 
per replicate 
Replicates 
Total 
neonates per 
treatment 
Total 
mortalities per 
treatment 
Remaining 
replicates 
Untreated control 0.00 30 6 180 0 6 
PVP control 0.00 30 6 180 0 6 
Bulk silver control 4.70 30 6 180 0 6 
AgNP High 4.70 30 8 240 106 4 
AgNP Mid 2.35 30 6 180 21 5 
AgNP Low 1.18 30 6 180 0 6 
AgNP V Low 0.59 30 6 180 0 6 
Ag High 0.28 30 6 180 0 6 
Ag Mid 0.14 30 6 180 0 6 
Ag Low 0.07 30 6 180 0 6 
Ag V Low 0.04 30 6 180 0 6 
Ag Filtrate - 30 6 180 0 6 
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Table 9.5: Number of mortalities occurring in each treatment group over the 24 h exposure period prior to RTt-qPCR analysis in Chapter 6. 
Treatment group 
Nominal total 
Ag conc. (µg/l) 
Neonates per 
replicate 
Replicates 
Total neonates 
per treatment 
Total 
mortalities per 
treatment 
Remaining 
replicates 
Untreated 
control 
0 10 5 50 0 5 
AgNP Mid 2.35 10 5 50 50 0 
AgNP Low 1.18 10 5 50 22 3 
Ag Mid 0.14 10 5 50 0 5 
Ag Low 0.07 10 5 50 0 5 
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9.4 Tables of annotated variables that change significantly in intensity in response to AgNP and Ag+ exposure  
Table 9.6: List of significantly changing gene-spots with putative human analogue Ensembl gene IDs reported in Chapter 5.  P-values are included 
after correcting for the multiple-testing hypothesis. FC AgNP refers to the fold increase as calculated for the AgNP High group. 
Observed  Statistics   Ensemble: Human Orthologues 
Gene ID  P-value FC AgNP High   
Human Ensembl 
gene code 
Human 
Symbol Putative Human Function  
DM00071  0.00000 3.4743   ENSG00000109971 HSPA8 heat shock 70kDa protein 8 
DM01384  0.00000 0.4075   ENSG00000159640 ACE 
angiotensin I converting enzyme 
(peptidyl-dipeptidase A) 1 
DM03092  0.00001 6.5768   ENSG00000064703 DDX20 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 20 
DM02355  0.00001 3.9502   ENSG00000157326 DHRS4 
dehydrogenase/reductase (SDR 
family) member 4 
DM04280  0.00001 0.6873   ENSG00000100902 PSMA6 
proteasome (prosome, macropain) 
subunit, alpha type, 6 
DM05899  0.00001 0.2121   ENSG00000119471 HSDL2 hydroxysteroid dehydrogenase like 2 
DM01056  0.00001 3.1685   ENSG00000155016 CYP2U1 
cytochrome P450, family 2, 
subfamily U, polypeptide 1 
DM02516  0.00002 0.4515   ENSG00000067167 TRAM1 
translocation associated membrane 
protein 1 
DM04714  0.00002 2.9871   ENSG00000003436 TFPI 
tissue factor pathway inhibitor 
(lipoprotein-associated coagulation 
inhibitor) 
DM12060  0.00002 0.5487   ENSG00000185420 SMYD3 SET and MYND domain containing 3 
DM01303  0.00002 0.4776   ENSG00000187546 AGMO alkylglycerol monooxygenase 
DM03602  0.00003 0.6865   ENSG00000108479 GALK1 galactokinase 1 
DM12557  0.00003 0.6622   ENSG00000167740 CYB5D2 cytochrome b5 domain containing 2 
DM02250  0.00003 0.6092   ENSG00000178537 SLC25A20 
solute carrier family 25 
(carnitine/acylcarnitine translocase), 
member 20 
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DM02371  0.00003 0.3549   ENSG00000161544 CYGB cytoglobin 
DM03493  0.00003 1.7435   ENSG00000174684 B3GNT1 
UDP-GlcNAc:betaGal beta-1,3-N-
acetylglucosaminyltransferase 1 
DM01371  0.00003 0.6477   ENSG00000205323 SARNP 
SAP domain containing 
ribonucleoprotein 
DM06641  0.00004 2.8733   ENSG00000003436 TFPI 
tissue factor pathway inhibitor 
(lipoprotein-associated coagulation 
inhibitor) 
DM05885  0.00004 0.6029   ENSG00000182551 ADI1 acireductone dioxygenase 1 
DM03367  0.00005 1.4806   ENSG00000103647 CORO2B coronin, actin binding protein, 2B 
DM10805  0.00007 0.7180   ENSG00000157326 DHRS4 
dehydrogenase/reductase (SDR 
family) member 4 
DM00456  0.00007 2.3591   ENSG00000115758 ODC1 ornithine decarboxylase 1 
DM00027  0.00007 0.5642   ENSG00000071894 CPSF1 
cleavage and polyadenylation 
specific factor 1, 160kDa 
DM03119  0.00007 1.5733   ENSG00000166140 ZFYVE19 
zinc finger, FYVE domain containing 
19 
DM05446  0.00007 0.5743   ENSG00000136783 NIPSNAP3A nipsnap homolog 3A (C. elegans) 
DM01260  0.00008 1.9029   ENSG00000134250 NOTCH2 notch 2 
DM02432  0.00010 3.0783   ENSG00000003436 TFPI 
tissue factor pathway inhibitor 
(lipoprotein-associated coagulation 
inhibitor) 
DM05927  0.00010 1.5919   ENSG00000151458 ANKRD50 ankyrin repeat domain 50 
DM05852  0.00011 1.7372   ENSG00000138764 CCNG2 cyclin G2 
DM02266  0.00012 0.5420   ENSG00000142606 MMEL1 
membrane metallo-endopeptidase-
like 1 
DM04755  0.00012 0.6413   ENSG00000137486 ARRB1 arrestin, beta 1 
DM11586  0.00013 0.6439   ENSG00000242485 MRPL20 mitochondrial ribosomal protein L20 
DM05408  0.00013 0.2412   ENSG00000075035 WSCD2 WSC domain containing 2 
DM00376  0.00022 2.4874   ENSG00000115159 GPD2 
glycerol-3-phosphate dehydrogenase 
2 (mitochondrial) 
DM09960  0.00025 1.5097   ENSG00000132669 RIN2 Ras and Rab interactor 2 
DM02468  0.00025 0.6631   ENSG00000094841 UPRT 
uracil phosphoribosyltransferase 
(FUR1) homolog (S. cerevisiae) 
  
228 
 
DM02494  0.00026 0.7962   ENSG00000149177 PTPRJ 
protein tyrosine phosphatase, 
receptor type, J 
DM11264  0.00026 0.6574   ENSG00000111713 GYS2 glycogen synthase 2 (liver) 
DM02335  0.00027 0.6839   ENSG00000254772 EEF1G 
eukaryotic translation elongation 
factor 1 gamma 
DM00069  0.00029 1.7820   ENSG00000145284 SCD5 stearoyl-CoA desaturase 5 
DM04140  0.00035 0.6427   ENSG00000099991 CABIN1 calcineurin binding protein 1 
DM03961  0.00040 3.9691   ENSG00000115758 ODC1 ornithine decarboxylase 1 
DM00952  0.00043 1.9785   ENSG00000133063 CHIT1 chitinase 1 (chitotriosidase) 
DM05995  0.00046 3.5313   ENSG00000115758 ODC1 ornithine decarboxylase 1 
DM03816  0.00048 1.8132   ENSG00000164684 ZNF704 zinc finger protein 704 
DM00562  0.00055 0.3695   ENSG00000175550 DRAP1 
DR1-associated protein 1 (negative 
cofactor 2 alpha) 
DM02393  0.00057 3.8465   ENSG00000109971 HSPA8 heat shock 70kDa protein 8 
DM09969  0.00057 0.6957   ENSG00000100243 CYB5R3 cytochrome b5 reductase 3 
DM11923  0.00057 0.4722   ENSG00000128274 A4GALT alpha 1,4-galactosyltransferase 
DM01236  0.00069 2.0997   ENSG00000133063 CHIT1 chitinase 1 (chitotriosidase) 
DM02379  0.00069 0.7852   ENSG00000108591 DRG2 
developmentally regulated GTP 
binding protein 2 
DM04460  0.00071 1.7384   ENSG00000163629 PTPN13 
protein tyrosine phosphatase, non-
receptor type 13 (APO-1/CD95 
(Fas)-associated phosphatase) 
DM04081  0.00071 0.2714   ENSG00000167972 ABCA3 
ATP-binding cassette, sub-family A 
(ABC1), member 3 
DM15042  0.00072 0.6538   ENSG00000183077 AFMID arylformamidase 
DM02966  0.00072 0.7871   ENSG00000259494 MRPL46 mitochondrial ribosomal protein L46 
DM03524  0.00080 0.7412   ENSG00000189091 SF3B3 splicing factor 3b, subunit 3, 130kDa 
DM01093  0.00092 0.6413   ENSG00000072042 RDH11 
retinol dehydrogenase 11 (all-
trans/9-cis/11-cis) 
DM14267  0.00092 2.0238   ENSG00000134398 ERN2 
endoplasmic reticulum to nucleus 
signaling 2 
DM00345  0.00100 1.6183   ENSG00000198650 TAT tyrosine aminotransferase 
DM02147  0.00101 0.6576   ENSG00000066926 FECH ferrochelatase 
DM09632  0.00108 1.8781   ENSG00000031823 RANBP3 RAN binding protein 3 
DM12494  0.00118 2.7924   ENSG00000105321 CCDC9 coiled-coil domain containing 9 
  
229 
 
DM00720  0.00130 1.3355   ENSG00000185100 ADSSL1 adenylosuccinate synthase like 1 
DM02970  0.00137 0.3504   ENSG00000189058 APOD apolipoprotein D 
DM08384  0.00137 3.5998   ENSG00000174469 CNTNAP2 contactin associated protein-like 2 
DM14638  0.00142 0.6788   ENSG00000172922 RNASEH2C ribonuclease H2, subunit C 
DM12851  0.00143 0.7374   ENSG00000131795 RBM8A RNA binding motif protein 8A 
DM00035  0.00150 0.2480   ENSG00000033050 ABCF2 
ATP-binding cassette, sub-family F 
(GCN20), member 2 
DM08209  0.00150 1.8361   ENSG00000115159 GPD2 
glycerol-3-phosphate dehydrogenase 
2 (mitochondrial) 
DM01101  0.00154 1.4681   ENSG00000167972 ABCA3 
ATP-binding cassette, sub-family A 
(ABC1), member 3 
DM01736  0.00154 0.8078   ENSG00000136238 RAC1 
ras-related C3 botulinum toxin 
substrate 1 (rho family, small GTP 
binding protein Rac1) 
DM07379  0.00156 0.5620   ENSG00000113369 ARRDC3 arrestin domain containing 3 
DM00278  0.00167 0.6331   ENSG00000168002 POLR2G 
polymerase (RNA) II (DNA directed) 
polypeptide G 
DM01270  0.00185 3.7642   ENSG00000115758 ODC1 ornithine decarboxylase 1 
DM01416  0.00188 0.7152   ENSG00000105323 HNRNPUL1 
heterogeneous nuclear 
ribonucleoprotein U-like 1 
DM05158  0.00192 0.7594   ENSG00000184719 RNLS 
renalase, FAD-dependent amine 
oxidase 
DM11181  0.00192 1.4593   ENSG00000142459 EVI5L ecotropic viral integration site 5-like 
DM05670  0.00205 1.4628   ENSG00000110172 CHORDC1 
cysteine and histidine-rich domain 
(CHORD) containing 1 
DM01911  0.00206 2.6526   ENSG00000003436 TFPI 
tissue factor pathway inhibitor 
(lipoprotein-associated coagulation 
inhibitor) 
DM06071  0.00219 2.4197   ENSG00000161011 SQSTM1 sequestosome 1 
DM00320  0.00222 1.3789   ENSG00000124766 SOX4 
SRY (sex determining region Y)-box 
4 
DM09628  0.00222 1.7530   ENSG00000198355 PIM3 pim-3 oncogene 
DM02562  0.00250 1.6677   ENSG00000163399 ATP1A1 
ATPase, Na+/K+ transporting, alpha 
1 polypeptide 
DM03699  0.00250 1.3408   ENSG00000078098 FAP fibroblast activation protein, alpha 
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DM05812  0.00250 2.2108   ENSG00000167107 ACSF2 
acyl-CoA synthetase family member 
2 
DM09238  0.00250 3.6838   ENSG00000116690 PRG4 proteoglycan 4 
DM06700  0.00251 1.4004   ENSG00000198355 PIM3 pim-3 oncogene 
DM06034  0.00257 0.5968   ENSG00000187021 PNLIPRP1 pancreatic lipase-related protein 1 
DM03922  0.00268 0.5584   ENSG00000133884 DPF2 
D4, zinc and double PHD fingers 
family 2 
DM08519  0.00268 0.3507   ENSG00000186897 C1QL4 
complement component 1, q 
subcomponent-like 4 
DM02678  0.00284 0.7231   ENSG00000167553 TUBA1C tubulin, alpha 1c 
DM14232  0.00303 0.6694   ENSG00000136783 NIPSNAP3A nipsnap homolog 3A (C. elegans) 
DM00310  0.00318 0.6772   ENSG00000143870 PDIA6 
protein disulfide isomerase family A, 
member 6 
DM06413  0.00323 1.5949   ENSG00000171916 LGALS9C 
lectin, galactoside-binding, soluble, 
9C 
DM12561  0.00328 0.6833   ENSG00000177830 CHID1 chitinase domain containing 1 
DM01880  0.00341 1.8506   ENSG00000111405 ENDOU endonuclease, polyU-specific 
DM05671  0.00352 2.2624   ENSG00000115159 GPD2 
glycerol-3-phosphate dehydrogenase 
2 (mitochondrial) 
DM02765  0.00355 0.7735   ENSG00000116171 SCP2 sterol carrier protein 2 
DM05908  0.00367 0.6004   ENSG00000137413 TAF8 
TAF8 RNA polymerase II, TATA box 
binding protein (TBP)-associated 
factor, 43kDa 
DM01420  0.00371 0.8060   ENSG00000109736 MFSD10 
major facilitator superfamily domain 
containing 10 
DM12081  0.00387 0.4370   ENSG00000146416 AIG1 androgen-induced 1 
DM04939  0.00388 2.1361   ENSG00000145284 SCD5 stearoyl-CoA desaturase 5 
DM04096  0.00414 0.7541   ENSG00000128918 ALDH1A2 
aldehyde dehydrogenase 1 family, 
member A2 
DM00781  0.00417 1.2590   ENSG00000129991 TNNI3 troponin I type 3 (cardiac) 
DM07815  0.00421 0.5645   ENSG00000198721 ECI2 enoyl-CoA delta isomerase 2 
DM01388  0.00424 0.8393   ENSG00000198876 DCAF12 
DDB1 and CUL4 associated factor 
12 
DM03781  0.00436 0.6683   ENSG00000115593 SMYD1 SET and MYND domain containing 1 
DM00602  0.00452 1.2076   ENSG00000123933 MXD4 MAX dimerization protein 4 
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DM05074  0.00454 0.6283   ENSG00000106392 C1GALT1 
core 1 synthase, glycoprotein-N-
acetylgalactosamine 3-beta-
galactosyltransferase, 1 
DM09447  0.00454 1.4681   ENSG00000139970 RTN1 reticulon 1 
DM10991  0.00459 3.3813   ENSG00000100003 SEC14L2 SEC14-like 2 (S. cerevisiae) 
DM02885  0.00473 3.7623   ENSG00000134716 CYP2J2 
cytochrome P450, family 2, 
subfamily J, polypeptide 2 
DM05652  0.00486 0.3468   ENSG00000166321 NUDT13 
nudix (nucleoside diphosphate linked 
moiety X)-type motif 13 
DM09366  0.00508 1.4645   ENSG00000141568 FOXK2 forkhead box K2 
DM12655  0.00513 5.1607   ENSG00000158457 TSPAN33 tetraspanin 33 
DM00273  0.00521 0.5957   ENSG00000196367 TRRAP 
transformation/transcription domain-
associated protein 
DM03467  0.00536 0.6592   ENSG00000185630 PBX1 pre-B-cell leukemia homeobox 1 
DM10733  0.00537 0.8482   ENSG00000144021 CIAO1 
cytosolic iron-sulfur protein assembly 
1 
DM05824  0.00538 3.3987   ENSG00000166579 NDEL1 
nudE nuclear distribution E homolog 
(A. nidulans)-like 1 
DM03365  0.00577 1.7260   ENSG00000134597 RBMX2 RNA binding motif protein, X-linked 2 
DM00183  0.00587 0.8556   ENSG00000174611 KY kyphoscoliosis peptidase 
DM04796  0.00630 0.7763   ENSG00000105323 HNRNPUL1 
heterogeneous nuclear 
ribonucleoprotein U-like 1 
DM03103  0.00631 0.6805   ENSG00000131368 MRPS25 mitochondrial ribosomal protein S25 
DM06307  0.00643 0.6628   ENSG00000103275 UBE2I ubiquitin-conjugating enzyme E2I 
DM05946  0.00648 0.5949   ENSG00000146070 PLA2G7 
phospholipase A2, group VII 
(platelet-activating factor 
acetylhydrolase, plasma) 
DM05988  0.00648 0.7258   ENSG00000067829 IDH3G 
isocitrate dehydrogenase 3 (NAD+) 
gamma 
DM04366  0.00651 1.7302   ENSG00000155016 CYP2U1 
cytochrome P450, family 2, 
subfamily U, polypeptide 1 
DM03797  0.00670 0.5019   ENSG00000184674 GSTT1 glutathione S-transferase theta 1 
DM01908  0.00756 2.8001   ENSG00000185432 METTL7A methyltransferase like 7A 
DM00756  0.00773 1.7984   ENSG00000183569 SERHL2 serine hydrolase-like 2 
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DM09398  0.00776 0.3835   ENSG00000065000 AP3D1 
adaptor-related protein complex 3, 
delta 1 subunit 
DM02669  0.00783 0.7745   ENSG00000105664 COMP cartilage oligomeric matrix protein 
DM03384  0.00789 0.6022   ENSG00000155189 AGPAT5 
1-acylglycerol-3-phosphate O-
acyltransferase 5 
DM03709  0.00801 1.7615   ENSG00000226589 VARS valyl-tRNA synthetase 
DM01455  0.00807 0.6682   ENSG00000004700 RECQL 
RecQ protein-like (DNA helicase Q1-
like) 
DM00040  0.00808 0.6637   ENSG00000104774 MAN2B1 
mannosidase, alpha, class 2B, 
member 1 
DM00814  0.00822 1.4942   ENSG00000076685 NT5C2 5'-nucleotidase, cytosolic II 
DM03658  0.00843 6.4938   ENSG00000164344 KLKB1 
kallikrein B, plasma (Fletcher factor) 
1 
DM01074  0.00851 1.7454   ENSG00000197763 TXNRD3 thioredoxin reductase 3 
DM00339  0.00852 0.7378   ENSG00000198947 DMD dystrophin 
DM03428  0.00857 2.4011   ENSG00000119396 RAB14 
RAB14, member RAS oncogene 
family 
DM03819  0.00857 2.0453   ENSG00000100003 SEC14L2 SEC14-like 2 (S. cerevisiae) 
DM06039  0.00895 0.5742   ENSG00000108784 NAGLU N-acetylglucosaminidase, alpha 
DM00614  0.00904 0.7319   ENSG00000168872 DDX19A 
DEAD (Asp-Glu-Ala-Asp) box 
polypeptide 19A 
DM01731  0.00930 1.8245   ENSG00000198886 MT-ND4 
mitochondrially encoded NADH 
dehydrogenase 4 
DM05720  0.00930 0.2438   ENSG00000112077 RHAG Rh-associated glycoprotein 
DM02909  0.00934 0.7466   ENSG00000132485 ZRANB2 
zinc finger, RAN-binding domain 
containing 2 
DM03081  0.00941 1.3132   ENSG00000115828 QPCT glutaminyl-peptide cyclotransferase 
DM05126  0.00941 0.5954   ENSG00000160282 FTCD 
formiminotransferase 
cyclodeaminase 
DM03475  0.00944 0.5008   ENSG00000115875 SRSF7 serine/arginine-rich splicing factor 7 
DM08925  0.00974 0.6897   ENSG00000142655 PEX14 peroxisomal biogenesis factor 14 
DM02019  0.00988 0.3276   ENSG00000120053 GOT1 
glutamic-oxaloacetic transaminase 1, 
soluble (aspartate aminotransferase 
1) 
DM05560  0.01010 0.7534   ENSG00000108797 CNTNAP1 contactin associated protein 1 
DM02525  0.01050 0.7949   ENSG00000184270 HIST2H2AB histone cluster 2, H2ab 
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DM05163  0.01070 1.8849   ENSG00000178445 GLDC 
glycine dehydrogenase 
(decarboxylating) 
DM12100  0.01100 1.6479   ENSG00000072310 SREBF1 
sterol regulatory element binding 
transcription factor 1 
DM11844  0.01110 0.8117   ENSG00000100815 TRIP11 
thyroid hormone receptor interactor 
11 
DM00943  0.01120 1.5845   ENSG00000110047 EHD1 EH-domain containing 1 
DM05392  0.01120 3.5749   ENSG00000167107 ACSF2 
acyl-CoA synthetase family member 
2 
DM06233  0.01120 0.7756   ENSG00000162928 PEX13 peroxisomal biogenesis factor 13 
DM05985  0.01140 2.0461   ENSG00000167671 UBXN6 UBX domain protein 6 
DM05947  0.01150 0.1584   ENSG00000130508 PXDN peroxidasin homolog (Drosophila) 
DM11143  0.01200 1.3378   ENSG00000171603 CLSTN1 calsyntenin 1 
DM02065  0.01210 1.2674   ENSG00000044574 HSPA5 
heat shock 70kDa protein 5 
(glucose-regulated protein, 78kDa) 
DM00032  0.01280 1.3250   ENSG00000084110 HAL histidine ammonia-lyase 
DM03339  0.01310 0.7243   ENSG00000124098 FAM210B 
family with sequence similarity 210, 
member B 
DM00992  0.01340 2.6057   ENSG00000163982 OTOP1 otopetrin 1 
DM00259  0.01370 4.1704   ENSG00000158552 ZFAND2B zinc finger, AN1-type domain 2B 
DM09286  0.01410 1.7400   ENSG00000151726 ACSL1 
acyl-CoA synthetase long-chain 
family member 1 
DM00547  0.01440 2.3924   ENSG00000178896 EXOSC4 exosome component 4 
DM01392  0.01440 0.3464   ENSG00000133063 CHIT1 chitinase 1 (chitotriosidase) 
DM04518  0.01440 3.6908   ENSG00000175567 UCP2 
uncoupling protein 2 (mitochondrial, 
proton carrier) 
DM04572  0.01440 0.7092   ENSG00000126777 KTN1 kinectin 1 (kinesin receptor) 
DM00569  0.01450 2.3902   ENSG00000065526 SPEN 
spen homolog, transcriptional 
regulator (Drosophila) 
DM03695  0.01470 2.7305   ENSG00000130856 ZNF236 zinc finger protein 236 
DM09474  0.01500 1.5888   ENSG00000092295 TGM1 
transglutaminase 1 (K polypeptide 
epidermal type I, protein-glutamine-
gamma-glutamyltransferase) 
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DM00617  0.01510 1.1574   ENSG00000091664 SLC17A6 
solute carrier family 17 (sodium-
dependent inorganic phosphate 
cotransporter), member 6 
DM03451  0.01510 0.6833   ENSG00000030582 GRN granulin 
DM01960  0.01520 3.2948   ENSG00000109971 HSPA8 heat shock 70kDa protein 8 
DM00744  0.01560 0.7250   ENSG00000077097 TOP2B topoisomerase (DNA) II beta 180kDa 
DM02429  0.01580 2.1818   ENSG00000151692 RNF144A ring finger protein 144A 
DM08720  0.01580 0.6490   ENSG00000160200 CBS cystathionine-beta-synthase 
DM05292  0.01600 0.6014   ENSG00000147485 PXDNL 
peroxidasin homolog (Drosophila)-
like 
DM05304  0.01600 0.8035   ENSG00000103091 WDR59 WD repeat domain 59 
DM10155  0.01600 1.2110   ENSG00000118263 KLF7 Kruppel-like factor 7 (ubiquitous) 
DM05806  0.01610 0.3293   ENSG00000105404 RABAC1 Rab acceptor 1 (prenylated) 
DM01520  0.01620 0.5384   ENSG00000143933 CALM2 
calmodulin 2 (phosphorylase kinase, 
delta) 
DM01477  0.01670 0.8266   ENSG00000108852 MPP2 
membrane protein, palmitoylated 2 
(MAGUK p55 subfamily member 2) 
DM04687  0.01680 1.2811   ENSG00000165591 FAAH2 fatty acid amide hydrolase 2 
DM14363  0.01710 0.7894   ENSG00000203837 PNLIPRP3 pancreatic lipase-related protein 3 
DM00674  0.01730 0.8392   ENSG00000111596 CNOT2 
CCR4-NOT transcription complex, 
subunit 2 
DM03815  0.01740 0.5297   ENSG00000064651 SLC12A2 
solute carrier family 12 
(sodium/potassium/chloride 
transporters), member 2 
DM00530  0.01750 0.7300   ENSG00000147082 CCNB3 cyclin B3 
DM01805  0.01750 0.7357   ENSG00000213619 NDUFS3 
NADH dehydrogenase (ubiquinone) 
Fe-S protein 3, 30kDa (NADH-
coenzyme Q reductase) 
DM10996  0.01750 0.5632   ENSG00000140395 WDR61 WD repeat domain 61 
DM05804  0.01830 2.2211   ENSG00000149554 CHEK1 checkpoint kinase 1 
DM03096  0.01860 1.4295   ENSG00000241685 ARPC1A 
actin related protein 2/3 complex, 
subunit 1A, 41kDa 
DM02745  0.01880 1.6944   ENSG00000198682 PAPSS2 
3'-phosphoadenosine 5'-
phosphosulfate synthase 2 
DM01821  0.01970 1.2436   ENSG00000138279 ANXA7 annexin A7 
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DM01875  0.02000 1.3462   ENSG00000151726 ACSL1 
acyl-CoA synthetase long-chain 
family member 1 
DM02090  0.02030 0.7083   ENSG00000115042 FAHD2A 
fumarylacetoacetate hydrolase 
domain containing 2A 
DM01347  0.02050 1.1305   ENSG00000213614 HEXA 
hexosaminidase A (alpha 
polypeptide) 
DM11028  0.02050 0.7818   LRG_75 IRAK4 
interleukin-1 receptor-associated 
kinase 4 
DM02091  0.02090 1.3297   ENSG00000182149 IST1 
increased sodium tolerance 1 
homolog (yeast) 
DM05080  0.02110 1.4501   ENSG00000165985 C1QL3 
complement component 1, q 
subcomponent-like 3 
DM00759  0.02120 1.2840   ENSG00000105220 GPI glucose-6-phosphate isomerase 
DM10960  0.02130 5.4013   ENSG00000186212 SOWAHB 
sosondowah ankyrin repeat domain 
family member B 
DM01820  0.02150 0.6506   ENSG00000166311 SMPD1 
sphingomyelin phosphodiesterase 1, 
acid lysosomal 
DM04083  0.02150 0.7963   ENSG00000173566 NUDT18 
nudix (nucleoside diphosphate linked 
moiety X)-type motif 18 
DM06245  0.02150 1.6354   ENSG00000142606 MMEL1 
membrane metallo-endopeptidase-
like 1 
DM01624  0.02180 1.4893   ENSG00000168036 CTNNB1 
catenin (cadherin-associated 
protein), beta 1, 88kDa 
DM02684  0.02180 1.1872   ENSG00000100116 GCAT glycine C-acetyltransferase 
DM12738  0.02180 0.7614   ENSG00000013573 DDX11 
DEAD/H (Asp-Glu-Ala-Asp/His) box 
helicase 11 
DM04913  0.02200 1.4767   ENSG00000135407 AVIL advillin 
DM01030  0.02230 1.1823   ENSG00000114790 ARHGEF26 
Rho guanine nucleotide exchange 
factor (GEF) 26 
DM00546  0.02250 0.6590   ENSG00000156413 FUT6 
fucosyltransferase 6 (alpha (1,3) 
fucosyltransferase) 
DM10721  0.02280 0.6726   ENSG00000144848 ATG3 autophagy related 3 
DM00702  0.02300 0.5463   ENSG00000130508 PXDN peroxidasin homolog (Drosophila) 
DM06133  0.02300 0.5579   ENSG00000184674 GSTT1 glutathione S-transferase theta 1 
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DM00525  0.02360 0.8154   ENSG00000146426 TIAM2 
T-cell lymphoma invasion and 
metastasis 2 
DM00864  0.02360 0.5624   ENSG00000197894 ADH5 
alcohol dehydrogenase 5 (class III), 
chi polypeptide 
DM09002  0.02370 0.6354   ENSG00000116213 WRAP73 
WD repeat containing, antisense to 
TP73 
DM13877  0.02370 0.8008   ENSG00000168259 DNAJC7 
DnaJ (Hsp40) homolog, subfamily C, 
member 7 
DM05449  0.02390 5.2312   ENSG00000197601 FAR1 fatty acyl CoA reductase 1 
DM01979  0.02430 1.3491   ENSG00000137968 SLC44A5 solute carrier family 44, member 5 
DM12852  0.02430 1.8929   ENSG00000130508 PXDN peroxidasin homolog (Drosophila) 
DM06151  0.02490 0.4107   ENSG00000100241 SBF1 SET binding factor 1 
DM06053  0.02500 0.6146   ENSG00000140526 ABHD2 abhydrolase domain containing 2 
DM02027  0.02530 0.7880   ENSG00000103187 COTL1 coactosin-like 1 (Dictyostelium) 
DM11602  0.02530 0.5966   ENSG00000090273 NUDC 
nuclear distribution C homolog (A. 
nidulans) 
DM03430  0.02540 4.0099   ENSG00000175567 UCP2 
uncoupling protein 2 (mitochondrial, 
proton carrier) 
DM06999  0.02540 0.7439   ENSG00000076201 PTPN23 
protein tyrosine phosphatase, non-
receptor type 23 
DM02224  0.02570 0.7344   ENSG00000072163 LIMS2 
LIM and senescent cell antigen-like 
domains 2 
DM01291  0.02580 0.6272   ENSG00000072315 TRPC5 
transient receptor potential cation 
channel, subfamily C, member 5 
DM08804  0.02600 0.6633   ENSG00000108829 LRRC59 leucine rich repeat containing 59 
DM03652  0.02610 0.3232   ENSG00000125454 SLC25A19 
solute carrier family 25 
(mitochondrial thiamine 
pyrophosphate carrier), member 19 
DM08435  0.02610 0.7020   ENSG00000108561 C1QBP 
complement component 1, q 
subcomponent binding protein 
DM00977  0.02670 1.1959   ENSG00000187391 MAGI2 
membrane associated guanylate 
kinase, WW and PDZ domain 
containing 2 
DM10506  0.02690 2.0427   ENSG00000164181 ELOVL7 ELOVL fatty acid elongase 7 
DM04007  0.02710 0.5360   ENSG00000109790 KLHL5 kelch-like family member 5 
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DM02114  0.02760 0.5015   ENSG00000174100 MRPL45 mitochondrial ribosomal protein L45 
DM05601  0.02760 0.5002   ENSG00000124120 TTPAL 
tocopherol (alpha) transfer protein-
like 
DM10942  0.02790 1.5663   ENSG00000164494 PDSS2 
prenyl (decaprenyl) diphosphate 
synthase, subunit 2 
DM08652  0.02800 2.3691   ENSG00000100906 NFKBIA 
nuclear factor of kappa light 
polypeptide gene enhancer in B-cells 
inhibitor, alpha 
DM04383  0.02820 0.4924   ENSG00000114520 SNX4 sorting nexin 4 
DM12203  0.02850 0.7146   ENSG00000134216 CHIA chitinase, acidic 
DM00611  0.02870 0.6816   ENSG00000112357 PEX7 peroxisomal biogenesis factor 7 
DM01818  0.02910 1.1943   ENSG00000163041 H3F3A H3 histone, family 3A 
DM02257  0.02910 0.6360   ENSG00000225830 ERCC6 
excision repair cross-complementing 
rodent repair deficiency, 
complementation group 6 
DM02922  0.03030 1.3361   ENSG00000129151 BBOX1 
butyrobetaine (gamma), 2-
oxoglutarate dioxygenase (gamma-
butyrobetaine hydroxylase) 1 
DM10005  0.03090 0.5078   ENSG00000099901 RANBP1 RAN binding protein 1 
DM01395  0.03100 0.8492   ENSG00000113460 BRIX1 
BRX1, biogenesis of ribosomes, 
homolog (S. cerevisiae) 
DM12306  0.03110 1.3932   ENSG00000167107 ACSF2 
acyl-CoA synthetase family member 
2 
DM04392  0.03150 0.8824   ENSG00000126561 STAT5A 
signal transducer and activator of 
transcription 5A 
DM11804  0.03190 0.5956   ENSG00000148335 NTMT1 
N-terminal Xaa-Pro-Lys N-
methyltransferase 1 
DM03205  0.03220 2.5635   ENSG00000101333 PLCB4 phospholipase C, beta 4 
DM05399  0.03240 1.2646   ENSG00000166825 ANPEP alanyl (membrane) aminopeptidase 
DM01354  0.03280 1.0180   ENSG00000134255 CEPT1 
choline/ethanolamine 
phosphotransferase 1 
DM04942  0.03280 0.6358   ENSG00000196116 TDRD7 tudor domain containing 7 
DM00825  0.03330 0.7612   ENSG00000176658 MYO1D myosin ID 
DM02522  0.03330 1.2194   ENSG00000173812 EIF1 
eukaryotic translation initiation factor 
1 
DM04056  0.03360 0.6679   ENSG00000196547 MAN2A2 mannosidase, alpha, class 2A, 
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member 2 
DM11370  0.03360 3.2553   ENSG00000175115 PACS1 
phosphofurin acidic cluster sorting 
protein 1 
DM01693  0.03390 0.6056   ENSG00000109971 HSPA8 heat shock 70kDa protein 8 
DM07156  0.03430 0.7771   ENSG00000131018 SYNE1 
spectrin repeat containing, nuclear 
envelope 1 
DM02259  0.03480 0.2481   ENSG00000161544 CYGB cytoglobin 
DM05007  0.03480 0.8308   ENSG00000188603 CLN3 ceroid-lipofuscinosis, neuronal 3 
DM04586  0.03520 1.9758   ENSG00000006652 IFRD1 
interferon-related developmental 
regulator 1 
DM13920  0.03530 4.0838   ENSG00000129151 BBOX1 
butyrobetaine (gamma), 2-
oxoglutarate dioxygenase (gamma-
butyrobetaine hydroxylase) 1 
DM05006  0.03570 2.5752   ENSG00000107290 SETX senataxin 
DM02416  0.03580 0.5340   ENSG00000080819 CPOX coproporphyrinogen oxidase 
DM04009  0.03630 0.7202   ENSG00000099797 TECR trans-2,3-enoyl-CoA reductase 
DM12865  0.03630 3.2559   ENSG00000038219 BOD1L1 
biorientation of chromosomes in cell 
division 1-like 1 
DM06954  0.03670 0.8743   ENSG00000100644 HIF1A 
hypoxia inducible factor 1, alpha 
subunit (basic helix-loop-helix 
transcription factor) 
DM12393  0.03670 0.3965   ENSG00000115839 RAB3GAP1 
RAB3 GTPase activating protein 
subunit 1 (catalytic) 
DM01522  0.03710 0.6450   ENSG00000168522 FNTA 
farnesyltransferase, CAAX box, 
alpha 
DM05043  0.03710 2.0267   ENSG00000154646 TMPRSS15 transmembrane protease, serine 15 
DM01837  0.03760 0.5948   ENSG00000109971 HSPA8 heat shock 70kDa protein 8 
DM03456  0.03830 0.1695   ENSG00000136856 SLC2A8 
solute carrier family 2 (facilitated 
glucose transporter), member 8 
DM00042  0.03860 1.1277   ENSG00000185100 ADSSL1 adenylosuccinate synthase like 1 
DM05418  0.03870 1.9117   ENSG00000001084 GCLC 
glutamate-cysteine ligase, catalytic 
subunit 
DM11223  0.03870 1.7351   ENSG00000072803 FBXW11 
F-box and WD repeat domain 
containing 11 
DM10263  0.03880 1.1620   ENSG00000100003 SEC14L2 SEC14-like 2 (S. cerevisiae) 
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DM12082  0.03880 1.7198   ENSG00000130508 PXDN peroxidasin homolog (Drosophila) 
DM13482  0.03900 2.1348   ENSG00000067533 RRP15 
ribosomal RNA processing 15 
homolog (S. cerevisiae) 
DM01049  0.03970 0.7165   ENSG00000162613 FUBP1 
far upstream element (FUSE) 
binding protein 1 
DM08668  0.04000 1.7412   ENSG00000088826 SMOX spermine oxidase 
DM01024  0.04060 1.1780   ENSG00000145819 ARHGAP26 Rho GTPase activating protein 26 
DM09085  0.04070 1.6929   ENSG00000164181 ELOVL7 ELOVL fatty acid elongase 7 
DM00260  0.04090 2.1557   ENSG00000142168 SOD1 superoxide dismutase 1, soluble 
DM02382  0.04110 0.7867   ENSG00000111058 ACSS3 
acyl-CoA synthetase short-chain 
family member 3 
DM03031  0.04140 2.0241   ENSG00000162813 BPNT1 3'(2'), 5'-bisphosphate nucleotidase 1 
DM07644  0.04140 0.7879   ENSG00000062716 VMP1 vacuole membrane protein 1 
DM01043  0.04190 1.4569   ENSG00000173542 MOB1B MOB kinase activator 1B 
DM00597  0.04220 1.9817   ENSG00000178445 GLDC 
glycine dehydrogenase 
(decarboxylating) 
DM00728  0.04220 0.7212   ENSG00000175193 PARL presenilin associated, rhomboid-like 
DM00234  0.04310 0.8052   ENSG00000122545 39326 septin 7 
DM05727  0.04380 2.2515   ENSG00000125772 GPCPD1 
glycerophosphocholine 
phosphodiesterase GDE1 homolog 
(S. cerevisiae) 
DM00340  0.04420 0.6613   ENSG00000100836 PABPN1 poly(A) binding protein, nuclear 1 
DM01110  0.04420 3.6811   ENSG00000132437 DDC 
dopa decarboxylase (aromatic L-
amino acid decarboxylase) 
DM12380  0.04460 0.9633   ENSG00000151092 NGLY1 N-glycanase 1 
DM11440  0.04490 0.8970   ENSG00000140474 ULK3 unc-51-like kinase 3 (C. elegans) 
DM06069  0.04510 1.7856   ENSG00000127314 RAP1B 
RAP1B, member of RAS oncogene 
family 
DM01168  0.04520 0.7934   ENSG00000100321 SYNGR1 synaptogyrin 1 
DM09437  0.04520 1.4785   ENSG00000185100 ADSSL1 adenylosuccinate synthase like 1 
DM11378  0.04530 0.7715   ENSG00000072422 RHOBTB1 
Rho-related BTB domain containing 
1 
DM05084  0.04540 0.7196   ENSG00000091136 LAMB1 laminin, beta 1 
DM07213  0.04590 0.8237   ENSG00000135862 LAMC1 laminin, gamma 1 (formerly LAMB2) 
DM00469  0.04720 0.2671   ENSG00000161544 CYGB cytoglobin 
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DM04850  0.04780 0.7455   ENSG00000116260 QSOX1 quiescin Q6 sulfhydryl oxidase 1 
DM00780  0.04830 0.7994   ENSG00000120063 GNA13 
guanine nucleotide binding protein 
(G protein), alpha 13 
DM00932  0.04880 0.7501   ENSG00000183044 ABAT 4-aminobutyrate aminotransferase 
DM03407   0.04890 0.8409     ENSG00000104969 SGTA 
small glutamine-rich tetratricopeptide 
repeat (TPR)-containing, alpha 
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Table 9.7: List of significantly changing m/z peaks and their putative empirical formulae and KEGG names reported in Chapter 5.  P-values are 
included after correcting for the multiple testing hypothesis. FC AgNP refers to the fold increase as calculated for the AgNP High group. 
Observed  Statistics  Identification 
m/z  Adj. P-values 
FC AgNP 
High 
Loads 
Rank 
 Empirical 
formula  Ion form 
Neutral 
mass (Da) 
Mass 
error  KEGG Compound Names 
127.0167  0.001 0.813 761  C4H10O2 [M+K-2H]
-
 90.0681 -0.29 
['(R,R)-Butane-2,3-diol', '(S,S)-
Butane-2,3-diol'] 
127.0167  0.001 0.813 761  C3H8O3 [M+Cl]
-
 92.0473 -0.76 ['Glycerol'] 
129.0137  0.007 0.740 862  C3H8O3 [M+(
37
Cl)]
-
 92.0473 -0.75 ['Glycerol'] 
161.0456  0.015 1.744 339  C4H6O3 [M+Hac-H]
-
 102.0317 0.57 
['(S)-Methylmalonate 
semialdehyde', '2-Oxobutanoate', 
'Acetoacetate', 'Succinate 
semialdehyde'] 
193.0872  0.030 1.560 259  C9H10O [M+Hac-H]
-
 134.0732 0.89 ['Phenylacetone'] 
161.0456  0.015 1.744 339  C6H10O5 [M-H]
-
 162.0528 0.57 
['(2R,3S)-2,3-Dimethylmalate', '(R)-
2-Ethylmalate', '(R)-3,3-
Dimethylmalate', '(S)-2-
(Hydroxymethyl)glutarate', '1,5-
Anhydro-D-fructose', '2-Dehydro-3-
deoxy-D-fuconate', '2-Dehydro-3-
deoxy-L-fuconate', '2-Dehydro-3-
deoxy-L-rhamnonate', 'L-Fucono-
1,5-lactone', 'L-Rhamnono-1,4-
lactone'] 
239.0774  0.000 4.523 14  C6H12O6 [M+Hac-H]
-
 180.0634 0.65 
['D-Fructose', 'D-Fuconate', 'D-
Galactose', 'D-Glucose', 'D-
Mannose', 'D-Sorbose', 'D-
Tagatose', 'L-Fuconate', 'L-
Rhamnonate', 'L-Sorbose', 'alpha-
D-Glucose', 'beta-D-Glucose', 
'myo-Inositol'] 
249.0803  0.007 0.630 1185  C8H14O3S [M+Hac-H]
-
 190.0664 0.28 
['2-Oxo-7-methylthioheptanoic 
acid'] 
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239.0328  0.008 1.282 539  C12H10O4 [M+Na-2H]
-
 218.0579 0.8 ['4-Methylumbelliferyl acetate'] 
277.1115  0.007 0.775 1127  C10H18O3S [M+Hac-H]
-
 218.0977 0 ['2-Oxo-9-methylthiononanoic acid'] 
261.1077  0.000 1.300 750  C13H20O3 [M+(
37
Cl)]
-
 224.1412 0.05 ['(6S,9R)-Vomifoliol'] 
263.0092  0.000 1.865 135  C6H13O7P [M+Cl]
-
 228.0399 -0.36 
['(R)-4-Phosphopantoate', '(R)-5-
Phosphomevalonate'] 
261.0968  0.000 1.342 746  C10H16N4O3 [M+Na-2H]
-
 240.1222 -0.42 
['Homocarnosine', 'N(alpha)-
gamma-L-Glutamylhistamine', 
'beta-Alanyl-N(pi)-methyl-L-
histidine'] 
243.0624  0.025 1.531 133  C9H12N2O6 [M-H]
-
 244.0695 0.45 ['Uridine'] 
249.0803  0.007 0.630 1185  C10H18O5S [M-H]
-
 250.0875 0.28 
['2-(5-Methylthio)pentylmalic acid', 
'3-(5-Methylthio)pentylmalic acid'] 
266.0895  0.010 1.939 49  C10H13N5O4 [M-H]
-
 267.0968 0.23 ['Adenosine', 'Deoxyguanosine'] 
267.0735  0.008 4.127 1  C10H12N4O5 [M-H]
-
 268.0808 0.17 ['Inosine'] 
333.0591  0.001 1.711 157  C7H15O9P [M+Hac-H]
-
 274.0454 -0.29 
['1-Deoxy-D-altro-heptulose 7-
phosphate'] 
274.0391  0.000 1.759 203  C10H13NO6S [M-H]
-
 275.0464 0.06 ['L-Tyrosine methyl ester 4-sulfate'] 
277.1115  0.007 0.775 1127  C12H22O5S [M-H]
-
 278.1188 0 
['2-(7-Methylthio)heptylmalic acid', 
'3-(7-Methylthio)heptylmalic acid'] 
277.2173  0.019 1.929 46  C18H30O2 [M-H]
-
 278.2246 -0.01 
['(9Z,12Z,15Z)-Octadecatrienoic 
acid'] 
282.0844  0.000 2.373 44  C10H13N5O5 [M-H]
-
 283.0917 -0.01 ['Guanosine'] 
324.1582  0.006 1.150 457  C15H29NO4 [M+K-2H]
-
 287.2097 -0.08 ['L-Octanoylcarnitine'] 
329.1063  0.023 0.652 1253  C19H20N2O [M+K-2H]
-
 292.1576 0.46 ['Cinchonidinone', 'Cinchoninone'] 
349.0765  0.004 4.522 5  C12H16N4O7 [M+Na-2H]
-
 328.1019 -0.34 
['7-Hydroxy-6-methyl-8-ribityl 
lumazine'] 
328.0451  0.019 2.513 27  C10H12N5O6P [M-H]
-
 329.0525 -0.45 
["2',3-Cyclic AMP", "3',5-Cyclic 
AMP"] 
333.0591  0.001 1.711 157  C9H19O11P [M-H]
-
 334.0665 -0.29 
['2-(alpha-D-Galactosyl)-sn-
glycerol 3-phosphate', '2-(beta-D-
Glucosyl)-sn-glycerol 3-phosphate', 
"alpha-D-Galactosyl-(1,1')-sn-
glycerol 3-phosphate", 'sn-glycero-
3-Phospho-1-inositol'] 
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395.0420  0.006 1.463 314  C14H19N2O7P [M+K-2H]
-
 358.0930 0.89 
['N1-(5-Phospho-alpha-D-ribosyl)-
5,6-dimethylbenzimidazole'] 
483.1833  0.000 1.779 213  C16H28N2O11 [M+Hac-H]
-
 424.1693 0.26 ['Chitobiose'] 
530.0613  0.000 2.554 112  C15H23N5O10P2 [M+Cl]
-
 495.0920 -0.29 
['Isopentenyladenosine-5-
diphosphate'] 
563.1831  0.000 4.086 10  C18H32O16 [M+Hac-H]
-
 504.1690 0.44 
['Cellotriose', 'D-Gal alpha 1->6D-
Gal alpha 1->6D-Glucose', 
'Raffinose'] 
 
